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Foreword
Providing health care is among the most complex and risky activities carried out in the world. Each person and their circumstances are unique; care is delivered by frontline staff often working in teams 
and in many different settings, supported by teams of managerial and administrative staff, and using 
complex technologies. The outcomes for patients that materialise depend on a multitude of factors 
that relate to the context of care delivery; for example, the quality of the interactions between staff 
and patient, established practice, national and local initiatives designed to improve care, and the mix of 
financial and non-financial incentives at play. The task of the evaluator hoping to assess accurately the 
impact of a programme or initiative is to understand how interventions interact with this surrounding 
context. As many have stated before, ‘intervention plus context equals outcome’.1 And, the more complex 
an intervention is, the more likely context is to influence outcome.
This volume brings together contributions of leading thinkers to present a ‘state of the art’ in the 
evaluation of complex interventions. It is clear from the contributions in many essays that the task of 
evaluating complex interventions is almost as complex as the systems being evaluated. Important questions 
include how can evaluators describe interventions and context and the relationship between these? How 
can observational studies deal with internal validity, when individuals are recruited into treatments in such 
heterogeneous ways? What is the role of randomised controlled trials in situations where health-care 
practitioners and service users may be far from equipoise? How can the evaluation findings be synthesised 
when so much depends on the detail of local implementation and context?
These are technical questions, but the need now to renew thinking has never been clearer. In England, 
the NHS faces an unprecedented financial squeeze, adult social care faces significant cuts, and there is 
huge pressure on investment in prevention and population health. This profound challenge is coupled with 
rising numbers of people living with multiple and long-term comorbidities and needing care and support. 
These pressures are common to all countries, although they may materialise differently. They require a 
complex response and a step change in the historic performance of the health, health care and social care 
system. The ability of health systems to respond to these challenges depends on skilful design and robust 
implementation of a range of initiatives, not just once but in a dynamic stream, rooted in and modified by 
information on impact: in short, rooted in intelligent evaluation that is sensitive to the complexity.
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We have become aware of the importance of context as well as the intervention in making change: in a 
masterly review on the subject, Penelope Hawe noted the ‘background becomes the foreground’.2 But health 
services research has not kept up with this insight: many evaluations appear to be ‘acontextual’, many just 
assume that the intervention is as unchanging as a ‘pill’ in its scope, size and intensity, and many are summative 
rather than formative. It is timely to reflect on these issues and to reassess the methods used by health services 
researchers in this area and their contribution to change. This volume is one step in that direction.
Jennifer Dixon, Chief Executive, The Health Foundation 
References
1. Bate P, Robert G, Fulop N, Øvretveit J, Dixon-Woods M. Perspectives on Context. London:  
The Health Foundation; 2014.
2. Hawe P. Lessons from complex interventions to improve health. Ann Rev Public Health 
2015;36:307–23. http://dx.doi.org/10.1146/annurev-publhealth-031912-114421
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Foreword
The Medical Research Council’s (MRC’s) strategy is built around three simple words: we prioritise, discover and transform, so that medical research can change lives.
The MRC supports robust, reproducible advances in medical knowledge, and key to this is the 
development and implementation of rigorous methodologies for research. As this volume clearly 
articulates, we are in a time of significant transformation and it is crucial that we take this opportunity 
to conduct appropriately designed evaluative research, to ensure that health care is delivered in the most 
evidence-based and effective manner possible.
Partnership is crucial; the MRC and the National Institute for Health Research (NIHR) work hand in 
hand, through the MRC–NIHR Methodology Research Programme, to develop and implement modern 
methodologies in biomedical and health-care research. In supporting the development of this volume,  
we have teamed up with a third partner, The Health Foundation.
No innovation can be said to have been successful without robust evaluation of its effects and – arguably – 
no innovation should be implemented without plans for evaluation. This volume will support researchers, 
to ensure that they understand the range and applicability of methods available for the evaluation of 
system-level innovations in health care and public health. This will enable the generation of the highest 
quality evidence to support, in turn, the decisions of commissioners of health care and public health 
services, and of policy-makers.
The excellent work done by the editors and authors of this volume, as well as the participants in the 
workshop which informed it, should enable a significant enhancement in the quality and quantity of 
evaluative research around innovations in health care and public health systems.
Much as the MRC, NIHR and The Health Foundation have come together to support this initiative, each 
bringing unique skills, experience and knowledge, so we encourage researchers, health-care providers and 
policy-makers to come together to enable a new generation of evaluated health-care innovations. This 
volume will enable these groups to discover the most up-to-date methodologies for evaluative research, to 
prioritise these methods and implement them in the most appropriate manner (meeting the needs of both 
the research community and care providers), and thereby to transform the provision of health care and 
public health.
John Savill, Chief Executive, Medical Research Council
Published May 2016
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Foreword
Health-care systems face major challenges. These challenges partly reflect major successes, in particular steadily increasing life expectancy. The health needs of an ageing population are more complex. 
Challenges also arise from expanding expectations of what might be provided by services as well as the 
inherent dynamism and inventiveness of medical technology. Challenges also provide opportunities. In 
the case of health services, policy statements such as NHS England’s Five Year Forward View make cogent 
cases that current pressures on services require innovation and experiment to produce new sustainable 
solutions to health care. This in turn requires research so that innovations are rapidly identified and their 
potential is evaluated and disseminated.
I am delighted that the resources and distinct expertise of the National Institute for Health Research (NIHR), 
The Health Foundation, the Medical Research Council and Universities UK have combined to produce this 
collection of position papers on how to evaluate health care and public health services. Key contributions 
to the volume came from two parts of NIHR. The Collaborations for Leadership in Applied Health Research 
and Care (CLAHRCs) are partnerships between universities, the NHS, public health and other relevant 
organisations to carry out world-class applied health research, particularly in relation to chronic disease and 
public health interventions. The Health Services and Delivery Research (HSDR) programme aims to produce 
rigorous and relevant evidence to improve the quality, accessibility and organisation of health services.
The volume provides a clear and authoritative explanation for the range of methods that can now be 
brought to bear to evaluate services. A wide spectrum of methods are described from novel forms of 
randomised trials to innovative statistical techniques for analysing data about services, outcome measures 
focused on patients’ priorities, and new focuses of research such as how to implement best practice. An 
impressive range of experts were mobilised to contribute to the debates out of which the position papers 
emerged. As well as providing accessible state-of-the-art explanations of best methods for evaluative 
research, the volume contains other important messages. These messages are that evaluation involves 
partnership between health professionals, providers, commissioners and researchers; and that innovation 
will best emerge from early and close dialogue between these different partners.
I congratulate those involved in producing this volume in providing a promising route map for generating 
evidence to inform the improvement of services.
Sally Davies, Chief Medical Officer, Department of Health
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We are all familiar with the dynamic whereby proposed innovations in medicines have to be subjected to detailed scrutiny of evidence claiming to support new products. There is considerable agreement 
about the types of evidence required, and regulatory arrangements are in place to ensure that such 
evidence is made available and is as supportive as industry claims. No such consensus exists about the 
nature and importance of evidence required when changes are proposed to health, social care and public 
health services. This is a paradox when one considers the claims made for proposed changes in services 
and the scale of costs and benefits that may follow from changes. This collection of essays is intended to 
address at least the first part of the paradox, the relative lack of consensus about how to evaluate changes 
in services.
Concerns about the pressures that face current and future health and social care budgets and that make 
change urgent are well rehearsed.1,2 Populations in high-income countries such as the UK have enjoyed 
steady and consistent improvements in life expectancy. Accompanying these developments have been 
the increasing numbers of individuals with long-term conditions and the frailties of older age. Among 
individuals with long-term conditions it is now common for more than one long-term condition to occur.3 
The needs for interventions and support of individuals become more complex and extensive, especially 
given the scope for modifying the relationship between ageing and disability.4
The majority of health-care use, and hence of costs, stems from individuals with long-term conditions 
and disabilities of ageing. Systems and services need to make multiple, extensive adjustments in response 
to the complexity and volume of problems presented. It might be argued that, until recently, the default 
or assumed model of illness around which Western health care has developed has been the single acute 
problem and its diagnosis and management; that is no longer appropriate for the complex and long-term 
medical, social and emotional features of modern morbidity. It is now recognised that heterogeneity of 
treatment effects and the organisation and delivery of the same intervention, together with the need to 
shift from the perspective of the service to that of the patient with respect to care delivery across diseases 
and settings, must all be taken into account when evaluating outcomes.
Health services in high-income economies have a fairly consistent tendency to grow in scale, complexity 
and cost. This partly reflects the changing nature of morbidity outlined above. Individuals with health 
problems such as diabetes, multiple sclerosis or stroke may receive a wide range of interventions from 
diverse staff and services; co-ordinating such diversity, along prevention, treatment, rehabilitation and 
palliation pathways, becomes the challenge. Growing scale and costs are also shaped by the inherent 
inventiveness and dynamism of health-care sciences. Some analyses identify medical technology as the 
largest source of growth in costs.5 Growing societal expectations are also important. By far the most 
striking example of these trends is found in the USA, which devotes > 17% of Gross Domestic Product to 
health care (that is exclusive of social care expenditure). No other country nearly matches that proportion 
of expenditure but all systems show inherent growth that seldom reverses. In summary, the commonest 
perception of these universal trends is that escalating costs are unsustainable and solutions to manage 
costs are urgently needed from within health-care systems.
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Another striking feature of health care in the USA is its great diversity.6 Because there are so many 
funders and providers of services, it is often referred to as pluralist in nature. There are few overarching 
mechanisms to standardise what services are provided or how they are organised. A common assumption 
is that systems such as the NHS will have less diversity because of the dominant influence of public funds 
and centrally determined health policy, plans and specific targets. In reality, and despite the existence of 
a variety of mechanisms that might standardise services, variations also exist in systems such as the NHS.7 
The very diversity of ways of organising services forcefully raises the question of how best to provide 
services. This in turn indicates the need for evidence to explain variations and inform decisions to change.
Over 40 years ago, a compelling case was made that, while in many respects an outstanding institution, 
the NHS had one fundamental weakness, namely a lack of evidence of what works. Cochrane expressed 
the problem in terms of a complete absence of analysis of relationships between inputs and outputs.8 The  
problems that he identified with the evidence base are still relevant to health-care systems today. For 
example, he raised the issue of how best to capture the outputs of services. He questioned the lack of 
evidence for the commonest practices in terms of diagnostic tests, length of hospital stay and where and 
how services are delivered. His book is most often cited for its successful advocacy of the experiment, 
the randomised controlled trial (RCT), to provide evidence for the health service. Subsequently, the trial 
became recognised as the most unbiased method for evaluating interventions and in terms of influencing 
decisions the systematic review of trials is commonly cited as the gold standard.
The RCT is, however, a method that has required adaptation to be useful in the evaluation of systems  
and services as opposed to drugs or other simple discrete interventions. In 2000, the Medical Research 
Council (MRC) published guidance for the evaluation of complex interventions, with a view to developing 
methods for evaluating services which comprise complex and varying elements and contributions, for 
example a stroke unit, a decision aid or a health promotion campaign.9 The guidance made the case 
for the importance of other methods, for example modelling, simulation and qualitative methods, to 
complement well-established core methods, including the RCT and cohort study. Subsequent versions of 
the guidance extended the first version and also defined methods for process evaluation on the basis that 
evidence on how to implement a novel intervention was as important as evidence of its efficacy.10,11 Other 
collections of guidance, largely based on NHS Research and Development- and subsequently, National 
Institute for Health Research (NIHR)-funded work, continued to be published, expanding the range of 
methods for service evaluation, particularly in areas such as qualitative methods, economic evaluation and 
evidence synthesis.12,13
In the recent past, The Health Foundation has also played a key role in sponsoring work that, among other 
things, developed methods for evaluation and quality improvement emphasising non-linear, adaptive 
processes whereby complex health systems change.14 Many key concepts and insights emerged. Their 
work emphasised the many ways and levels at which context shapes service development.15 Such insights 
highlight the value of shifting from the traditionally used binary question of effectiveness (yes/no), towards 
a more sophisticated exploration of, for example, generalisable determinants of beneficial outcomes. The 
Health Foundation supported thinking about the value of early formative assessment where researchers 
breach conventional independence from services being evaluated to share researchers’ emerging insights.16
Cochrane himself, and much of the subsequent guidance, acknowledged that many uncertainties about 
service development, innovation and reorganisation could not be addressed by the classic RCT, but still 
effectively gave this method primacy of attention and recognition. We have reached the point now 
where attention in terms of articulating, refining and developing principles can be given to a much wider 
array of methods. Funders of evaluation have become more pragmatic in supporting research methods 
fit to address any given problems. Users of evaluative research can gain understanding of problems and 
potential solutions through many other kinds of evidence in addition to the classic large-scale multicentre 
RCT. This volume aims to set out the current state of play in a broad menu of methods as well as 
identifying challenges and potential future directions.
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All involved in this volume felt that the need for an authoritative overview was pressing. A key trigger 
was the publication in 2014 by NHS England of the NHS Five Year Forward View.17 It highlighted the now 
familiar challenges facing health-care systems in terms of rapidly changing patterns of ill-health and the 
need for matching service reform. However, very striking and novel were the document’s articulation of 
the urgency of such change, and the suggestion that reconfiguration of services can be as beneficial as the 
introduction of new technologies, devices and drugs. Notable also was the aspiration that such changes 
should no longer be centrally driven. Instead, the NHS was encouraged to pursue local and regional 
experiments to bring about a range of new models of care schematically outlined in the document. 
Innovation was henceforth to be achieved from the ‘bottom up’.17 Evaluative research was explicitly 
recommended as part of the solution, but no real detail was provided.
The ‘forward view’ provided exactly the right stimulus to collaborate for three major UK health research 
funders whose interests and roles in developing the methodological underpinnings for evaluative research 
have already been mentioned: The Health Foundation, the MRC and NIHR [specifically via its Health 
Services and Delivery Research programme and the Collaborations for Leadership in Applied Health 
Research and Care (CLAHRCs)]. CLAHRCs represent the NIHR infrastructure most directly charged to 
carry out applied health research in partnership between the NHS and researchers. The common thread 
to all partners was the sense that bottom-up transformation has to be shown to work, using a range 
of appropriate research methods, that we need to clarify underlying mechanisms and accommodating 
contexts and that we must provide research evidence in a timely fashion to ensure effective dissemination 
and adoption of optimal system and service change.
The three research funding bodies, together with Universities UK, therefore, funded a high-level meeting 
in London in June 2015 to present and discuss the eight key evaluation themes presented in this volume. 
Over 90 senior applied health researchers came together for an intense 2 days of challenge and debate. 
Each of the eight topics was the focus of plenary sessions, with the invited attendees (listed below) 
discussing the presentations at dedicated sessions. Discussions were recorded and transcripts made 
available together with plenary presentations to the authors invited to lead in drafting the essays. Many 
of the lead authors, all experts in the relevant field, were drawn from the 13 CLAHRCs. Drafts were 
sent to all plenary speakers for critique and revision; revised versions were sent to the two editors, who 
suggested final modifications. The outcome is the essays collected here, further revised in the light of a set 
of reviews of independent referees. Prepress Projects Ltd, who support the NIHR Journals Library, provided 
professional editorial input.
The contributors to this volume responded to the challenge to state as clearly as possible the state of play 
in the eight chosen areas and to identify remaining challenges. They were given discretion as to how best 
to express the degree of consensus in their area. As a result, a minority of essays’ authors reported the 
range of views expressed at the London meeting, whereas a majority preferred to use a more conventional 
format of authorial consensus. The editors, and indeed all involved in producing this volume, recognised 
that different approaches would be appropriate for different topics. In particular, it was accepted that 
the degree of consensus would necessarily differ across contributions. This diversity was accepted and 
welcomed from the outset and is reflected in the range of formats in which different fields are discussed in 
the contributions.
Samuel I Watson and colleagues provide an excellent starting point by emphasising the central role of 
evidence in helping decision-makers. They also make clear claims for the importance of models and 
theories in pulling together how different components of a system may interact. For many problems, 
new primary research may not be needed and decision-makers can be advised by a synthesis of available 
evidence. This synthesis has to factor in the quality of different studies. The authors’ approach is a Bayesian 
solution to the various challenges of drawing conclusions from disparate existing evidence.
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Helen Barratt and colleagues provide an overview of how the RCT has evolved to be relevant to complex 
health service/public health research needs. Cluster RCTs and stepped-wedge designs permit randomisation 
of the unit or organisational entity rather than the individual patient and are, therefore, especially 
relevant here; the authors clearly delineate their respective advantages and disadvantages. Overall, they 
argue for pragmatic trial designs developed with service providers, with process evaluation also given 
strong emphasis.
Quantitative methods relevant to RCTs are now relatively well understood and best practices are agreed. 
Health services and public health research have a rich and growing body of observational data, largely 
from NHS records but also from specifically collected quantitative data. Clare Gilles and colleagues provide 
an authoritative overview of analytic strategies and quantitative methods that may be used to test for 
causal connections and address potential biases in observational data. Many of the methods have been 
developed and applied in economics-led data analysis and, to date, less widely used in evaluative health 
research. They begin by making the strong case for observational data to test the external validity of 
inferences made in RCTS. They go on to describe a number of methods that will become increasingly 
widely adopted: difference in difference methods, synthetic controls, instrumental variables and 
propensity scores.
Patient-reported outcome measures (PROMs) are a potentially powerful method of addressing a key 
issue in evaluative research. Elizabeth Gibbons and colleagues describe the increasing areas of agreement 
about how to capture what matters to patients in terms of outcomes. The use of PROMs has steadily 
expanded from secondary outcomes in clinical trials to main outcomes in major initiatives, such as the 
NHS’s national PROMs programme. To be more widely applicable, for example in evaluating services for 
long-term conditions, the patient and the health professional need to be engaged to participate in PROMs 
completion and use in decisions by seeing their potential relevance to routine care.
Rosalind Raine and colleagues provide a cogent reminder of the critical importance of taking a population 
perspective when evaluating services. They remind us that inequalities of access and outcomes are a 
key dimension in terms of which to evaluate the performance of services. They show how, to properly 
address inequalities, researchers have to take account of the different level of health need across the 
socioeconomic gradient and among different sociodemographic groups in a population. They consider 
critical issues in designing interventions to address inequalities in health and conclude that interventions 
must be targeted at multiple levels to work. They also raise population- and system-level issues that may 
arise from austerity-driven reductions in health-care coverage.
Simon Turner and colleagues address the most challenging of all kinds of evaluation, major system change, 
for example where broad top-down changes are introduced into a health-care system, as is increasingly 
happening both regionally and nationally across the NHS. There are numerous difficulties, including the 
inherent problems of causal narrative with multiple changes at different levels and the influence of the 
overall social, economic and political context. They provide an overview of examples and, drawing on 
management and organisational literature, argue for the centrality of theory and of mixed methods to 
navigate towards explanation of system-level changes in services.
There are echoes of the essay on system changes in the following essay by Emma Howarth and colleagues, 
who address contextual issues and qualitative research. Qualitative research plays a crucial role in 
conjunction with quantitative evaluative research, not least in elucidating the specific context in which 
a trial or evaluative study was carried out. Qualitative research may be used before a trial to develop an 
intervention, or during or after the trial to assist interpretation and interpretation of results. The authors 
recognise that research funding is on a trajectory of growing acceptance of qualitative methods. They 
argue that greater weight and resource should be given to the qualitative component of mixed-methods 
research studies where investigators have greater appreciation of the need to inform and influence 
subsequent implementation.
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Chrysanthi Papoutsi and colleagues bring the volume to a close with an essay on implementation science, 
the study of implementing evidence-based practice. The field, although vital, is a relatively new component 
of evaluative research, so that contributors to this essay were reluctant to be too tied down to specific 
definitions, approaches or methods, and they make the case that the essay will itself stimulate work 
towards consensus. As with some other essays, there is agreement on the importance of theory, and a 
number of specific theoretical options such as process normalisation theory are outlined for the reader.
The authors of the essays were encouraged to think about the future of their chosen subjects and some 
commonly expressed general points seem to emerge that are optimistic for the future development of 
evaluative health research and its impact. First and foremost, there is significant consensus on the value of 
a repertoire of quantitative and qualitative methods working in conjunction to produce relevant evidence. 
Second, there is shared ground on the importance of researchers working more closely with providers, 
commissioners and health professionals from the earliest stage to define uncertainties requiring research 
and to communicate insights and results in suitable formats at different stages. Third, there is an emerging 
sense of pragmatism, not in the sense of supporting anything other than excellence, but in carrying out 
research good enough to make timely contributions to inform decisions. Fourth, there is optimism that 
health care and public health systems will develop in ways that produce increased appetite for research as 
there is growing shared understanding of its value. Finally, specific features of health care/public health will 
eventually make research easier, as routine health data, with appropriate safeguards, become more open 
to use by research and information technology facilitates the integration of health data for the purposes of 
both care and research.
The eight chosen themes do not define the entire field of evaluative research in this area. They were 
considered sufficiently important to start a process of defining the state of play of the field but it is 
recognised that other subjects would undoubtedly emerge in subsequent iterations of the volume. It 
is also important to express here the hope that the volume itself will be live and open to revision. The 
NIHR Journals version will have a conventional published form, as with all NIHR monographs, but other 
platforms will allow commentary and update. It is thereby hoped that this volume will be a continuing 
stimulus to research that informs the improvement of services and our health, social and public 
health systems.
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Abstract
Policies and interventions in the health-care system may have a wide range of effects on multiple patient 
outcomes and operate through many clinical processes. This presents a challenge for their evaluation, 
especially when the effect on any one patient is small. In this essay, we explore the nature of the  
health-care system and discuss how the empirical evidence produced within it relates to the underlying 
processes governing patient outcomes. We argue for an evidence synthesis framework that first models 
the underlying phenomena common across different health-care settings and then makes inferences 
regarding these phenomena from data. Bayesian methods are recommended. We provide the examples of 
electronic prescribing and increased consultant provision at the weekend.
Scientific summary
Decisions to adopt new health technologies rely on evidence of their effectiveness along with their costs. 
For targeted clinical interventions, this evidence may come from randomised studies with well-defined 
end points. The effects of structural interventions or policy changes in health-care services are not as easily 
measured, as they are often disparate, affect multiple processes and end points, and may only be small in 
any one patient. The evaluation of structural interventions and policies therefore requires the synthesis of 
multiple forms of evidence from across the causal pathway that links the intervention to the outcomes that 
are relevant for the decision-making process.
The health-care system is a complex system that features multiple, interacting causal processes, emergent 
behaviours at different levels and non-linear responses to change. However, there are phenomena that 
are consistent across different health-care settings, and the causal processes by which an intervention 
may affect patient clinical outcomes are generally understood. These phenomena are distinct from the 
data from which they are inferred. These data may take multiple forms and be subject to many sources of 
bias and error. A researcher can, through literature review and expert consultation, construct a qualitative 
causal model of the phenomena of interest. This provides a framework both for identifying the relevant 
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literature and for the development of estimators of the effect of interest. Well-established evidence 
synthesis tools such as meta-analysis and bias modelling can then be used to make inferences about the 
phenomena of interest and their relationships. A Bayesian methodology is best suited to this form of 
research, as it permits the propagation of uncertainty through models, fits naturally in a decision-making 
framework and allows researchers to update results when new information becomes available.
Ongoing developments in evidence synthesis, such as methods for rapid reviews, bias modelling, and 
synthesising qualitative and quantitative evidence, will improve the evaluation of structural interventions. 
Many interventions converge on the same causal processes; research can be optimally targeted at 
understanding such pathways to facilitate future evaluations.
The purpose of evidence synthesis
A wide range of policies and interventions is available to the health-care system. Each of these has a 
potential effect on patient health and quality-of-life outcomes and a decision must be made whether or 
not to implement each policy or intervention. Any choice, including doing nothing, has an opportunity 
cost, which is the best outcome that could have been achieved using the same resources. The appropriate 
policy decision must, therefore, turn on the basis of whatever evidence is available.
The purpose of evidence synthesis is often to inform clinical decisions.1 For example, the National Institute 
for Health and Care Excellence in England uses systematic reviews and meta-analyses to produce clinical 
guidelines,2 often based on cost-effectiveness analyses, which may themselves include evidence syntheses.3 
Such evidence synthesis is generally only across studies. In the more complex case of health services 
research, synthesis takes place both within and between studies. The reason for this is to be found in the 
complex nature of casual pathways that exist in health services research.
A feature of health service interventions is that they propagate themselves across the health-care system. 
That is to say, there is a causal chain that may involve many mediating variables between an intervention 
and its effects on patients.4 It follows that changes in the system which are captured by intervening 
variables are important in interpreting and explaining the effect of service interventions. A simple example 
of such a causal chain is shown in Figure 1.1. The system is conceptualised as having different levels which 
may begin at the patient level and end in the Department of Health. Within this framework, interventions 
could be classified according to the ‘level’ at which they act on the system. Clinical interventions, such as 
clinical guidelines, are designed to impact on clinicians; generic interventions, such as a human resources 
policy, are designed to impact at a managerial level; and policy interventions, such as the method of 
reimbursement, may be designed to interact across many organisations.
FIGURE 1.1 Causal chain showing how interventions at different levels may impact on downstream processes  
and outcomes. Reproduced from Evaluating policy and service interventions: framework to guide selection and 
interpretation of study end points, Lilford RJ, Chilton PJ, Hemming K, Girling AJ, Taylor CA, Barach P, vol. 341,  
p. c4413, 2016,4 with permission from BMJ Publishing Group Ltd.
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The purpose of an evidence synthesis is to piece together the various observations from each level that 
have been made of a particular system to gain knowledge of the relationships between the variables in this 
system. An individual study may provide insight into a number of aspects of the health-care system. It may 
observe a number of relevant variables that impact on the effect of an intervention across the causal chain. 
But, as in health technology assessment, this evidence must be assimilated in combination with other 
studies examining the same phenomena. There may be biases within any study, including randomised 
controlled trials (RCTs). Indeed, within any one study there may be biases as a result of study design, 
problems with implementation or interacting factors from other parts of the organisation, each of which 
needs to be considered when making any inferences. Between studies there may be differences  
in the observed relationships between variables, whether through natural variation or differing institutional 
contexts, and there may be publication biases. Thus, evidence synthesis needs to takes place both within 
and across studies.
The decision-maker needs to understand how an intervention functions and to be able to predict its 
effects. The process by which it functions may be relatively simple, such as how a particular medication 
affects the risk of mortality, or more complex, such as how a policy within a hospital affects patient length 
of stay, for example. In the former case, the intervention and the outcome can often be measured directly, 
along with any relevant variables that may causally related, in an experimental setting. In the latter case, 
the effect on any one patient may be too small, the duration between implementing the intervention  
and observing changes in patient outcomes may be too long, or there may be co-occurring changes to the 
institution to warrant any single study and make reliable inferences from it; in these cases the evidence 
is generally limited to other more upstream outcomes.4 In this case, evidence produced from across the 
causal pathway would need to be synthesised to quantify the effect of interest.
What is clear is that the nature of the system producing the evidence observed needs to be understood 
for inferences to be made from such evidence. A ‘black box’ approach is not recommended, for reasons 
we explain later. For large systems, such as the health-care system, inference often takes place in a 
piecemeal fashion, with many small studies each examining parts of the whole system. There may be 
a number of different candidate causal models which explain the phenomena of interest that may be 
empirically indistinguishable from one another.5 Specific knowledge of the health-care system is required 
for development of a valid causal theory. Thus, all forms of evidence produced may help to clarify the 
question under consideration, from ethnographic and qualitative evidence to quantitative evidence, both 
observational and experimental.
Decisions have been emphasised as an important motivating reason for conducting an evidence synthesis. 
Bayesian inference works more naturally with decision analysis. A decision-maker may want to know, once 
we have taken the evidence into account, what the probability is that an intervention is effective, or what 
the odds are that the value of an effectiveness parameter lies in a particular region. A Frequentist must 
remain tongue-tied in the face of such a question, whereas Bayesian methods results can be interpreted in 
this way. The choice of methods should therefore reflect not only what is being studied but also the reason 
for which it is being studied.
The nature of the system
Health service institutions are complex systems. It is important here to distinguish between a complex 
system and a complex intervention. The latter describes an intervention that may be composed of multiple 
interacting components which may differ depending on the context in which it is used; one example of 
this is an electronic prescribing system for hospitals.6 Guidance already exists for the evaluation of complex 
interventions.7 A complex system, on the other hand, describes a set of dynamic properties of a system. 
These properties make analysis and evaluation more challenging, and methods usually used to evaluate 
simple, clinical interventions may not be appropriate.8 (Issues of complexity in evaluation are further 
discussed in Essay 6.)
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Let us consider why a health-care institution is a complex system.9 It comprises many interacting, casual 
processes. As stated above, there are multiple levels of the system, so patterns of behaviour can be 
observed at the individual patient and clinician level, or at more aggregate levels such as the ward or 
even hospital level. There are emergent processes – by which we mean that the behaviour of the system, 
when viewed at an aggregate level, arises from the interaction of agents at a lower level, despite those 
agents not exhibiting the same behaviours. For example, increases in waiting times or systematic failures 
may occur in accident and emergency departments despite the behaviour of all the clinical staff and their 
interactions with patients remaining the same. Non-linear relationships exist in health care and the output 
may be greater or less than the sum of its parts. Small changes to processes whereby components of the 
health-care system interact, such as an information technology system to identify medication errors in 
general practice,10 may have large effects on patients. This may then improve patient outcomes, freeing 
up clinician time and other resources, leading to further improvements for other patients: these are 
spillover effects.
One may view the complexity of a health-care system as prohibiting successful modelling of that system, 
but this view would ignore the successes of other fields which study complex systems. For example, to 
model infectious disease epidemiology, we generally use simple models at an aggregate level, such as the 
Susceptible, Infected, Recovered model.11 From a more general perspective, the methods of biology are 
different from those of physics despite biological objects comprising physical objects such as atoms and 
molecules. Biology enjoys success despite being a study of complex systems.
The difficulty of conducting experiments differs across various types of complex system. In biology it may 
be possible to conduct experiments at the system level: cells or individual people can be randomised to 
different conditions. In climate science, on the other hand, the system as a whole cannot be subject to 
experimentation, although experiments could be conducted on parts of the system. Health services offer 
an intermediate position; sometimes experiments, specifically RCTs, are possible, especially for interventions 
that interact ‘close to the patient’ (e.g. targeted service interventions in Figure 1.1). The repertoire of types 
of trial for health services research is further discussed in Essay 2 in this volume. For example, there are 
many hundreds of trials of methods to improve adherence to quality standards (e.g. Flodgren et al.12,13).  
Experiments have even been conducted at the level of whole hospitals or wards (e.g. Hillman et al.,14 
Cumming et al.15). Nevertheless, there are many circumstances in which experiments are just not possible 
and have not been done. Alas, even when experiments have been done, it is still necessary both to 
understand why or how the intervention succeeded or failed, and to link the outcomes in the observed 
study to many other relevant patient clinical outcomes. And, to make rational and consistent scientific 
judgements about the effects of interventions on phenomena outside of the study design, or in a new 
time or place, an understanding of mechanisms is required.
The aim of models is to predict and explain phenomena in the health-care system. Each element in the 
model is representative of a phenomenon, which we can describe as a stable feature of the health-care 
system. Phenomena here are distinguished from the data from which they are inferred.16 This distinction 
leads to a number of important conclusions relevant to evidence synthesis. Phenomena are generally stable 
and are the result of the confluence of a manageable number of causal factors, whereas data are noisy 
measures of the phenomena that are generated by a very large number of factors, including measurement 
error and bias.
Consider the model presented in Figure 1.2, which shows the relatively simple example of how an 
electronic prescribing system may impact on patient clinical outcomes. The phenomenon of an adverse 
drug event in this model is caused by a medication error made in the process of health-care delivery. There 
may be other relevant causal factors, such as the presence or absence of a monitoring system, but the 
underlying theory is fairly straightforward. The data from which the presence of an adverse drug event 
is inferred may be very noisy. Typically, adverse drug events are identified by case note review; different 
reviewers may have different thresholds for what is considered an adverse drug event, the quality of 
case notes might differ from hospital to hospital, and so forth. We can, therefore, distinguish between 
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assessing the reliability of data and explaining the underlying phenomenon.16 This may be considered a 
viewpoint from a realist philosophy of science. For example, in the evaluation of a patient safety initiative, 
Benning et al.17,18 measured errors and adverse events in multiple institutions. Multiple expert reviewers 
were used in the case note review, and there were controls for seasonal effects as well as reviewer learning 
and fatigue. However, these very real issues of data quality should not be conflicted with the phenomena 
to which they relate: in this case the link between intervention components and intervening variables and 
the link between intervening variables, clinical processes and adverse events (see Figure 1.1). We return 
to the question of assessing data reliability later and of methods for dealing with biases. To quote Bogen 
and Woodward:16
In undertaking to explain phenomena rather than data, a scientist can avoid having to tell an 
enormous number of independent, highly local, and idiosyncratic causal stories involving the (often 
inaccessible and intractable) details of specific experimental and observational contexts. He can 
focus instead on what is constant and stable across different contexts. This opens up the possibility 
of explaining a wide range of cases in terms of a few factors or general principles. It also facilitates 
derivability and the systematic exhibition of dependency-relations.
The models can and should reflect important aspects of the system, such as why there are non-linearities  
in the system, but ultimately we are trying to explain why an intervention works and predict its effects.  
The function of the data is to help with this task.
There are both observable and unobservable processes governing a health-care system. For example, the 
mortality rate may be easily measurable, but levels of staff morale are not. The question to the researcher 
then is how to gain knowledge of these processes and their structure in order to develop a model. 
We take the point of view that abduction is how knowledge is gained: the theory that is inferred from 
observation is that which is most likely, and most simple.19
To illustrate the abductive process, Lipton provides the example of Ignaz Semmelweis.19 Semmelweis 
wanted to find the cause of childbed (puerperal) fever in order to prevent the high rates of mortality it was 
causing in the Viennese hospital where he worked in the 1840s. Semmelweis had competing hypotheses 
about why the incidence of childbed fever was much higher in one maternity division than the other. The 
accepted explanation at the time was one of ‘epidemic influences’ that descended over entire districts, 
but that could not explain the difference between the divisions. Other explanations considered included 
that medical students and midwives received their training in different divisions, that a priest giving last 
rites had to always pass through one division to get to the other, and that women were delivered on their 
sides in one division but on their backs in the other. After he observed his colleague die from a disease 
FIGURE 1.2 Qualitative causal model showing the effects of an electronic prescribing system on patient-level 
outcomes.
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resembling childbed fever after puncturing a finger during an autopsy, Semmelweis inferred that ‘cadaveric 
matter’ was the cause. To test this he had medical students disinfect their hands after performing 
autopsies and the mortality rate dropped significantly.
Semmelweis did not require knowledge of the germ theory of disease to produce knowledge of how 
the high mortality rate was being caused. Nor did he require knowledge of how he could measure the 
mortality rate or even an agent-based model of clinicians on the ward. Contrastive explanation and the 
weighing up the probabilities of hypotheses can help us to understand complex systems. Simple models 
may be objected to on the basis that they do not capture the minutiae of reality. But do we need to know 
how being tired can cause a clinician to make an error to know that clinicians sometimes make errors and 
that some of those errors cause patients harm and that an intervention that causes fewer errors reduces 
patient harm? Indeed, the underlying casual model may be fairly simple; it is the processes governing the 
data we observe that may be highly complex and context dependent.
With the use of appropriate models and methods, evidence can be synthesised to gain understanding 
of the health-care system, and to make predictions about the effects of policies and interventions. To 
reinstate, many forms of evidence are required to make accurate inference and knowledge can be  
gained about phenomena in a model. Moreover, this line of argument also leads us further to support a 
Bayesian perspective, as it permits us to weigh up the probabilities of different hypotheses and, in the last 
analysis, even the models themselves, allowing us to predict what happens when we intervene.19
Methods of evidence synthesis
Thus far, we have discussed both why evidence syntheses might take place within health services 
research and what the nature of the system producing the evidence may be. How does this translate 
into methodology? We consider three main steps: theory, data collection and evaluation, and evidence 
synthesis. These steps hopefully provide a useful and logical method by which a scientifically valid  
and useful evidence synthesis may be conducted. Where methods are lacking or underdeveloped, we have 
tried to offer tentative suggestions.
Theory
First, an underlying theory for the phenomenon or phenomena being studied needs to be explicated. 
This theory comes in the form of a model of how the system of interest functions at the level of interest. 
Consider again the diagram in Figure 1.1 which provides a taxonomy of interventions depending on the 
level at which they interact with the system. This will act as our starting block for developing a model.  
For a clinical intervention the model may be very simple. Figure 1.3 shows the example of clopidogrel  
(Plavix®, Bristol-Myers Squibb) for the prevention of myocardial infarction. The intervention directly acts on 
a single, easy-to-measure patient outcome (although other outcomes, such as costs and quality of life, may 
equally be of interest). Certain intervening variables may affect the chance of experiencing a myocardial 
infarction and some may, in practice, affect how likely it is for a patient to receive or comply with the 
treatment. Some of these intervening variables may be unobservable. Nevertheless, in a well-conducted 
RCT, these intervening variables should be the same in both control and treatment groups. The role of 
intervening variables cannot be overlooked, however, because they may interact with how the intervention 
works in a clinical context.
A generic service intervention may have a more complicated model. Figure 1.2 shows again the relatively 
simple example of how an electronic prescribing system may impact on patient clinical outcomes. The aim 
of such a system is to reduce the medication errors that occur, and contingent patient harm in the form of 
adverse drug events. These in turn may have effects on patient clinical outcomes such as death or quality 
of life. Furthermore, the effectiveness of the intervention may depend on some other set of intervening 
factors, for example the ability of physicians to understand and follow clinical advice from the computer.20 
Similarly, other intervening factors may affect the risk of experiencing a medication error, adverse drug 
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FIGURE 1.3 Qualitative causal model for the effects of clopidogrel on acute myocardial infarction.
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event and clinical outcomes, such as the skill and morale of clinical staff and the availability of other 
interventions in the hospital environment. For many generic service and policy interventions, local hospital 
culture, the presence or absence of mediating factors and patient case mix are all intervening factors.21 
Indeed, such models may become quite complex as the scope of the intervention grows. Figure 1.4 shows 
a candidate model for the effects of increasing consultant-to-patient ratios.
At a more practical level, how are these models interpreted? They encode our assumptions about the 
conditional dependencies between variables making them clear to any reader. The models presented in 
Figures 1.2–1.4 are Bayesian causal networks represented as directed acyclic graphs, a common form 
of model used in a variety of fields, including epidemiology, statistics, philosophy and economics.22–24 
These models provide an economical representation of joint probability functions and facilitate efficient 
inferences from multiple observations.23 More specifically, the model encodes the conditional dependencies 
between a set of random variables, some of which may be unobservable. In Figure 1.2, the model 
represents the relationships between the variables and encodes probabilistic statements about these 
relationships, such that we would not observe an effect of electronic prescribing on adverse drug events 
statistically if we condition on medication errors. On the basis of these models, we can derive, for example, 
FIGURE 1.4 Qualitative causal model.
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the risk of mortality for a patient treated in a hospital with an electronic prescribing system in terms of the 
intervening variables. This is important in order to derive estimates from multiple studies from across the 
causal pathway. We will return to this topic in the section Evidence synthesis.
It may not seem satisfactory for a researcher, in isolation, to develop a model. The researcher may lack 
important understanding of the causal factors involved. Agents within the system, such as doctors, 
nurses and managers, have important first-hand knowledge of the system. Through expert focus groups, 
ethnography and other qualitative means, theory can be developed and then reflected in the model. An 
iterative process can be used, whereby a model may be presented back to experts and clinical staff and 
refined further.
Developing a model iteratively raises the issue of the level of granularity and choice of variables appropriate 
for the model. Granularity refers to the grouping of variables. For example, should we include a general 
‘medication errors’ variable in the model or a number of more specific variables relating to different 
types of medication error, such as dosing errors or allergies, or even more specific such as not prescribing 
low-molecular-weight heparin, on the basis of patient weight or prescribing penicillin to a patient who 
has already demonstrated an allergy? For both points, we suggest two criteria: (1) does the model better 
explain the phenomenon (as opposed to the data) or permit more precise predictions; and (2) does 
the model facilitate inferences that can be made about the phenomena from data? To illustrate these 
questions, we consider again medication errors: (1) more granularity may more precisely explain how 
an electronic prescribing platform reduces medication errors, as it may only act through certain types 
of error. However, it may hinder our ability to make predictions, particularly quantitative predictions, as 
the relationship between each of the medication errors and their relationship with adverse drug events 
would need to be explicated unless some fairly strong assumptions were made, such as independence 
between different types of medication errors. For (2), there may be far fewer data available for each type 
of medication error than for medication errors overall, and these data may be less reliable given low event 
rates of very specific events. This may prohibit inferences about the phenomena in a more granular model. 
And, as both the more and the less granular models are positing the same causal model in essence, we are 
not committing an error of conflating the data with the model. An example of grouping variables is given 
in the context of an intervention to reduce adverse events following discharge from hospital.25
It may be questioned why we are concerned specifically with modelling all the way to patient outcomes 
rather than being satisfied with more upstream outcomes. The response to this is a general health 
economic concern. Given the limited resources of the health-care system and potentially unlimited  
health-care needs, the portfolio of policies and interventions that are invested in should maximise the 
returns (equity considerations aside); but we are left with the issue of comparing interventions that have 
a wide range of potential outcomes. Health benefits may be compared on the basis of a ‘natural’ unit, 
such as deaths averted. However, this may be too narrow and capture only a small range of possible 
outcomes, which is especially likely to be true in the case of policy or generic service interventions. In this 
case, the quality-adjusted life-year is often used, which accounts for changes to both quality and length of 
life. For these reasons, it is important to determine the effect of these interventions on patient outcomes. 
Once a satisfactory model for doing so has been developed, the next step is to identify and evaluate the 
available evidence.
Identifying and evaluating evidence in the literature
Here, we will only provide an overview of methods that may be of practical use for the evidence synthesis 
methods we describe.
The question for the literature search is what needs to be found. The model developed for the synthesis 
guides the search for literature: data from which the phenomena and conditional probabilities in the 
model can be inferred are required. For the model in Figure 1.3, the only essential studies are those which 
have examined the change in risk of acute myocardial infarction conditional on clopidogrel therapy.26
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For the model in Figure 1.2, a greater number of searches are required: the risk of experiencing a 
medication error conditional on there being an electronic prescribing platform, the risk of experiencing 
an adverse drug event conditional on electronic prescribing, the risk of various patient clinical outcomes 
conditional on electronic prescribing, the relationship between medication errors and adverse drug events, 
and the relationship between adverse drug events and patient clinical outcomes and costs. The first three 
of these searches concern the relationship between electronic prescribing and the various variables that 
may be considered outcomes. As previously discussed, the more downstream an outcome is from the 
intervention, the smaller the potential effect and hence the greater the required sample size required to 
detect such an effect in a study. This is likely to translate into fewer studies the greater the distance there is 
between the intervention and outcomes on the causal chain, and the greater the noise associated with the 
result. For example, a recent systematic review and meta-analysis of computerised physician order entry 
(CPOE) systems, which are an important component of electronic prescribing platforms, found 16 studies 
taking medication errors as their end point, and six that addressed adverse drug events. No studies were 
identified that looked directly at patient clinical outcomes.27 Furthermore, these were just the quantitative 
studies; qualitative studies were not considered. Methods for identifying relevant qualitative studies differ 
somewhat from those used to identify quantitative studies, but are well established.28,29
As the model becomes more complex, such as that shown in Figure 1.4, more searches are required. This 
may present a large burden in terms of time and resources for a researcher. In many cases, interventions 
at the generic service intervention level or policy level converge on the same processes, namely reducing 
patient harm and costs through reducing adverse events. As a result, the results from a literature search of 
this relationship can be used in many syntheses; indeed, we are conducting such a review currently.30
Advances are being made in improving the efficiency with which literature reviews are conducted. For 
example, Tsafnat et al.31 describe automated systematic review procedures and examine the impact 
such an automated process may have on each of the stages of the systematic review. However, much 
of this technology focuses on the review of RCTs, which are generally reported more consistently than 
observational studies which are likely to constitute much of the evidence for policy and generic service 
interventions. Indeed, many rapid-review methodologies still require the searching of multiple databases 
and manual review of retrieved abstracts.32,33
Once relevant studies have been identified, the next step is to assess them for quality. Quality assessment 
criteria have been widely established for both RCTs and observational studies. For observational studies 
there is the Newcastle–Ottawa scale,34 and for RCTs there is the Cochrane Risk of Bias tool.1 This tool is 
designed to facilitate the researcher to identify where there is a high risk of bias in various aspects of the 
trial design and conduct, such as the randomisation and allocation. However, the question then remains 
concerning what we should do with studies that may, potentially, be biased; we return to this question 
shortly. The key point is that the studies need to be assessed for their reliability for making inferences 
about the underlying phenomenon.
There is widely considered to be a hierarchy of evidence, with certain study designs providing more reliable 
evidence of effectiveness than others. Setting aside systematic reviews and meta-analyses, the RCT is 
generally considered to be the top of the hierarchy as the experimental design allows for the control 
of both observed and unobserved confounding factors and should generally be easily replicable. In an 
ideal world, all interventions about which there is uncertainty surrounding the existence or magnitude of 
an effect would be assessed in such an experimental setting, but this is obviously not possible for both 
practical and ethical reasons. There are many who eschew non-experimental evidence. Observational 
evidence is often argued to be ‘too biased’ to make important health policy decisions. But this would be 
to take an extreme position. Under the right conditions, a well-conducted observational study can produce 
unbiased results. Indeed, these studies may be more reliable than a poorly conducted RCT. Differential 
dropout, for example, can lead to a large bias.35 A recent Cochrane review comparing treatment effects 
reported in observational studies with RCTs found that, ‘on average, there is little evidence for significant 
effect estimate differences between observational studies and RCTs, regardless of specific observational 
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study design, heterogeneity, or inclusion of studies of pharmacological interventions’.36 That said, in some 
cases there are considerable differences between the results of randomised and non-randomised studies of 
the same intervention.37,38
Bias is an important concern for all study types. For non-randomised studies, case-mix adjustment is 
demonstrably imperfect and in certain cases can even worsen potential biases.39 Discarding any non-
randomised studies, though, is extreme. Accepting these studies at face value may also be imprudent. 
A middle ground is perhaps more satisfactory: modelling the biases in studies. Turner et al.40 describe a 
method to model bias in evidence syntheses. They consider both internal biases, those biases which may 
cause the results of the study to deviate from those from a perfectly conducted study, and external biases, 
which may undermine generalisability to the target population of interest. The authors provide a method 
of adjusting study results for both internal and external additive and proportional biases. To determine 
the magnitude of the biases, the authors discuss a method of expert elicitation, where a number of 
independent reviewers provide their beliefs about the potential size of effect that might be observed as a 
result of bias if there was no intervention effect. A number of different categories are considered, similar to 
those in the Cochrane Risk of Bias tool, and include selection, performance and allocation biases. Sterne  
et al.41 discuss methods of dealing with publication biases that may be apparent in the literature.
Deciding which studies to include is a topic of perennial interest in evidence synthesis, even after modelling 
potential biases. Data may need to be lumped together or split,42 and the impact of these decisions  
should be explored through sensitivity analysis.43 For example, the sensitivity of results to the inclusion of 
low-quality studies should be explored.1
Evidence synthesis
At this stage we have identified the available evidence to ‘populate’ our causal model. To synthesise this 
evidence we need to derive an estimator for the effect of interest from our model. We will first consider 
only quantitative evidence and then discuss the inclusion of qualitative evidence. The effect of interest is 
the average treatment effect of the intervention. Considering the model in Figure 1.2, and assuming that 
we are only interested in mortality as the outcome, Y, then the average treatment effect is
P(Y jeP = 1)� P(Y jeP = 0), (1)
that is, the probability of mortality for a patient treated in a hospital with an electronic prescribing system 
minus the probability of mortality for a patient in a hospital without an electronic prescribing system. 
Following Pearl,23 we can derive a non-parametric estimator of this effect.
The intervening variables, X, have been included in the model as they were deemed of scientific interest. 
We may be interested in deriving the conditional effect P(Y jeP = 1,X = x), for example. In the above 
equation, we are calculating the effect of electronic prescribing averaged over the possible values of X. 
However, they are not strictly relevant in this model to the causal process by which electronic prescribing 
has its effect. It may be decided to leave out these variables as the results from the identified studies are 
already conditioning on these characteristics. More importantly, these data may not be available or the 
studies that investigate them may be underpowered.44 This presents a problem when these same factors 
may lead to a different probability of adoption of an electronic prescribing system in practice. In this case 
it may still be possible to identify an estimator for the causal effect; Tian and Pearl determine the general 
conditions under which this is possible.45
For simplicity in this illustration we will consider the model in Figure 1.2 but without the intervening 
variables, X, so that we have the simple model eP→ME→ADE→Y . Then, using the variable symbols in 
Figure 1.2,
P(Y jeP = 1) � P(Y jeP = 0) =∑ADEP(Y jADE)P(ADEjME = 1)½P(ME = 1jeP = 1) � P(M = 1jeP = 0), (2)
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where we have used the fact that an adverse drug event must be preceded by a medication error (i.e. 
it is a preventable adverse drug event). Each of the components on the right hand side of the equation 
can be estimated using the studies identified. For example, the term P(ME = 1jeP = 1)� P(M = 1jeP = 0) 
represents the absolute risk difference for a medication error with and without and electronic prescribing 
system. This can be estimated using standard meta-analytic techniques to combine the results from studies 
where this is estimated. As an illustration of this, consider the effect of CPOE on medication errors, as 
discussed above. Sixteen studies examine this, which are provided in Nuckols et al.27 When the absolute 
risk differences are meta-analysed using a random effects meta-analysis,46 they produce the results shown 
in Figure 1.5 (the posterior distribution of the risk difference). To incorporate the studies which take 
adverse drug events as their end point, we can use the fact that
P(ADEjME = 1)½P(ME = 1jeP = 1) � P(M = 1jeP = 0) = P(ADEjeP = 1) � P(ADEjeP = 0). (3)
Within-study correlations may need to be considered when both end points are measured in the 
same study.
A Bayesian approach has been recommended throughout this essay. Estimation of a parameter in a 
statistical model in Bayesian analysis involves updating a prior distribution for the parameter, which 
represents what is already known about the parameter, with data, which enters via a likelihood 
function. A prior distribution can be informative or non-informative. A non-informative prior means 
that no prior information is provided and may, for example, allow for all values of the parameter to 
be of equal probability. A posterior distribution for the parameter can then be determined from the 
prior and likelihood. This posterior distribution represents our subjective uncertainty about the value of 
the parameter. Methods for the synthesis of both qualitative and quantitative evidence using Bayesian 
methods have been previously discussed in the context of health services research or policy, although 
FIGURE 1.5 Posterior distribution from a random-effects meta-analysis of the absolute effect of CPOE on the risk 
of a patient experiencing a medication error compared with prescribing with a paper-based system.
0.10
D
en
si
ty
0.05
0.00
–20 –10 0
Risk difference (percentage point)
10
DOI: 10.3310/hsdr04160-1 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 16
13
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Raine et al. under the terms of a commissioning contract issued by the Secretary of State for  
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be 
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science 
Park, Southampton SO16 7NS, UK.
methods have not been well developed. Roberts et al.47 use qualitative evidence to generate an 
informative prior using expert elicitation methods. This is then updated with quantitative evidence. Voils 
et al.,48 on the other hand, generate quantitative data from qualitative studies by attempting to determine 
the frequency of an association from individual reports in each study and then update a non-informative 
prior. In both cases, the qualitative and quantitative evidence can be used to infer the values of interest, 
and both provide relevant information.
Expert elicitation methods are often used to generate prior distributions in Bayesian analyses.49,50 The 
example of electronic prescribing also highlights another way in which they may be of use. The only 
studies providing relevant evidence may be of a similar but not identical intervention to the one of interest. 
CPOE is only one component of a full electronic prescribing system, yet only studies examining CPOE are 
available. A prior distribution for the parameters in the electronic prescribing model may be elicited from 
experts who are asked to extrapolate from the evidence of CPOE.
Ultimately, in whichever way the various forms of evidence are combined, the effect of interest can then 
be evaluated over the posterior distributions of each of the parameters. Or, if no data are available, it may 
be evaluated over the prior distributions even if some of these are non-informative.
Decision analysis
It was emphasised at the beginning of the essay that policy decisions are often the purpose of evidence 
syntheses. Bayesian decision analysis provides methods to determine the optimal decision within a 
normative utilitarian framework.51,52 A loss function is specified based on a utility function which represents 
the losses to a decision-maker. The benefits of an intervention can be determined using the methods 
described in this essay: the model and evidence synthesis can take place within a decision model.
Conclusions
In this essay we have provided a framework for evidence synthesis in health services research involving 
synthesis of external evidence from the literature and evidence internal to a study relating to salient 
phenomena contributing to the link between cause and effect. The evaluation of generic service 
interventions and policies within health systems is often hampered by the fact that the effect of these 
interventions on any one patient is often very small. Sample sizes required to detect such an effect may be 
prohibitively large, and, unless the study is perfectly conducted, the magnitude of the bias may overwhelm 
the size of the effect. It also may not be feasible, ethical or even necessary to conduct a randomised trial. 
Synthesising evidence from across the causal pathway may provide a method of estimating the effects of 
these interventions on the patient outcomes of interest.
Many forms of evidence are available from which the effects of interest can be inferred. However, in many 
cases there may be a risk of bias. This bias may arise anywhere from the conceptual stage in choosing 
which interventions to study right through to the publication of results where negative findings may not be 
published. We have discussed methods to model such biases. The Bayesian framework we have described 
also permits the synthesis of both qualitative and quantitative evidence: the most likely values for the 
phenomena described by the causal model can be ‘triangulated’ from the available evidence.
The methods described here combine many different methods elaborated elsewhere. However, in some 
cases further research is required to establish the optimal techniques. For example, there is no consensus 
on the best method for the integration of both qualitative and quantitative methods. Similarly, further 
research is required to elucidate the causal pathways present in health-care institutions. This essay is 
intended to provide a foundation onto which these techniques can be built, enabling estimation of the 
effects of generic service and policy interventions.
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Abstract
Complex interventions and large-scale transformations of services are necessary to meet the health-care 
challenges of the 21st century. However, the evaluation of these types of interventions is challenging and 
requires methodological development.
Innovations such as cluster randomised controlled trials, stepped-wedge designs and non-randomised 
evaluations provide options to meet the needs of decision-makers. Adoption of theory and logic models 
can help clarify causal assumptions, and process evaluation can assist in understanding delivery in context. 
Issues of implementation must also be considered throughout intervention design and evaluation to 
ensure that results can be scaled for population benefit. Relevance requires evaluations conducted under 
real-world conditions, which in turn requires a pragmatic attitude to design. The increasing complexity of 
interventions and evaluations threatens the ability of researchers to meet the needs of decision-makers 
for rapid results. Improvements in efficiency are thus crucial, with electronic health records offering 
significant potential.
Scientific summary
Complex interventions and large-scale transformations of services are necessary to meet the health 
and social care challenges of the 21st century. The evaluation of complex interventions and large-scale 
transformations of services is challenging and continues to demand methodological innovation
Innovations in design (cluster randomised controlled trials, stepped-wedge designs and non-randomised 
evaluations) provide decision-makers with a variety of options to meet their evaluation needs. The 
complexity of modern interventions requires effective intervention development. The use of theory and 
logic models can make explicit how the intervention is expected to impact on process and outcome. The 
use of detailed process evaluation to understand delivery in context is also important. Relevance requires 
that evaluations are conducted under real-world conditions, which in turn requires changes in the design 
of randomised trials (e.g. greater use of pragmatic trials). Intervention design and process evaluation 
need to explicitly consider issues of implementation to ensure that trial results can be scaled to drive 
population benefit.
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The increasing complexity of interventions and their evaluation threatens the speed and efficiency of the 
evaluation, and the ability to meet the needs of decision-makers for rapid results. Innovations such as the 
more effective use of electronic health records have significant potential to facilitate rapid trial delivery.
Introduction
Attempts to improve health outcomes or tackle public health problems increasingly make use of complex  
interventions. These are commonly defined as interventions that contain several interacting components.1 
Additional dimensions of complexity include the number of different behaviours required by those 
delivering or receiving the intervention; the range of stakeholders or structures targeted (patients, 
professionals, systems of care); and the degree of variation when the intervention is delivered in 
different contexts.
Complex interventions present a number of specific problems for evaluators. Many of these relate to the 
difficulty of standardising such interventions; their sensitivity to features of local context; and the length 
and complexity of the causal chains linking the intervention with outcome.1 Complexity exists not only in 
the interactions of the different components of the intervention2 but also in its interaction with the wider 
system in which the intervention is embedded.
Although a range of experimental and non-experimental approaches to evaluation have been proposed, 
randomised controlled trials (RCTs) remain the optimal method for obtaining unbiased estimates of 
effectiveness.3 The UK Medical Research Council (MRC) has set out guidance on developing and evaluating 
complex interventions in trials, originally published in 2000, and revised and extended in 2008.1 Others 
have further extended our understanding of relevant research methods in this area.4
As the pace and scope of change in health services has increased, there is also a growing need to evaluate 
not just complex interventions, but also large-scale transformations of services. These have been defined 
as ‘interventions aimed at coordinated, system wide change affecting multiple organisations and care 
providers, with the goal of significant improvements in the efficiency of health care delivery, the quality of 
patient care, and population-level patient outcomes’.5 ‘Integrated care’ for long-term conditions represents 
an excellent exemplar of such a transformation, involving complex packages of care as well as more 
profound changes in workforce configuration, service organisation and funding. The rigorous evaluation 
of such change represents a new level of challenge. The issues of scale and complexity in the evaluation of 
services are further discussed in Essay 6 in this volume.
Evaluators also face additional pressures. Designing, delivering and understanding the operation of 
a complex intervention may require complex, multimethod research designs to both provide rigorous 
assessment and assist in the interpretation of results. Classic RCTs are traditionally long, complicated 
and expensive exercises and are, therefore, under significant scrutiny in an era of financial restrictions 
in research funding and major concerns about research waste.6 New, more pragmatic RCT designs are 
receiving increasing attention.
There is pressure from policy-makers and service managers for rapid evaluation to support short- and 
medium-term decision-making in areas where they face pressing problems of demand and supply. 
While methodological rigour remains critical, increasing importance is placed on the speed with which 
research findings are delivered and translated into practice. Developing and testing innovations to enable 
implementation at ‘pace and scale’ is considered crucial to ensure reach and long-lasting and replicable 
effects. This requires greater attention to the balance between internal and external validity, building 
consideration of later implementation into the design of interventions at an early stage, and may set limits 
around the cost, time scales and sophistication of research designs.
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In this essay, we first describe recent methodological developments in relation to RCTs for the evaluation 
of complex interventions and large-scale transformation. We review current knowledge about available 
approaches, comparing and contrasting methods for different scenarios. We then go on to outline issues 
and practical challenges that could usefully be addressed by those who conduct, fund and regulate 
such research.
Randomised methods
In a conventional RCT, individuals are randomly allocated between alternatives. However, complex 
interventions and large-scale transformations often target levels other than the individual participant. For 
example, whole communities may be targeted by public health programmes; other interventions may be 
aimed at groups of health professionals, or organisations such as general practices.
Contamination of the control group, leading to biased estimates of effect size, is a drawback of RCTs 
of population-level interventions.7 This is likely to occur in situations in which different public health 
promotion interventions are tested within the same community, or the same clinician delivers different 
types of health care to patients.8
Cluster randomised controlled trials
Cluster randomised controlled trials (cRCTs) have emerged partly as a means of addressing such problems. 
The units randomised are pre-existing, natural or self-selected clusters. Cluster members all have an 
identifiable feature in common (such as patients in a single general practice), and outcomes are measured 
in all or in a representative sample. The clusters can vary widely depending on the setting, and range in 
size from families to entire communities.
Methodological discussion of the cRCT appears to have begun in the field of education in the 1940s,8 but 
the design saw only sparse use before the 1980s. However, the last half-century has seen a steady increase 
in cRCTs published in the medical literature: from one per year in the 1960s to over 120 in 2008.8 The 
main implication of the cRCT design is that the outcomes of individuals within the same cluster tend to  
be correlated, which must be accounted for in the analysis. The statistical measure of correlation is known 
as the intracluster correlation coefficient (ICC), defined as the proportion of variation in the outcome that  
can be explained by the variation between clusters. Sample size estimates need to account for this, 
taking into account both the size of the clusters and the ICC. Reliable estimates of ICCs are essential 
for robust sample size calculations. There is increased understanding of the factors that affect clustering 
and therefore the likely magnitude of an ICC. For example, Campbell et al.9 demonstrated that ICCs are 
sensitive to a number of trial-related factors, particularly the setting and the type of outcome. Analysing 
a range of data sets, mainly from the UK, they found that ICCs were significantly higher for process 
than outcome variables and for outcomes in specialist settings compared with primary care. The effects 
of disease prevalence and trial size were less clear-cut.9 Other studies, meanwhile, suggest that ICC is 
associated with prevalence for binary outcome measures.10
There is also growing understanding of how to calculate sample sizes for cRCTs, including scenarios in 
which the size of individual clusters varies.11 This has been incorporated into standard statistical packages, 
and relevant online tools are also available.12
The third development has been the publication of reporting guidelines for cRCTs. These guidelines 
highlight that it is important to indicate the level at which the interventions were targeted, hypotheses 
were generated, randomisation was done and outcomes were measured.13 In 2012, specific guidance 
was published, based on the 2010 version of the Consolidated Standards of Reporting Trials (CONSORT) 
statement and the 2008 CONSORT statement for the reporting of abstracts.14 The guidance includes 
a checklist of items that authors should address when reporting cRCTs, in conjunction with the main 
CONSORT guidelines.15
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There has also been the development of an appropriate ethical framework, The Ottawa Statement on the 
Ethical Design and Conduct of Cluster Randomised Trials. This sets out 15 recommendations, providing 
guidance on the justification for a cRCT; the need for ethical review; the identification of research 
participants; obtaining informed consent; the assessment of benefits and harms; and the protection of 
vulnerable participants.16
Stepped-wedge trials
The stepped-wedge trial has emerged as an alternative to the standard parallel-group cRCT and is 
increasing in popularity for evaluating complex interventions and large-scale transformations.17 The design 
includes an initial period during which no clusters are exposed to the intervention and therefore act as 
controls. Subsequently, at regular intervals (the ‘steps’), one cluster (or a group of clusters) is randomised 
to cross over from control to intervention. This process continues until all clusters have crossed over and 
are exposed to the intervention (Figure 2.1). The appeal of the design is that, at the end of the study, 
there will be a period when all clusters are exposed, but the order of intervention delivery is determined 
at random. Data collection continues throughout the study, so that each cluster contributes observations 
during both control and intervention observation periods.19
The rationale for using this approach, as well as specific methodological considerations, has been 
described in more detail elsewhere.19,20 However, the principal advantage is that it may more adequately 
reconcile the differing needs and priorities of policy-makers and service managers on the one hand, and 
evaluators on the other. It has intuitive appeal, as each cluster eventually receives the intervention and 
acts as its own control. As a consequence, it is particularly suited to interventions in which there is a lack 
of evidence of effectiveness but a strong belief that they will do more good than harm,21 such as efforts 
to improve hand hygiene. It also promotes the phased implementation of novel interventions, permitting 
time for staff training, if this is required. In addition, the researcher may study the effect of time on an 
intervention, such as whether or not adoption or learning is maintained.
Nevertheless, because data collection usually takes place at each time point in the study, the data burden is 
potentially significant. It may also take time before every cluster receives the intervention. In addition, the 
analysis is more complex than that required for a conventional cRCT. Sample size calculations and analysis 
must make allowance for both the clustered design and the confounding effect of time.20 In a stepped-
wedge design, more clusters are exposed to the intervention towards the end of the study than in its early 
stages. Consequently, the effect of the intervention might be confounded by any underlying temporal 
trends if, for example, there has been a general move towards improved patient outcomes, external to the 
study.19 Of course, judging whether or not an intervention is likely to do more good than harm is complex, 
especially when considering wider issues such as opportunity costs. A stepped wedge may mean that all 
clusters are exposed to an ineffective intervention if initial estimates of effect prove unfounded.
FIGURE 2.1 Stepped-wedge trial schema. Shaded cells represent intervention periods, blank cells represent 
control periods and each cell represents a data collection point. Reproduced from Brown and Lilford under the 
terms of the Creative Commons Attribution Licence (CC-BY 2.0), which permits unrestricted use, distribution, and 
reproduction in any medium, provided the original work is properly cited.18
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Selecting a randomised approach
Stepped-wedge trials and cRCTs both offer a means of evaluating complex interventions and large-scale 
transformations. In what situation should one be preferred? Consider a hypothetical study, involving a 
group-based weight loss programme with internet support. Early pilot investigations suggest that the 
intervention is effective, with a primary outcome of weight loss after 6 months. There is interest locally in 
implementing the programme; eight obesity clinics have provisionally agreed to participate.
In this example, we assume a minimum duration of follow-up of 6 months, and monthly introduction of 
the intervention into new clusters. In the event that the intervention is effective, the final results would 
be available in 14 months using a stepped-wedge design. By that stage, all the study clusters would have 
at least 6 months’ experience of using the intervention, and have been reaping the benefits. In contrast, 
if a parallel-arm cRCT were used, this result would have been known within 6 months. Four of the 
clusters would have been delivering the programme since the start of the trial. However, it would now be 
necessary to ‘fast track’ the intervention in the four control clusters.
On the other hand, consider if the intervention were not effective. With a stepped-wedge design, the final 
results would again be available in 14 months. However, by that point, all of the clusters would have been 
exposed to an intervention that does not work, and all would have been delivering it to patients for at 
least 6 months. Consequently, ethical scrutiny of this type of trial is important. In addition, because data 
collection usually takes place sequentially, the researchers would have collected a full set of trial data on 
14 separate occasions (although a smaller number of data collection periods could be considered). If a 
cRCT were used, the results would be known within 6 months. Only half of the clusters would have been 
exposed to an intervention that did not work, and trial data would have been collected only once.
Key questions to be addressed before commencing such a trial include:
 z What is the strength of the evidence that the intervention is more likely to do more good than harm? 
Considerations of costs and opportunity costs may be relevant.
 z As well as effectiveness, what other issues are being assessed by the trial, such as learning and 
possible decay of the intervention effect?
 z How quickly could an effective intervention be rolled out to control clusters if a cRCT were conducted?
The optimal conditions for a stepped wedge are likely to be when there is a lack of evidence of 
effectiveness but a strong belief that the intervention will do more good than harm.20 It may also 
be relevant when measurement of the effect of the intervention over time is important, including 
evaluation of staff learning and the effect of the service ‘bedding down’. In contrast, a cRCT may be 
more appropriate when the evidence of effectiveness is not clear-cut and rapid implementation in control 
clusters is possible. cRCTs have the added advantage that half of the study sample is ‘protected’, should 
the intervention not work, and the data collection burden is minimised.
In many situations, the concerns of those commissioning the evaluation may outweigh methodological 
issues. The constraints under which policy-makers and service managers operate may mean that a 
stepped wedge is the only way to gain agreement to randomisation, because all clusters will receive the 
intervention during the research. As a consequence, stepped-wedge designs may be particularly useful 
when policy dictates that an initiative will be rolled out widely, and there is scope to do this in a stepped 
way to enhance evaluation.
There are examples of successful cRCTs of complex policy interventions, which have successfully negotiated 
issues around randomisation and implementation, such as a cRCT of a scheme to provide free healthy 
breakfasts in Welsh primary schools.22 Of the 608 schools invited to participate, 111 agreed to be 
randomised and participate in data collection activities. Stepped-wedge designs have the potential to 
appear more attractive to stakeholders and may encourage higher levels of participation.
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Pragmatic and explanatory attitudes to trial design
The PRagmatic-Explanatory Continuum Indicator Summary 2 (PRECIS-2) tool is designed to support trial 
design decisions consistent with the intended purpose of a planned RCT. This tool is especially useful if the 
intention is to design a RCT that will have results widely applicable within usual care at whatever level of 
the health service this may be, from primary to tertiary care settings. PRECIS-2 consists of nine domains: 
eligibility criteria, recruitment, setting, organisation, flexibility (delivery), flexibility (adherence), follow-up, 
primary outcome and primary analysis (Figure 2.2). These are discussed until a consensus is reached that 
that particular element of the trial is designed in a way which promotes the goal of the trial, be it a  
real-world applicability or research designed purely to understand efficacy. The process makes research 
teams more aware of the range of opinions and can help to ensure that design decisions are matched to 
the needs of those who will ultimately use the results of the trial.23
FIGURE 2.2 The PRECIS-2 wheel. Reproduced from The PRECIS-2 tool: designing trials that are fit for purpose, 
Loudon K, Treweek S, Sullivan F, Donnan P, Thorpe KE, Zwarenstein M, vol. 350, p. h2147, 2015,23 with permission 
from BMJ Publishing Group Ltd.
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Non-randomised methods
Policy-makers overseeing the rollout of a new programme may not be willing to accept any form of 
randomisation. Even a lack of control over the order of entry of clusters into a stepped wedge may be 
unacceptable. This may be for political reasons, as we have described, or may occur when the intervention 
is already in widespread use, or key decisions about how it will be implemented have already been 
taken.1 In this scenario, the best evidence may come from a study design further down the conventional 
evidence hierarchy, such as a controlled before-and-after study or an interrupted time series. The revised 
MRC guidance cites a range of studies that have successfully evaluated complex interventions using 
non-randomised methods, including bans on smoking in public places,24 the impact of advice about sleep 
position on the incidence of sudden infant deaths25 and the impact of financial incentives on quality.26
Non-randomised methods that attempt to deal with the effects of selection, allocation and other biases 
include matching, conventional covariate adjustment using regression models and propensity score 
methods.27 A propensity score is defined as the conditional probability of an individual receiving an 
intervention, given the observed covariates. It can be used to balance the covariates between study 
groups, and therefore reduce the risk of bias.
This approach is potentially useful for the evaluation of complex interventions where randomisation is 
not feasible or desirable. However, further work is required to enable better adjustment for case-mix 
differences. For example, confounding by indication offers challenges to the analyst. In this situation, 
allocation to treatment is not otherwise ignorable but instead is subject to some latent (unrecognised 
or unmeasured) process associated with those who are treated, for example when skilled clinicians 
use their expert judgement to decide whether or not to treat a patient. This judgement may include 
criteria describing illness severity or patient frailty not included in the propensity score or, more likely, not 
formally measured. Methods such as propensity scores account only for known and observed patient 
characteristics.28 Methods that are better able to deal with unobserved factors include differences-in-
differences analysis, instrumental variable analysis and regression discontinuity designs.29 There is further 
discussion of non-randomised designs in Essay 3 in this volume.
Of course, selection bias is only one form of bias in evaluations of complex interventions and large-scale 
transformations. There are other aspects of good RCT design and delivery that can mitigate other sources 
of bias (such as protocols, pre-specified primary outcomes and analytic plans) which can be applied to both 
randomised and non-randomised designs.30
Many non-randomised designs use routine data, which can have significant limitations in terms of accuracy 
and scope. Such data may lack patient-oriented outcomes such as quality of life and patient experience.  
A recent assessment of a primary care policy initiative in the North West to improve access to care31 was 
able to use routinely collected patient experience data from the General Practice Patient Survey to provide 
a more rounded assessment of outcomes, alongside admissions and health-care utilisation data.
Wider practical issues
In the final section of this essay, we outline practical issues of relevance to those seeking to implement 
RCTs of complex interventions and large-scale transformations.
Challenges in intervention design
As the revised MRC complex interventions guidance highlights, best practice is to develop complex 
interventions systematically and then to test them via pilot studies, before moving on to an exploratory 
and then a definitive evaluation.1 In practice, however, policy implementation often does not follow this 
model, leaving researchers with less opportunity to influence intervention design or delivery. An example 
from England would be the government’s population-wide prevention programme for cardiovascular 
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disease (the NHS Health Check programme), which was rolled out despite a number of uncertainties 
about the evidence base underpinning this approach and how best to encourage the necessary uptake 
among patients to achieve the expected gains.32 Ideally, all intervention development should begin with 
identification of a relevant evidence base. This will often need to be supplemented by the application 
of appropriate theory, which may lead to greater probability of an effective intervention than a purely 
empirical or pragmatic approach.33
Even in cases where researchers cannot influence the design and implementation of an intervention, they 
can usefully help decision-makers to develop a theoretical understanding of the likely process of change by 
articulating the rationale behind it. This includes the changes that might be expected, and how change is 
to be achieved. A ‘logic model’ can help clarify causal assumptions, which may be drawn from behavioural, 
social science or organisational theory. Making explicit the causal assumptions and mechanisms of effect 
can allow external scrutiny of its plausibility and help evaluators decide which aspects of the intervention 
or its context to prioritise for investigation.3
Increasing attention is being paid to the possibility of researchers and decision-makers working together 
to design and subsequently evaluate interventions. One such example is the Practical Approach to Lung 
Health in South Africa (PALSA) trial, conducted in South Africa.34 From the start, researchers worked with 
front-line clinicians and managers to develop a guideline for the management of respiratory disease, which 
was tested and refined prior to implementation and evaluation. This approach is not without controversy, 
not least because decision-makers typically have a commitment to making an intervention work, which 
may impact on the evaluation and interpretation. For example, a metaregression describing features of 
effective computerised clinical decision support systems demonstrated that studies conducted by the 
system developers were more likely to show benefit than those conducted by a third party.35
Importance of process evaluation
Randomised controlled trials remain the best method for making causal inference and providing a reliable 
basis for decision-making. However, the basic RCT design cannot assess how or why an intervention does 
or does not achieve outcomes. To understand this, process evaluations should be routinely included in all 
evaluations of complex interventions to explain discrepancies between expected and observed outcomes, 
to understand how context influences outcomes and to provide insights to aid further implementation.1
Process evaluation can usefully investigate how the intervention was delivered, providing decision-
makers with information about how it might be replicated. Issues considered may include training and 
support, communication and management structures, and how these structures interact with attitudes 
and circumstances of staff to shape the intervention. Process evaluations also commonly investigate the 
reach of interventions, for example whether or not the intended audience comes into contact with the 
intervention, and how.3 On the other hand, interventions may work, but in ways that were not expected 
or predicted.34 Qualitative or quantitative process evaluation may allow modification or updating of ‘logic 
models’ to account for the new data and plan further research. Further consideration is given to the role of 
qualitative methods in evaluative research in Essay 7.
The recently published MRC guidance on process evaluation of complex interventions provides a general 
framework for conducting and reporting this type of study.3 Grant et al.36 also provide a framework for 
design and reporting which is specific to cRCTs and encourages researchers to consider both the processes 
involving individuals in the target population on whom outcome data are collected and the processes 
relating to the clusters within which individuals are nested.
‘Realist’ evaluation methods purport to go beyond conventional evaluations to consider not just ‘what 
works’, but ‘what works, for whom, and in what circumstances?’ In order to answer these questions, 
realist evaluators aim to develop and continually update relevant programme theory, to identify the 
underlying generative mechanisms that explain ‘how’ the outcomes were caused and the influence 
of context.
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Although realist methods are often contrasted with conventional RCTs and systematic reviews, the 
differences may not be so acute.2 For example, quantitative methods linked to RCTs exist for the analysis 
of mediation (to explore ‘how’) and moderation (to assess ‘for whom’), which can usefully complement 
qualitative work.37 Bonell et al.2 also propose that ‘realist’ aims can be examined in the context of RCTs. 
Such ‘realist’ RCTs should aim to examine the effects of intervention components separately and in 
combination, for example using multiarm studies and factorial designs; explore mechanisms of change, for 
example how pathway variables mediate intervention effects; use multiple RCTs to test how intervention 
effects vary with context; draw on complementary qualitative and quantitative data; and be oriented 
towards building and validating ‘mid-level’ programme theories which would set out how interventions 
interact with context to produce outcomes.2 ‘Realist’ RCTs, which not only provide an unbiased average 
effect estimate but also test and refine programme theory, are a potentially important extension of 
existing pragmatic RCT methods. Examples where this approach has been used successfully include a cRCT 
assessing the impact of school fruit ‘tuck shops’ on children’s consumption of fruit and snacks in deprived 
areas in south Wales and South West England38 and an evaluation of a peer-led intervention that aimed to 
prevent smoking uptake in secondary schools in England and Wales.39
The addition of process evaluations to RCTs does highlight potential tensions between quality and depth 
of evaluation, and its speed and efficiency. Process evaluations may require detailed qualitative and 
observational work, which may add significantly to the costs of the research and its duration. There is 
also a tension between an ‘independent’ process evaluation designed to make sense of the eventual 
trial results, and the desire for feedback from the evaluation mid-stream to deal with issues that may be 
limiting effectiveness.3
Designing for implementation
To successfully improve health care and population health, we need complex interventions with a degree 
of flexibility, resilient to contextual variation and therefore more likely to be implemented widely. We 
also require a clear understanding of contextual dependencies (such as target group, resources, system 
requirements) and system impacts. As we have outlined, attention to implementation issues in intervention 
design and understanding how or why an intervention works in the trial setting are both crucial to 
determining whether or not the intervention can be reliably disseminated to other settings.
The traditional linear ‘phases of research’ model remains influential. However, this may not be optimal for 
complex interventions, because it assumes that real-world effectiveness research naturally follows from 
successful efficacy research. As we outlined at the start of this essay, complex interventions interact with 
the context in which they are delivered. Contextual factors that may moderate the effectiveness of the 
intervention across settings and populations may not be adequately considered in design, which means 
that an intervention proven to be efficacious in one context may fail to demonstrate effectiveness when 
implemented in contexts for which it has not been designed.
Work in implementation science seeks to challenge the linear model of translation. It has been suggested 
that the characteristics which cause an intervention to be successful in efficacy research (e.g. intensive, 
complex, highly standardised) are fundamentally different from, and often at odds with, programmes that 
succeed in population-based effectiveness settings (e.g. having broad appeal, being adaptable for both 
participants and intervention agents).40 The Reach, Effectiveness, Adoption, Implementation, Maintenance 
(RE-AIM) model proposed for evaluating complex interventions is intended to refocus priorities on wider 
issues, and give balanced emphasis to internal and external validity.41 The model seeks to determine the 
characteristics of interventions that can reach large numbers of people, especially those who can most 
benefit; be widely adopted by different settings; be consistently implemented by staff with moderate levels 
of training and expertise; and produce replicable and long-lasting effects (and minimal negative impacts) 
at reasonable cost. An alternative model, normalisation process theory, highlights a series of constructs 
representing different types of work that people do in implementation that could inform intervention 
design, and linking it to ideas about agency, social and cognitive mechanisms, and collective action from 
sociology and psychology.42 A range of other relevant frameworks and models have been reviewed.43,44 For 
further discussion of current issues in implementation, see Essay 8 in this volume.
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Greater attention needs to be paid to planning and documenting intervention reach, adoption, 
implementation and maintenance. One solution is to extend feasibility and pilot studies. Such studies 
would not only optimise evaluation methods, and further develop underlying theories or logic models, but 
also allow detailed consideration of how interventions would be adopted, implemented and maintained in 
real-world contexts. However, such methods may increase the cost and duration of evaluation and may not 
always be feasible.
Trial speed and efficiency
As noted in Selecting a randomised approach, a key limitation of current RCTs is their lack of speed and 
high cost, and there is significant interest in ways of making RCT delivery more efficient.
Randomised controlled trials rely on patients, staff and organisations to volunteer to take part. However, 
patient recruitment and retention remains a significant problem45 and the evidence base for recruitment 
and retention is very sparse.46,47 Many health organisations are disengaged with the research production 
infrastructure, which has implications for the generalisability of findings. To maximise replicability, studies 
need to be conducted in a wide range of settings to avoid the clear gaps between the populations in 
research and those to which the results are expected to apply.
There is an urgent need for research to support the more efficient delivery of RCTs.48 This might involve 
use of qualitative research to explore delivery49 or patient and public involvement to design trials more 
sensitive to the needs of patients and other stakeholders.50 More consistent outcome measurement and 
reporting51 might avoid excessive measurement burden. Methodological studies may be usefully embedded 
in existing trials to grow the evidence base for efficient delivery.52,53 The cohort multiple RCT uses routine 
measurement of patients in a cohort to facilitate both recruitment and outcome measurement. Routine 
measurement of patients in the cohort eases the identification of patients for RCTs, while the cohort may 
provide a recruitment process which more naturally replicates clinical practice.
There are exemplars for more efficient trial delivery. The Ontario Printed Education Message Trials 
demonstrate the possibility of conducting large-scale, randomised studies at relatively low cost.54 General 
practitioners in Ontario, Canada, were randomised by practice to receive a range of reminders about 
retinal screening in diabetic patients. The reminders were mailed to each physician in conjunction with a 
widely read professional newsletter. All general practitioners in the province were included in the study, 
and hence the result provides both a pragmatic and a reliable assessment of the intervention in that 
context. Alongside a study of the effectiveness of the various interventions,54 the authors also conducted a 
theory-based process evaluation to assess physicians’ intentions related to referring patients for retinopathy 
screening, as well as their attitude, subjective norm and perceived behavioural control.55
Medical care and associated research is undergoing something of a paradigm shift with the introduction 
and use of electronic health records. These provide major opportunities owing to their scope and 
amenability to analysis. The idea of a ‘learning health-care system’ is based in part on better use of these 
data to support rapid evaluation (including RCTs and other quasi-experiments) and system-wide learning.56 
The potential power of electronic health records in the context of RCTs is beginning to receive attention, 
particularly the potential to study large samples at relatively low cost, driving improvements in efficiency.57 
In the USA, Clinical Data Research Networks supported by PCORnet (National Patient-Centered Clinical 
Research Network) build capacity for conducting both RCTs and observational effectiveness studies by 
collating data in a compatible format from a range of different health-care providers, including integrated 
delivery systems, academic medical centres and safety net clinics.58
Similarly in the UK, cRCTs have been implemented using electronic health records to evaluate the 
effectiveness of computer-delivered decision support tools in reducing antibiotic prescribing for respiratory 
tract infections in primary care59 and improving risk factor control after first stroke.60 Both studies made 
use of electronic health records available via the Clinical Practice Research Datalink (CPRD), which includes 
anonymised data for approximately 7–8% of UK general practices, linked to a range of other data 
RANDOmISED CONTROLLED TRIALS OF COmpLEx INTERVENTIONS AND LARgE-SCALE TRANSFORmATION OF SERVICES
30
NIHR Journals Library www.journalslibrary.nihr.ac.uk
including mortality information and cancer registrations.61 This experience provides compelling evidence 
that RCTs may be performed efficiently in large samples of this kind. Process evaluation may also be carried 
out alongside this type of study.62
However, there are significant challenges. Those who contribute information to data sets such as CPRD 
are skilled at collecting data, and not necessarily representative of their peers. The geographical dispersal 
of sites in RCTs using electronic health records may present a challenge for research governance and 
intervention implementation.63 For example, in a cRCT which used electronic records to study antibiotic 
prescribing, because the practices contributing to the CPRD are anonymous, permission had to be 
sought from 155 separate commissioning organisations for the English general practices alone. Further 
permissions were required in Scotland, Wales and Northern Ireland. The process took almost a year to 
complete before the RCT could commence.63 Such requirements make it difficult to realise the potential 
efficiency gains of such trials.
There are always challenges concerning the accuracy of records, and these records also provide a 
potentially partial view of outcomes. For example, such records rarely include patient-centred outcomes 
such as self-reported quality of life or patient satisfaction. Sometimes, the lack of patient-oriented 
outcomes is less of a problem (e.g. where the focus is on professional behaviour), but there is a danger 
that the efficiency of RCTs using electronic health records means that patient-oriented outcomes are 
de-emphasised compared with ‘harder’ measures such as mortality, or policy-maker and manager priorities 
such as quality of care and health-care utilisation (especially hospital admissions).
Working with decision-makers
Finally, although the purpose of evaluation is to inform decision-making by policy-makers and service 
providers, there is currently something of a disconnect between those who commission research and those 
who deliver it. As we have outlined, challenges may arise because policy-makers are often keen to pilot a 
new intervention in favourable circumstances, and there may be an unwillingness to evaluate at all, in case 
the programme is not effective. Others argue that coproduction of research with decision-makers results 
in a loss of researcher independence. However, there are innovative examples of attempts to bridge this 
gap, such as the National Institute for Health Research Collaborations for Leadership in Applied Health 
Research and Care in England. Evaluability assessments have also been trialled in Scotland, encouraging 
early dialogue between researchers and decision-makers to establish whether or not and how to evaluate 
programmes and policies.64
One of the principal challenges, however, is managing potentially conflicting time scales. Decision-makers 
typically require a swift answer, which may be challenging to deliver using rigorous methods. This may 
be compounded where funding and regulatory approvals must be secured before an evaluation can 
commence, which may make it difficult to conduct baseline assessments prior to an intervention. On the 
other hand, in health systems in repeated flux, managerial staff may not be in post for extended periods of 
time, making it challenging for researchers to establish long-term relationships with key decision-makers. 
In these circumstances, service needs may over-rule methodological concerns, and researchers may have to 
use evaluation methods that would provide the best possible answer in the time available.
Conclusions
There is significant demand from decision-makers for evaluations and many complex interventions and 
service transformations remain unevaluated. Evaluation methodology has progressed significantly in the 
past 10 years. cRCTs are now well established, stepped-wedge designs show great promise, and there 
are an increasing array of non-randomised methods available. There is increasing acceptance of the 
importance of theory in intervention design, and of the role of process evaluation in helping to interpret 
why interventions succeed and fail.
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Nevertheless, we have identified important tensions which face the evaluation community. Development 
of interventions which are efficacious is no longer sufficient. There is now a demand for interventions 
which deliver better outcomes, can achieve those benefits in different contexts and can be implemented 
at pace and scale to ensure that local trial impacts translate into population health impact. At the same 
time, competition for research funding remains acute, and funders and decision-makers demand faster, 
more efficient evaluations that can better meet their needs and timelines. These demands will place a 
premium on continued methodological development to ensure that evaluation keeps pace with innovation 
in health services.
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Abstract
An understanding of the impact of health and care interventions and policy is essential for decisions 
about which to fund. In this essay we discuss quantitative approaches in providing evaluative evidence. 
Experimental approaches allow the use of ‘gold-standard’ methods such as randomised controlled 
trials to produce results with high internal validity. However, the findings may be limited with regard 
to generalisation: that is, feature reduced externality validity. Observational quantitative approaches, 
including matching, synthetic control and instrumental variables, use administrative, survey and other 
forms of ‘observational’ data, and produce results with good generalisability. These methods have been 
developing in the literature and are better able to address core challenges such as selection bias, and so 
improve internal validity. Evaluators have a range of quantitative methods available, both experimental 
and observational. It is perhaps a combination of these approaches that is most suited to evaluating 
complex interventions.
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Scientific summary
An understanding of the impact of health and care interventions and policy is essential to inform decisions 
about which to fund. Quantitative approaches can provide robust evaluative evidence about the causal 
effects of intervention choices.
Randomised controlled trials (RCTs) are well established. They have good internal validity: that is, 
they produce accurate estimates of causal effects for the study participants, minimising selection bias 
(confounding by indication). The findings may, however, be limited with regard to generalisation: that is, 
feature reduced externality validity.
Observational quantitative approaches, which use data on actual practice, can produce results with good 
generalisability. These methods have been developing in the literature and are better able to address core 
challenges such as selection bias, and so improve internal validity.
This essay aims to summarise a range of established and new approaches, discussing the implications for 
improving internal and external validity in evaluations of complex interventions.
Randomised controlled trials can provide unbiased estimates of the relative effectiveness of different 
interventions within the study sample. However, treatment protocols and interventions can differ from 
those used in routine practice, and this can limit the generalisability of RCT results. To address this issue, 
trial samples can be reweighted using observational data about the characteristics of people in routine 
practice, comparing the outcomes of people in the trial with those in practice settings. Evidence for 
similarity of outcomes can be assessed using ‘placebo tests’.
Observational studies may provide effect estimates confounded by indication (i.e. exhibit treatment-
selection bias) because the factors that determine actual treatment options for individuals are also likely to 
affect their treatment outcomes. Observational studies seek to address selection by trying to remove the 
consequences of the selection process. This can be done by using data on all relevant selection factors, 
applying matching methods, including recently developed ‘genetic’ matching, or using regression control.
When selection is likely to be influence by unobserved factors, alternative methods are available that 
exploit the existence of particular circumstances that structure the problem and data. These include 
instrumental variables, regression discontinuity and the difference-in-difference.
There a growing need to demonstrate effectiveness and cost-effectiveness of complex interventions. 
This essay has shown that evaluators have a range of quantitative methods, both experimental and 
observational. However, it is perhaps the use of a combination of these approaches that might be most 
suited to evaluating complex interventions.
Introduction
An understanding of the impact of different health and care interventions is essential in helping us 
to make the best choices when deciding which interventions and treatments to fund. Quantitative 
approaches can provide robust evaluative evidence about the causal effects of intervention choices. 
Randomised controlled trials (RCTs) are well established, but recently there have been significant advances 
and refinements in observational approaches, allowing complex interventions to be assessed in more 
pragmatic settings.
There are significant challenges in the evaluation of complex interventions. Complexity can be taken 
to mean complicated in the sense of interventions with many interdependency components but, more 
pertinently, complexity can also refer to systems that adapt to context and exhibit non-linear responses.1 
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Many health and care policy ‘interventions’ can be regarded as complex in the latter sense, for example 
policies to create closer integration across the care system or to support person-centred approaches to 
management of chronic disease.
Observational or non-experimental methods, though having their own limitations, are an alternative way 
to produce estimates of the causal effects of complex interventions. They rely on ‘natural’ variation in 
a population regarding the characteristics of the intervention, and the factors that affect its outcomes. 
As with experimental approaches such as RCTs, establishing the counterfactual outcome is the key to 
evaluation. In general, treatment choice is according to anticipated prognosis or performance. Hence a 
study that makes unadjusted comparisons of the outcomes of those units (e.g. patients or hospitals) is 
liable to provide estimates of the effect of treatment that are biased owing to selection into treatment 
(also known as confounding by indication). On their own, the observed outcomes of non-recipients of the 
intervention will not be good indicators of the counterfactual outcomes that would have been experienced 
by people who did use the intervention.
Observational approaches seek to address this problem by trying to identify and account for the 
consequences of this selection process. In RCTs, people are randomly assigned between intervention and 
(counterfactual) control groups. In most RCTs there is a selection process for including study participants, 
for example according to eligibility criteria, which may include requiring informed consent. By contrast, in 
observational studies the inclusion criteria tend to be less stringent, which allows these studies to observe 
outcomes for those patients and treatments that are relevant for routine practice.
These contrasting features of RCTs and observational approaches give rise to different properties when 
they are used in evaluations. Two important properties are those of internal and external validity. The 
former, that of internal validity, concerns the extent to which the contrast we are making allows accurate 
estimates of causal effects for the study participants: that is, the study avoids selection bias due to 
treatment selection (confounding by indication). The second, that of external validity, is about the extent 
to which the results of a study are generalisable and applicable to routine practice: that is, the study avoids 
selection bias due to sample selection.
Randomised controlled trials have far greater internal validity owing to the randomisation process 
which removes the effects of selection into treatment, but often have lower external validity owing to 
the restrictions an experimental study places on how an intervention can be delivered and who can be 
included: that is, sample selection. Other essays in this volume delineate the repertoire of randomised 
designs now available in health services research (e.g. Essay 2).
Observational studies, on the other hand, should provide results that are representative of what may be 
achieved in practice, and therefore may have greater external validity. However, the internal validity of 
observational studies is compromised because the assignment of the intervention is conditional on certain 
(unobserved) characteristics (not the play of chance) that also affect outcomes, and this introduces bias 
due to treatment selection.
In other words, we would expect RCTs to provide unbiased estimates of sample average treatment effects, 
but potentially biased estimates of the treatment effects of people receiving the intervention in routine 
practice: that is, of the population average treatment effects of the treated. Box 3.1 provides details.
When evaluating complex interventions, both of these validity requirements can be hard to achieve. 
With regard to internal validity, there are particular challenges in identifying and distinguishing the 
‘intervention’, and precluding cross-contamination between intervention and control groups. Turning 
to external validity, because complex interventions tend to be highly context-specific in their effects, 
generalising the results for policy and practice requires more nuanced analyses of why effects occur,  
not just an estimate of the magnitude of the effect within the RCT setting.
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Suppose we are trying to establish the effects of some intervention. Let y1 be the average observed outcome 
of people who received the intervention in question and y0 be the average observed outcome of people who 
received the comparator intervention. Outcomes will be affected by (a) which people get allocated into the 
intervention and control/comparator groups in a study; and (b) which people are eligible and are sampled 
into the study. We can denote these two processes as the treatment group allocation, t, which can be either 
the intervention (t = T) or the control group (t = C), and the study eligibility group process, s, which, for 
exposition, can be either the study sample group (s = S) or the (real-world) population of potential recipients 
group (s = P). Expected outcomes in a group are therefore conditional on these processes: y1ts = E[y
1jt, s] for 
people getting the intervention and y0ts = E[y
0jt, s] for people not getting the intervention.
Evaluators are often interested in population average treatment effects and, more specifically, the outcome 
of people who would actually be assigned to the intervention in practice (i.e. in the ‘real world’). This is the 
PATT: PATT = y1TP  y0TP. By contrast, the sample average treatment effect of the treated is: SATT = y1TS  y0TS.
In a RCT, the observed outcome from the intervention in the treatment group is y1RCT = y
1
TS and in the control 
group is yRCT = y
0 0
CS. As a result of randomisation, the characteristics of people in the control group will differ 
only on the basis of chance with those in the treatment group, i.e. y0CS = y
0
TS. Therefore, RCTs give unbiased  
(internally valid) estimates of SATT: y1RCT  y0RCT = y1TS  y0CS = y1TS  y0TS = SATT . (Random assignment 
means that in expectation SATT equals the sample average treatment effect.) However, because of the 
study eligibility criteria, RCTs might not give unbiased (externally valid) estimations of PATT. Suppose that 
y1TS = y
1
TP + ε
1
P and y
0
CS = y
0
CP + ε
0
CP  where the ε terms are the differences in outcomes between the sample 
and population. Then y1RCT  y0RCT = y1TP  y0TP + ε1TP  ε0CP = PATT + ε1TP  ε0CP. This is the form of bias known as 
sample selection bias.
An alternative is the non-randomised study. Suppose it is based on a representative sample of actual 
practice: in this case y, y1NRS = y
1
TP and y
0
NRS = y
0
CP. Without randomisation we cannot be confident that the 
treatment and control group have the same (average) characteristics. Therefore, y0NRS = y
0
CP = y
0
TP  µ0TP, 
where µ0TP denotes the difference in outcomes. As a result we have a potentially biased estimate of PATT, i.e. 
y1NRS  y0NRS = y1TP  y0TP + µ0TP = PATT + µ0TP. The term µ0TP is generally known as bias due to treatment selection 
(confounding by indication).
PATT, population average treatment effect of the treated; SATT, sample average treatment effect of the 
treated.
BOX 3.1 Estimation of treatment effects
This essay aims to summarise a range of both established and new approaches aimed at assessing 
and improving internal and external validity for both observational and experimental evaluations of 
complex interventions.
Improving external validity of randomised controlled trials
Why external validity is an issue
Randomised controlled trials, when carried out to a high standard, can provide unbiased estimates of the 
relative effectiveness of different interventions within the study sample. Although much time and attention 
have been given to ensuring maximisation of internal validity through high-quality design and conduct 
of RCTs, problems of external validity have been less rigorously addressed. In RCTs, treatment protocols 
and interventions can differ from those used in routine practice, and therefore results from a RCT may 
be unrepresentative of what would happen in practice. Moreover, regarding complex interventions, the 
effects of the intervention might depend closely on factors outside the study, making the results highly 
context specific. For example, the impact of telehealth could also be affected by local policies regarding 
health and social care integration.
ADVANCINg quANTITATIVE mETHODS FOR THE EVALuATION OF COmpLEx INTERVENTIONS
42
NIHR Journals Library www.journalslibrary.nihr.ac.uk
Assumptions are being made when directly generalising the results of a RCT to target populations: 
first, that the RCT participants have similar characteristics to the target population and that the control 
intervention in the RCT equates to what is provided as usual care in routine practice; and, second, that the 
intervention in the RCT is delivered as it would be if rolled out in practice.
Using observational data to improve external validity of randomised 
controlled trials
There have been recent developments in using observational approaches and data to address the issue 
of external validity. These involve comparing the characteristics of RCT study samples with data from the 
population of people using (or eligible for) the intervention. Trial samples can be reweighted in line with 
the characteristics of people in routine practice, and then the outcomes of the people in the trial can be 
compared with those of people in routine practice. Placebo tests can then be used to assess the evidence 
for similarity of outcomes.
Recent work by Hartman et al.2 has built on previous approaches which have considered the external 
validity and generalisability of results from RCTs. The work illustrates how to extrapolate from the 
sample average treatment effect estimated from a RCT to a population average treatment effect for the 
population of interest, by combining results from experimental studies with observational studies. In 
particular, they specify the assumptions that would be required for a reweighting of the treatment group 
population of a RCT – using observational data on a target population of treated individuals – to produce 
population-treatment effects of the treated.
As well as formally defining the assumptions required for estimating population treatment effects from 
RCT data, Hartman et al.2 also recommend that future randomised trials should consider how the results 
may be combined with observational data, and consider this when designing the trial.
Placebo tests
Placebo tests are an approach for assessing model validity by testing for an effect where none should 
exist. Placebo tests can be used to assess whether or not the assumptions required for generalising RCTs 
to routine practice are likely to be met. In Hartman et al.,2 the placebo tests contrast the outcomes for 
patients who receive the treatment in routine practice with those who receive that same treatment within 
the trial setting, after adjusting for differences in observed patient characteristics between the RCT and 
the routine practice settings. The placebo tests are formulated such that the null hypothesis is that the 
adjusted outcomes from the treatment group in the RCT are ‘not equivalent’ to the outcomes following 
treatment in routine practice.2 If the null is not rejected, then this is an indication that the results of the 
RCT are not generalisable because of differences in the patients or the treatments between the RCT 
and routine practice settings, or that there is insufficient statistical power to reject the null hypothesis 
(with reference to Box 3.1, this is essentially a test of y^1RCT (WTP) + y
1
TP(WTP) where WTP are the observed 
characteristics of the treated population and y^1RCT (WTP) are the reweighted RCT outcomes for the treatment 
group). Placebo tests can also be used to compare control groups in a similar way between sample and 
target populations.
As an example, the use of placebo tests can be discussed using the Whole Systems Demonstrator (WSD) 
cluster randomised trial as an example.3 This was a large RCT that evaluated telehealth against standard 
care. The trial randomised 3230 adults with chronic conditions to either telehealth or usual care, where 
the telehealth arm received home-based technology to record medical information, such as blood glucose 
level and weight, and to answer symptom questions. Information from patients was then transmitted 
automatically to monitoring centres staffed by employees from local health-care organisations. Published 
results were cautiously optimistic and suggested that telehealth patients experienced fewer emergency 
hospital admissions than controls over 12 months [incidence rate ratio 0.81, 95% confidence interval (CI) 
0.65 to 1.00; p = 0.046].4
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Concerns about the generalisability of the WSD trial were raised for several reasons, but in particular 
because emergency admission rates increased among control patients shortly after their recruitment, 
suggesting that these patients may not have received usual care. It was deemed unlikely that this increase 
in admissions represented a normal evolution in service use, and instead it was suggested that health-care 
professionals may have identified unmet needs while recruiting patients to the control group and changed 
the management of this group from usual care or, alternatively, the trial recruitment processes might have 
led to changes in behaviour among patients.4
To assess whether or not the control group in the WSD RCT was representative of usual care, placebo 
tests were carried out.4 A target population of patients who met the RCT inclusion criteria and who 
received usual care (n = 88,830) was identified from observational data. Of these, 1293 individuals were 
matched with the RCT controls on 65 identified baseline covariates (e.g. demographics, blood pressure, 
medications). The placebo test then contrasted outcomes from the RCT between the matched target 
control population and the control group of the WSD trial. This process is described in greater detail in 
Steventon et al.4
A comparison of the RCT control arm versus the matched controls from the observational data gave an 
incidence rate ratio of 1.22 (95% CI 1.05 to 1.43) for emergency admissions. In other words, emergency 
admissions were significantly higher in the control arm of the WSD trial than in a similar group of patients 
who did not participate in the trial. Consequently, the trial results may have shown an inflated beneficial 
effect of telehealth interventions. This example highlights the importance of assessing the generalisability 
of RCT results to a target population. For those settings in which placebo tests fail, Steventon et al.5 
propose sensitivity analyses.
Improving internal validity of observational studies
Addressing the selection problem
Observational studies, no matter how large, may provide effectiveness estimates confounded by indication: 
that is, exhibit treatment-selection bias. Where treatment or intervention assignment uses a decision rule 
that accounts for the characteristics of the individual – for example, the treatment may be more likely to 
be given to the patients in the poorest health – observed outcomes will provide a biased estimate of the 
intervention if these characteristics also directly impact on outcomes. In such an example, the intervention 
group will have lower observed outcomes as a result of their poor health, irrespective of the effects of 
the treatment.
Observational studies seek to address this selection problem by trying to remove the consequences of 
the selection process. The basis of this approach is to account as far as possible for the difference in 
characteristics between people who are getting the intervention and those who are not. This method 
generally relies on being able to observe all relevant characteristics, which in practice is never entirely 
possible. Where we anticipate having data on all relevant confounders, adjustment can be made using a 
number of well-documented methods, including regression and matching (e.g. propensity and prognostic 
scoring). More recent developments in this regard include ‘genetic’ matching.
When we do not anticipate being able to identify all confounders, adjustment is more complex. Where 
selection is on unobserved characteristics, methods include the use of instrumental variables (IVs), 
regression discontinuity and the difference-in-difference approach. These methods exploit the existence 
of particular circumstances that structure the problem and data to address the selection problem. There 
have been a number of significant refinements of these approaches in recent years, including the use of 
synthetic controls and improved diagnostics.
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The difference-in-difference method
The difference-in-difference approach addresses the selection problem by comparing the experiences of a 
control group with the intervention group before and after the intervention. The idea is that, under certain 
assumptions, selection bias can be controlled for by removing any difference in the outcome indicator 
between groups before the intervention from differences after the intervention.
From Figure 3.1, β
4 
is the unadjusted difference in outcome indicators between the two groups after 
the intervention. By contrast, β
3 
is the adjusted difference, and provides a (less) biased estimate of the 
intervention effect as it takes into account differences in the outcome measure between the two groups 
that were present at the start of the evaluation period. In this linear example, β
1
 is the size of the selection 
bias. The unbiased estimate β
3
 in this example is found by subtracting the difference β
1 
at baseline (time 
t = 0) from the difference β
4 
at time t = 1.
The difference-in-difference approach was utilised in an evaluation of personal health budgets (PHBs), 
which was a policy piloted in 2009 whereby patients were given control over their own budgets to meet 
their care needs.6 A fully RCT proved unfeasible, so a pragmatic design was chosen whereby some sites 
were randomised while others selected participants. The study comprised 2000 participants covering a 
range of health conditions. For illustration, one of the main outcome measures was care-related quality 
of life (Adult Social Care Outcomes Toolkit; ASCOT). At baseline the PHB group had (significantly) lower 
ASCOT scores than the control group. When measured at follow-up, the PHB group still had lower ASCOT 
scores than the control group, but the gap had closed. Subtracting the larger negative difference at 
baseline in the scores produced a result whereby the PHB group had significantly higher (better) scores 
than the control group at follow-up. Without accounting for the poorer quality of life of the PHB group 
prior to the intervention, this selection bias might have led to opposite conclusions about the effectiveness 
of PHBs.
A range of assumptions is required for the difference-in-difference approach to give unbiased estimates. 
It can be applied where there is only a partial uptake to a new intervention, allowing for a control group, 
and where there is a defined before-and-after time, recorded in the data. Although it can also control 
for persistent differences between groups that are not related to the intervention, it is a less appropriate 
FIGURE 3.1 The difference-in-difference approach.
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method where baseline factors may influence the rate of change of outcomes during the follow-up period, 
that is, when there are unobserved pretreatment differences between the groups whose effects change 
over the follow-up period. For this, the synthetic control method may be a more appropriate approach.
Synthetic controls
The synthetic control method also aims to control for treatment selection bias by using covariates and 
outcomes of the intervention and control groups prior to implementation to adjust outcomes after the 
intervention. The method exploits the availability of multiple time points and control units (e.g. different 
localities) prior to baseline to try and adjust for those unobserved characteristics whose effects may differ 
over time. A ‘synthetic’ control sample is constructed by weighting together multiple control units in 
such a way that the expected outcomes in the pre-implementation period are similar for the control and 
intervention groups, in order to minimise the treatment selection bias because of unobserved factors 
whose effects vary over time.
The synthetic control method estimates treatment effects by using this weighted synthetic control group 
to represent the counterfactual outcomes for the treated group after implmentation.7 The idea behind 
synthetic controls is that a combination of units (where units may be hospitals, general practices, an area 
or region, etc.) often provide a better comparison for the unit exposed to the intervention of interest  
than any single unit alone. Furthermore, as the choice of synthetic control does not require access to  
post-intervention outcomes, this method allows researchers to decide on study design without knowing 
how these decisions will affect the resulting conclusions: an important issue for reducing potential research 
bias in observational studies.7
Kreif et al.8 carried out an analysis to compare and contrast both the difference-in-difference method 
and synthetic controls for an evaluation of the Advance Quality (AQ) programme, which is a pay-for-
performance initiative linking health-care provider income to quality measures. The initiative was first 
introduced into 24 hospitals in the North West of England, with the other nine regions in England 
providing a potential comparison group of 132 hospitals. Figure 3.2 shows the trajectory of the difference 
from expected mortality rates before and after the implementation of the AQ programme, in both the 
North West and the rest of England. For control regions, the size of the difference from the expected 
mortality rate is relatively constant and fluctuates around zero for the period of observation. For the 
North West, the mortality rate is higher than would be expected before AQ, but this improves after the 
introduction of the AQ programme. What is clear from the graph is that there is little evidence to support 
the assumption of parallel trends required for a (standard) difference-in-difference approach.
For the synthetic control method, a control group was selected from the potential pool of 132 hospitals 
according to pre-intervention characteristics of hospital type, size and scale, and hospital quality measures. 
The controls were weighted according to the pretreatment trajectory of the intervention hospitals 
(Figure 3.3) and hence the synthetic control is more representative of the counterfactual outcome for the 
intervention hospitals.
For this particular example, when using a synthetic control comparator it was found that the AQ initiative 
did not significantly reduce 28-day hospital mortality. This is in contrast to the original analysis that found 
a significant reduction in mortality in the AQ group. This highlights the need to consider how well analysis 
assumptions are met when choosing an appropriate method, and also the importance of considering 
alternative approaches and contrasting the results. In this example, the difference-in-difference approach 
appeared to be flawed in that the parallel trends assumption was poorly met. The synthetic control 
method should be considered as an alternative approach if parallel trends are not present, although 
this method does require data on a sufficiently long pretreatment period to allow for the selection and 
weighting of an appropriate control group. More details on this analysis and other alternatives are 
provided in the paper by Kreif et al.8
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FIGURE 3.2 The observed risk adjusted mortality in pneumonia patients for the North West vs. rest of England 
before and after the introduction of AQ. Adapted from Kreif et al.,8 © 2015, John Wiley & Sons Ltd., under  
the terms of the Creative Commons Attribution International Public Licence (CC BY-NC 4.0), which permits use,  
distribution and reproduction in any medium, provided the original work is properly cited, the use is  
non-commercial and is otherwise in compliance with the licence.
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FIGURE 3.3 Comparison of the intervention hospitals with the weighted synthetic control group, pre and post 
intervention. Adapted from Kreif et al.,8 © 2015, John Wiley & Sons Ltd., under the terms of the Creative Commons 
Attribution International Public Licence (CC BY-NC 4.0), which permits use, distribution and reproduction in any 
medium, provided the original work is properly cited, the use is non-commercial and is otherwise in compliance 
with the licence.
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Instrumental variables
The concept of IVs has been around for over half a century, and they are widely used in economics 
because of the difficulty of doing controlled experiments in this field.9 Despite their popularity in 
economics, they have been little used in the biostatistical literature, but their popularity is growing as they 
may provide a useful methodology for addressing the selection problem posed by observational studies 
when relevant instruments can be identified.
The essence of an IV approach is to find an indicator that is highly related to the treatment or intervention 
being assessed but does not independently affect the outcome of interest.10 There is an analogy with the 
RCT approach in that the random allocator can be regarded as a perfect instrument.11 In an IV analysis, the 
intervention variable is therefore replaced by the chosen IV, to remove the dependence of the intervention 
variable (or assignment) on the unobserved confounders which might influence outcomes other than 
through the intervention. This reduces, or in the case of very large samples eliminates, the selection bias. 
The use of IVs will be illustrated with an example.
A 2009 survey of service care utilisation by the elderly was carried out, with the aim of assessing the  
cost-effectiveness of the services provided.12 In this case, the intensity of service utilisation was expected 
to be directly related to a patient’s level of frailty and ill-health, as these factors are key elements in the 
patient’s assessment of need. Therefore, methods had to be considered which distinguished the variation 
in care-related quality of life owing to service use as opposed to other factors.
Data were collected on a range of outcome measures, including a measure of social care-related quality 
of life (SCRQOL), using the ASCOT measure.13 As is common with health and care utilisation data, the 
observed relationship between the intensity of service utilisation and the outcome (care-related quality 
of life) was negatively sloped. In other words, unadjusted data would suggest a negative effect of care 
utilisation on care-related quality of life. However, this observed result was probably attributable to 
selection bias because the amount of service a person was offered in the care system was related to their 
baseline level of need (e.g. severity of health condition), which was in turn negatively correlated with their 
quality of life. Observed confounders – for example indicators of need or poor health – can be used to 
control for selection, but there may be many other unobserved factors that influence both selection  
(i.e. in this case the amount of service) and outcomes.
To address these, an IV analysis was carried out. An IV was needed that was related to the amount of 
service a person received but not their current SCRQOL score. As different local authorities used different 
service eligibility policies, this characteristic could be used as an instrument. With the use of the  
IV controlling for both known and unknown confounders, a significant positive association between 
intensity of service use and care-related quality of life was found.
Instrumental variables have a number of applications and have been used in recent studies assessing NHS 
expenditure on mortality and quality of life,14 impact of social care use on hospital utilisation15 and impact 
of care services on hospital delayed discharge rates,16 to name but a few. They can be an effective way  
to deal with unobservables, and are useful for adjusting for treatment selection problems that occur 
in non-randomised studies, but, as with all methods, there are limitations.11,17 The key challenge is to 
find suitable instruments and, once chosen, to demonstrate that the choice of IV was appropriate. A 
crucial assumption for the correct use of IVs is that the IV is (strongly) associated with the intervention of 
interest but not directly to the outcome. This condition cannot be directly evaluated, although a range of 
diagnostic tests may help to inform instrument specification. Nonetheless, the choice of the IV is often 
largely based on prior judgement. Poor or ‘weak’ instruments will lead to significant bias, potentially 
offsetting reductions in selection bias. IV analyses need a large sample, and results from an IV analysis 
may still be biased. Recommendations and guidance around the use of IVs for the evaluation of complex 
interventions would be a useful step for taking these methods forward.
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Propensity scores
The above sections discuss methods that are suitable when not all of the selection characteristics are 
known. When it is believed that all the factors on which selection of the intervention group has been 
based are known and observed, propensity scores can be used. Propensity scores were first described in 
the early 1980s.18 A propensity score is developed by using a statistical model to estimate the individual 
likelihood that patients will receive treatment, using known explanatory variables such as demographic 
and medical history, prescribed drugs and consultation behaviour. This enables a propensity score to 
be calculated for each patient: that is, the likelihood that they will receive treatment or ‘fitted value’. 
Propensity scores can then be used either for adjustment in statistical models or to create matched groups 
by selecting treatment and control groups with similar propensity scores.19 Propensity score approaches 
have been used extensively in applied health research.
Although propensity scores go some way towards adjusting for selection bias in observational studies, 
they do not assure internal validity. Propensity scores can only be based on known and observed 
patient characteristics.
There is evidence of how propensity score approaches can fail to adequately address bias. The Randomised 
Aldactone Evaluation Study (RALES)20 evaluated spironolactone (Aldactone, G.D. Searle LLC), an 
aldosterone inhibitor, compared with placebo, and found that it reduced mortality in patients with 
severe heart failure (hazard ratio 0.70, 95% CI 0.60 to 0.82; p < 0.001). The results of this RCT were 
subsequently confirmed in two further trials.21,22
Freemantle et al.19 attempted to replicate the results of the RALES and subsequent trials using data from 
the Health Improvement Network, with the ultimate objective of bridging from the trial population to 
a real-world population of people with heart failure. As it was believed that a number of factors would 
influence the prescribing of spironolactone to patients, a complex propensity score was developed to 
account for this, which included information on patient demographics, comorbidities and current drug 
treatments. Two groups (n = 4412) treated and not treated with spironolactone, tightly matched on 
propensity score, were then selected for the analysis. An initial comparison of the two matched groups 
appeared to show results contradictory to those from the RALES trial, in that patients treated with 
spironolactone had an increased mortality risk (hazard ratio 1.32, 95% CI 1.18 to 1.47; p < 0.001).
The performance of a propensity score may be evaluated by assessing its homogeneity at different points 
on the scale. Figure 3.4 shows that, for different values of the propensity score (divided into quartiles), 
different estimates of the effect of spironolactone on mortality risk were estimated. If the propensity score 
had worked well, one would expect to see similar treatment effects across all strata. For this example, 
it appears that the prescriber making the clinical decision to treat with spironolactone used additional 
information on severity of heart failure that was not captured by the propensity score. Therefore, the 
matching of the two groups for the analysis was not appropriate, resulting in individuals with too low 
a risk of mortality being matched to the spironolactone patients. In particular, this affects the results 
of the apparently low-propensity subjects: that is, the lowest two quartiles of the propensity score (see 
Figure 3.4), where the hazard ratio for spironolactone is particularly high, although a bias is present across 
the entire range of the score.
Propensity scores assume that all important variables have been included and that there are no additional 
processes related to disease severity that are associated with who receives the treatment of interest and 
who does not.
This analysis highlights the risks of using propensity scores where they do not adequately adjust for 
confounding by indication. Propensity scores, like all observational methods, need to be developed and 
used with caution, and results from propensity analyses need to be interpreted with caution. A useful 
starting point, as was taken in this example, is to start with the replication of a known treatment effect, 
and bridge from there to consider further unanswered questions. Considering the interaction between the 
propensity score and treatment outcome may also be a useful step to aid understanding of the score.
DOI: 10.3310/hsdr04160-37 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 16
49
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Raine et al. under the terms of a commissioning contract issued by the Secretary of State for  
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be 
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science 
Park, Southampton SO16 7NS, UK.
FI
G
U
R
E 
3.
4 
R
es
u
lt
s 
o
f 
th
e 
p
ro
p
en
si
ty
 s
co
re
 a
n
al
ys
is
 (
o
ve
ra
ll 
an
d
 in
 q
u
ar
ti
le
s)
 c
o
m
p
ar
ed
 w
it
h
 t
h
e 
re
su
lt
s 
o
f 
th
e 
R
A
LE
S 
tr
ia
l. 
H
R
, h
az
ar
d
 r
at
io
. A
d
ap
te
d
 b
y 
p
er
m
is
si
o
n
 f
ro
m
 B
M
J 
Pu
b
lis
h
in
g
 G
ro
u
p
 L
im
it
ed
. M
ak
in
g
 in
te
rf
er
en
ce
s 
o
n
 t
re
at
m
en
t 
ef
fe
ct
s 
fr
o
m
 r
ea
l w
o
rl
d
 d
at
a:
 p
ro
p
en
si
ty
 s
co
re
s,
 c
o
n
fo
u
n
d
in
g
 b
y 
in
d
ic
at
io
n
, a
n
d
 o
th
er
 p
er
ils
 f
o
r 
th
e 
u
n
w
ar
y 
in
 
o
b
se
rv
at
io
n
al
 r
es
ea
rc
h
, F
re
em
an
tl
e 
N
, M
ar
st
o
n
 L
, W
al
te
rs
 K
, W
o
o
d
 J
, R
ey
n
o
ld
s 
M
R
, P
et
er
se
n
 I,
 v
o
l. 
34
7,
 p
. f
64
09
, ©
 2
01
3.
19
 
0.
5
R
A
LE
S 
19
99
O
ve
ra
ll 
Pr
o
p
en
si
ty
 S
co
re
 M
at
ch
ed
 A
n
al
ys
is
Pr
o
p
en
si
ty
 S
co
re
 Q
u
ar
ti
le
 >
 7
5%
 t
o
 1
00
%
Pr
o
p
en
si
ty
 S
co
re
 Q
u
ar
ti
le
 >
 5
0%
 t
o
 <
 7
5%
Pr
o
p
en
si
ty
 S
co
re
 Q
u
ar
ti
le
 >
 2
5%
 t
o
 <
 5
0%
Pr
o
p
en
si
ty
 S
co
re
 Q
u
ar
ti
le
 <
 2
5%
0.
70
 (
0.
60
 t
o
 0
.8
2)
, p
 <
 0
.0
00
1,
 n
 =
 1
66
3,
 e
ve
n
ts
 =
 6
70
1.
32
 (
1.
18
 t
o
 1
.4
7)
, p
 <
 0
.0
00
1,
 n
 =
 4
41
2,
 e
ve
n
ts
 =
 1
28
5
1.
20
 (
0.
98
 t
o
 1
.4
7)
, p
 =
 0
.0
85
, n
 =
 1
10
3,
 e
ve
n
ts
 =
 3
69
0.
99
 (
0.
81
 t
o
 1
.2
1)
, p
 =
 0
.9
1,
 n
 =
 1
10
3,
 e
ve
n
ts
 =
 3
88
1.
46
 (
1.
16
 t
o
 1
.8
3)
, p
 =
 0
.0
01
, n
 =
 1
10
3,
 e
ve
n
ts
 =
 2
98
2.
01
 (
1.
54
 t
o
 2
.6
3)
, p
 <
 0
.0
00
1,
 n
 =
 1
10
3,
 e
ve
n
ts
 =
 2
30
H
R
 (
95
%
 C
I)
, p
, n
, e
ve
n
ts
1
2
5
ADVANCINg quANTITATIVE mETHODS FOR THE EVALuATION OF COmpLEx INTERVENTIONS
50
NIHR Journals Library www.journalslibrary.nihr.ac.uk
More recent studies have suggested that alternative approaches to generating a matched control group 
may perform better. An approach that may hold particular promise is ‘genetic matching’, which does not 
assume that there is a propensity score which is correctly specified but rather uses a multivariate matching 
(genetic) algorithm to produce a matched control group to maximise the balance of observed covariates 
between the treatment and control groups.23
Moving forward with quantitative methods for evaluating 
complex interventions
The growth in the availability of administrative, survey and other forms of ‘observational’ data offers huge 
potential for improved and more comprehensive evaluation of health and care interventions. Experimental 
trials, although allowing the use of ‘gold-standard’ methods such as RCTs, are often very expensive and 
time-consuming. Moreover, as outlined in this paper, the findings of RCTs may be limited with regard to 
generalisation: that is, feature reduced externality validity. Observational quantitative approaches can offer 
alternative methods of evaluation, particularly for complex interventions, by helping to both address  
issues of generalisability of RCT results and provide direct estimates of treatment effects. Methods for 
observational or non-randomisation studies have been advancing substantially in the literature, with many 
innovations now available to better address core challenges such as selection bias, and therefore to better 
improve internal validity Other essays in this volume (particularly Essays 6 and 7) describe other features of 
optimal study designs to evaluate complex features of health and care systems.
Observational studies will always be subject to treatment selection bias to some extent, and so have 
reduced internal validity compared with RCTs. Nonetheless, methods such as matching, synthetic control 
and IVs may mitigate the problem, if not completely eradicate any biases, especially when there are 
unknown confounding factors. Observational studies, therefore, can be used in place of RCTs to estimate 
treatment effects if careful consideration is given to the analysis and it is accepted that some bias will 
remain.24,25 Observational methods are also being used alongside RCTs to directly tackle the issue of 
representativeness of experimental studies.
The growing availability of routine data allows the use of observational methods. Although the quality, 
availability and completeness of routine data could always be improved to allow its easier use for the 
assessment of complex interventions, routine data can be used at relatively low cost and often have large 
scale and breadth (if not depth). Arguably, routine data sets are an underutilised resource, and greater 
investment to improve routine data sets and make them more research-friendly would increase their 
usage. Of course, routine data have their limitations: primary outcomes of interest may not be recorded, 
and there may be issues with the completeness and compatibility of data sets. In general, though, they 
have high external validity as they draw on data about everyday operation, and they can accommodate 
a high degree of subgroup analysis to explore why and when an intervention works. More pragmatically, 
observational studies based on routine data are generally low cost and have high feasibility.
Quantitative methods for estimating the causal effects of complex intervention inevitably make strong 
assumptions which must be critically examined. Future studies should report effectiveness estimates 
according to approaches that make different but plausible underlying assumptions. Where new methods 
are being utilised, it would be useful to compare the results with those from standard or appropriate 
alternative methodologies, and implications of the chosen analysis should also be explored through 
sensitivity analyses.
There is a growing need to demonstrate effectiveness and cost-effectiveness of complex interventions. 
Although just scratching the surface, this essay has shown that evaluators have a range of quantitative 
methods available, which include those in both the experimental and the observational toolboxes. 
However, it is perhaps the use of a combination of these approaches that might be most suited to 
evaluating complex interventions.
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Abstract
A growing consensus has emerged about patient-reported outcome measures (PROMs) as an important 
tool in the evaluation of services. There is little dispute regarding the range of relevant dimensions 
of health status, the types of measures available to capture what matters to patients, their required 
measurement properties and reporting standards when PROMs are used in studies. Their use on a large 
scale in the NHS national PROMs programme has produced valuable lessons about elective surgery but  
also about PROMs as tools.
There are outstanding issues if PROMs are to be further applied in the evaluation of services. Patients 
need to be actively engaged. Health professionals need to see the merits of this approach to patient care 
and outcome assessment. PROMs need to be integrated into health records. Some recent initiatives have 
attempted to address these three needs, and further development and testing of such initiatives is needed.
Scientific summary
A growing consensus has emerged about patient-reported outcome measures (PROMs) as important tools 
in the evaluation of services. There is little dispute regarding the range of relevant dimensions of health 
status, the types of measures available to capture what matters to patients, their required measurement 
properties and reporting standards when PROMs are used in studies. Their use on a large scale in the NHS 
national PROMs programme has produced valuable lessons about elective surgery but also about PROMs 
as tools.
Respondent engagement is fundamental to ensure adequate response rates to be able use outcomes 
for the evaluation of services. Evidence exists that patients with poorer health status at baseline impact 
on response rates which may produce misleading evidence of the effectiveness of services. Different 
mechanisms for the delivery and capture of PROMs are being developed such as electronic data collection 
and use of other media. This could complement existing paper-based methods and has the potential to 
reduce respondent burden of completion.
Specific populations pose particular challenges in engagement such as those with developmental 
limitations (children) and those with cognitive impairment such as patients with dementia or learning 
difficulties. In addition, the collection of baseline measurement in patients experiencing acute or 
emergency health problems poses difficulties.
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Missing or incomplete data present analytical problems and, despite a range of statistical procedures used, 
performance of services could be influenced by methods adopted.
Evidence suggesting there is diversity in levels of staff engagement from enthusiasm to scepticism. 
Difficulties are apparent in relation to understanding and interpretation of the data, as well as the 
challenges of incorporating data into existing systems and processes of care. This results in little impact  
of PROMs data used for service improvement.
Further evolution in PROMs is still needed so that they focus as much on practical, feasible and clinically 
actionable content as on the psychometrically validated content emphasised to date. Development  
and testing of feasible software, platforms and electronic health records needs to be developed to support 
PROMs as a routine feature of both clinical care and evaluative research. Training of staff to strengthen 
understanding of PROMs and interpreting will be essential. Most outstanding of all will be the need to 
establish benefits to patients. There is much speculation about PROMs supporting and informing  
patients’ choice of health-care options, health and consulting behaviour and self-management, but there 
are very few studies to demonstrate such benefits.
Introduction
Health services are under constant pressure to be more patient centred and positively valued by patients 
and the public. Evaluative research reflects that pressure by increasingly assessing outcomes as perceived 
by patients. Patient-reported outcome measures (PROMs) are a diverse array of questionnaires and related 
techniques intended to obtain patients’ own views of their health status and benefits experienced from 
receiving health services. Because of their focus on accurately capturing the patient’s perspective on 
outcomes, they have been seen for some time as having enormous and distinctive potential to transform 
the assessment of the performance of services.1 A recent overview described measures of health status 
(effectively PROMs) as ‘. . . the most important scientific development in the last 50 years in the field 
of health services research’.2 This essay provides an overview of the progress that has been made in the 
measurement of patients’ views of health status and outcomes, and identifies some of the key challenges 
to be faced in their further use to evaluate services.
Applications of patient-reported outcome measures
Patient-reported outcome measures have been considered as solutions to a diverse range of problems.  
First developed over 40 years ago, they were early on considered as invaluable outcome measures in  
health services research, for example in the widely cited randomised controlled trial (RCT) of alternative 
mechanisms of reimbursement, the RAND Health Insurance Experiment.3 Recent examples of the use of 
PROMs as outcomes in large multicentre health services research include their use to judge the benefits  
of personally controlled health budgets,4 and as outcomes of telehealth services.5 It is in the adjacent field 
of clinical trials that PROMs have been most widely applied, often as secondary outcomes to weigh against 
traditional indicators such as mortality but occasionally as the primary end point. A recent survey of nearly 
100,000 clinical trials published between 2007 and 2013 found that a PROM was used in 27% of trials.6  
A specific subset of such trials includes cost–utility analysis, estimating utility or net value of a treatment 
by means of a particular type of PROM described in Types of patient-reported outcome measure as 
utility measure.
Another use of the PROM is to provide alternative expressions of health need in the population. A classic 
example is the use of a measure, a version of the Sickness Impact Profile, to assess the epidemiology of 
disability in London.7 A related application is their use as prognostic variables and impressive evidence 
exists for this use in areas such as cancer.8
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Patient-reported outcome measures are beginning to be used as instruments to contribute to local quality 
improvement developments; for example, Nilsson et al.9 recently reviewed the use of PROMs in Swedish 
disease registers and found PROMs commonly used this way. There is growing interest in whether or 
not they have a role in improving individual patient care, for example by strengthening shared decision-
making or improving the detection and management of patients’ problems. Trials to date have had mixed 
results.10,11 As will be argued later, their acceptance in routine patient care may prove to be crucial to 
furthering their use in evaluative research.
The example of cancer provides compelling evidence of why validated PROMs are needed to evaluate the 
performance of services. Generally, health professionals show poor understanding of how cancer affects 
quality of life, both in regular care and in evaluative research. In clinical trials for ovarian cancer, patients 
reported more symptoms and reduced quality of life compared with clinician-completed toxicity scales.12 
Vera-Badillo et al.13 reviewed a series of breast cancer trials and found both bias and under-reporting of 
toxicities. Di Maio et al.14 compared the reports by patients and physicians of six specific toxicities reported 
by patients and physicians (anorexia, nausea, vomiting, constipation, diarrhoea and hair loss) in three RCTS 
for cancer. Physicians consistently under-recognised and under-reported toxicities. Such results mean not 
only that the benefit-to-harm ratio of treatments is often inaccurate but also that the higher burdens on 
patients experiencing these symptoms can lead to non-adherence or dose reductions limiting the expected 
clinical benefits.
Some recent developments have raised the visibility of PROMs as a distinctive lens through which to 
assess the quality of health services. In England, a national PROMS programme was introduced in 2009 
mandating the use of PROMs for NHS patients in relation to selected elective surgical procedures. This is 
described further in A case study: patient-reported outcome measures and NHS elective surgery because of 
its very size, ambition and potential lessons.
In the USA, major impetus for PROMs has stemmed from the establishment with major funding 
by Congress of the Patient-Centered Outcomes Research Institute (PCORI) designed to answer key 
uncertainties in health-care delivery by the conduct of patient-centred comparative effectiveness 
research. A key feature of the work of PCORI is that patients and patients’ values should be 
central to every stage of health research.15 Not surprisingly, the application and improved 
methods for patient-reported outcomes are therefore a priority (www.pcori.org/events/2013/
patient-reported-outcomes-pro-infrastructure-workshop).
Developing consensus
There is substantial and growing consensus about PROMs. This essay focuses on four key areas 
of agreement: relevant dimensions, required measurement properties, types of measure and 
reporting standards.
Relevant dimensions
A key feature of PROMs is that they assess health in the broadest sense. Individual instruments vary in 
content but the domains identified in Box 4.116 cover most aspects of health status addressed by PROMs. 
In their most common form, measures of dimensions of health status, such as are shown in Box 4.1, 
are assessed before and after an intervention, and, strictly, it is the change over time that renders the 
expression of an outcome that, in principle, may be attributed to an intervention.
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Measurement properties
There is broad agreement about the measurement properties required of a PROM and techniques used 
to assess such properties. Reliability is the extent to which a PROM is free from measurement error 
and reproducible. Face and content validity concern basic judgements about whether or not items of a 
questionnaire appear to address the experiences relevant to respondents. In practice, this is commonly 
judged from evidence of the extent to which patients have fully contributed to the derivation and approval 
of content of an instrument. Construct validity is evaluated to explore the hypothetical constructs it purports 
to measure and ensure that there is a statistical relationship between measures of similar constructs. The 
measure should avoid ceiling or floor effects demonstrating precision of measurement. Consideration of the 
ability of the measure to detect change and ensure responsiveness is particularly important for PROMs, most 
usefully tested against the respondent’s own retrospective judgement of change. When used to determine 
the ‘value’ of treatments from an international perspective, cultural sensitivity and appropriate forwards and 
backwards field-testing of translations are also vital to demonstrate.
These properties are familiar from other fields of measurement in science. They are tested by a range of 
methods familiar from classical psychometrics as well as more recently applied techniques such as Rasch 
Analysis and Item Response Theory.17
However, as PROMs are almost invariably used with patients receiving health care for real presenting 
problems, it is as important to consider the acceptability of PROMs along with their technical measurement 
properties in order to minimise burden. Minimal burden should also strengthen response rates and hence 
the generalisability of results.
Physical function
Mobility, dexterity, range of movement, physical activity
Activities of daily living: ability to eat, wash, dress
Symptoms
Pain, nausea, appetite, energy, vitality, fatigue, sleep and rest
Global judgements of health
Psychological well-being
Psychological illness: anxiety, depression
Coping, positive well-being and adjustment, sense of control, self-esteem
Social well-being
Family and intimate relations, social contact, integration, and social opportunities, leisure activities, sexual 
activity and satisfaction
Cognitive functioning
Cognition, alertness, concentration, memory, confusion, ability to communicate
Role activities
Employment, household management, financial concerns
Personal constructs
Satisfaction with bodily appearance, stigma and stigmatising conditions, life satisfaction, spirituality
Satisfaction with care
Reproduced with permission from Fitzpatrick et al.16 Contains information licensed under the Non-Commercial 
Government Licence v1.0’ from this link: http://www.journalslibrary.nihr.ac.uk/rights_and_permissions.
BOX 4.1 Dimensions of health in PROMs
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Types of patient-reported outcome measure
There is broad agreement about the range of types of PROM available and their respective merits.
Generic PROMs are more commonly multidimensional and applicable across a range of conditions, and 
enable comparison within and between different health conditions, populations and interventions.  
The SF-36 (Short Form Questionnaire-36 items) is probably the most widely used such measure.
Preference-based measures, such as the European Quality of Life-5 Dimensions (EQ-5D) (www.euroqol.
org/), provide a descriptive profile and index of a person’s health status in the form of a utility derived 
from public preferences for different health states and weighted accordingly. The distinctive role of such 
measures is therefore used in economic evaluations such as cost–utility analyses. They are a specific 
subtype of generic measure.
Disease- and or procedure-specific PROMs aim to represent particular aspects of health status relevant, 
for example, to patients living with diabetes or those undergoing a specific procedure, such as joint 
replacement. The distinctive merit of such measures is to be maximally sensitive to the particular 
challenges posed by a given disease and, therefore, maximally sensitive to benefits of an intervention for 
the condition.
Individualised measures of health status elicit patients’ personal goals and concerns regarding their health, 
thereby avoiding the standardised format of the other measures just described.
A common strategy in the evaluation of a specific intervention for a limited range of conditions is to 
recommend that an evaluation include a generic and a disease-specific measure to address the widest 
spectrum of anticipated and unanticipated outcomes.
Reporting standards
The field has evolved to the extent that a range of guidelines has now been developed relevant to many 
aspects of PROMs and their use. Thus, several influential guidelines have emerged regarding appropriate 
methods and standards for the development of a PROM.18,19 Other guidance focuses on how PROMs 
should be reported.20 Guidance also exists on how to carry out systematic reviews of the measurement 
properties of PROMs.21 Although invaluable for the development of the field, implicit in much of such 
guidance is a focus on clinical trials for single treatments. Much routine assessment of services needs to be 
based on more complex interventions delivered to heterogeneous populations, for which such guidance 
may be less helpful.
Strengthening use in health services research
A number of developments have occurred that may enhance the role of PROMs in health services research. 
Thus, studies have begun to show that shorter versions of PROMs may have equivalent measurement 
properties, a development that may significantly decrease burden and increase response rates.22 Caution 
must be used in methods of shortening to avoid losing key content.23 Juniper et al.24 proposed taking 
account of the frequency with which problems are reported in different items, combined with patients’ 
ratings of their importance, to select key items.
There may be circumstances when, for example, disease-specific PROMs have been used in the valuation 
of an intervention but there has been no preference-based measure, making cost–utility analyses difficult. 
A range of techniques have now been developed that map utility values across to non-preference-based 
measures; the advantage is that not only can utility values be calculated but potential additional precision 
of the disease-specific measure is retained.25
Methods for interpreting scores from PROMs have advanced. The most important scores generated by 
PROMs are usually the changes over time from before to after an intervention, but numerical change 
scores of non-intuitive scales may be difficult to interpret. Traditional solutions focused purely on statistical 
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solutions to establish minimally important differences. However, an alternative is to identify the smallest 
change that would be appreciated especially by patients, identified by relating change scores to patients’ 
retrospective judgements of how they value change. This approach, referred to as ‘anchor-based’, has the 
advantage of determining the meaning of PROMs from the patient’s perspective, which can still be  
cross-checked with more statistical approaches.26
The content of PROMs relevant to evaluative research is also being expanded to include related valued 
goals and concerns of the patient. Although some may challenge the extension of PROMs beyond 
health status, a range of related constructs may be just as important to the patient and closely related 
in potential causal chains between intervention and final health outcome, for example self-efficacy and 
patient activation. Additionally, the boundary between PROMs and patient experience may also need to be 
relaxed; when, for example, patients are capable of giving meaningful answers to validated questionnaires 
retrospectively judging the outcomes and benefits of treatments.27–29 An ongoing problem involves 
the phenomenon of response-shift bias, which occurs when a patient with a deteriorating condition 
nevertheless reports an unchanged quality of life owing to successful adaptation and a shift in the 
thresholds they themselves use to describe the severity or impact of a problem.
A case study: patient-reported outcome measures and NHS elective surgery
Since 2009, the providers of care for NHS patients have been required to collect data before and  
3 or 6 months after surgery with a condition-specific and a generic PROM for four elective procedures: 
hip replacements, knee replacements, groin hernia repair and varicose veins surgery. Importantly, the 
information generated is publicly available (www.hscic.gov.uk/proms) and guidance is provided to help the 
public navigate and interpret data for individual hospital trusts. The database has provided a uniquely rich 
source for evaluative research using the PROM.
Some overall patterns are striking; for example, the evidence for the effectiveness of joint replacement 
(especially in terms of condition-specific measures) and the relative lack of evidence of provider trusts 
being consistently poor outlier performers in relation to appropriately adjusted PROMs are reassuring 
for the NHS. There was somewhat more evidence of individual surgeons performing markedly poorer, 
according to PROMs, compared with the much lower variation according to 90-day post-surgical 
mortality.30 The national PROMs programme provide results that challenge conventional thinking. There is 
no support for the view that either individual surgeons or whole trusts with larger volumes of surgery have 
better results.31
The programme has provided important methodological insights, showing how response rates and choice 
of PROM may influence the comparative performance of trusts. As discussed below, these results illustrate 
the outstanding challenges for future use of PROMs.
Major challenges
Respondent engagement
Patient-reported outcome measures are unusual compared with almost all other health indicators, in 
that they require active input from the patient or respondent. For example, in the NHS national PROMs 
programme, whereas pre-operative recruitment rates to PROMs for patients receiving joint replacement 
surgery have been 68%, the rate is markedly lower, 41%, in patients receiving varicose vein repair surgery, 
although this is largely attributable to eligible patients not being invited.32 In a sample of patients recruited 
to complete PROMs for any of six long-term conditions recruited via general practices, the recruitment rate 
was lower again, at 38%.33 There is some evidence that response rates have deteriorated over time; Hazell 
et al.34 found marked deteriorations in response rate to an identical survey to patients about their asthma, 
from 71% in 1993 to 47% in 2004.
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Clearly, a number of factors may influence the response rate. In the examples just cited, patients were 
more likely to respond to surveys about receiving a specific surgical intervention than to primary care 
surveys about long-term conditions where there was no link to receiving treatment. The concern is that the 
lower the response rate, the harder it is to use the outcomes obtained to evaluate services.
However, the greater concern is if there is evidence of response bias: if important characteristics of either 
patients or services are associated with differential response rate. There is evidence that this may occur 
for PROMs. In the national PROMs programme, Hutchings et al.35 found that the poorer the health status 
in terms of comorbidities prior to surgery, the poorer the response rate to PROMs questionnaires mailed 
out after surgery. Similarly, in the primary care study of PROMs for long-term conditions referred to above, 
when patients were asked to return a follow-up PROM 1 year after the baseline, the response rate was 
lower in those with poorer baseline health status.36 It is clear that such biases may produce misleading 
evidence of the effectiveness of services.
There are more subtle forms of problem with PROMs if questionnaires are returned incomplete, for 
example if more sensitive or personal questions are not completed or more difficult items are omitted. 
Usually the development phase of PROMs reduces such risks. There is a range of statistical techniques for 
addressing missing or incomplete data from longitudinal data sets such as PROMs, most commonly the use 
of imputation methods derived from the information about respondents that has been obtained. Analysing 
missing data from the national PROMs programme, Gomes et al.37 found that inferences about the 
performance of services could be influenced by the assumptions and methods made to make imputations 
to address missing data.
To address the problem of non-response, most effort has gone into the design of PROMs and mechanisms 
of delivery (e.g. the use of the internet and other modern media), partly because these are practical 
solutions that can be implemented. The scope for innovative technology to enhance respondent 
engagement is significant, although, currently, for the majority of PROMs, evaluative research still relies on 
traditional survey methods, particularly the mailed questionnaire. Although beyond the scope of this essay, 
recent innovations in the core format of PROMs may also strengthen their acceptability and power  
to engage the respondent. The innovation is the use of computer adaptive testing (CAT) to tailor 
questionnaire items to the individual, with responses to initially administered items determining the choice 
of subsequent items. The total number of items required to be completed is significantly reduced. This has 
been the subject of a major National Institutes of Health-funded initiative in the USA, Patient Reported 
Outcome Measures System (PROMIS) (www.nihpromis.org/), to produce questionnaire items that can 
populate CAT systems. Although an exciting initiative in the science of PROMs, particularly in terms of their 
use in assessing individuals’ health, there is little evidence to date of their use in evaluative research.
The other major concern occurs where there are major difficulties in engaging respondents, whether 
because of major physical, cognitive or developmental limitations or because of social exclusion. One 
example is the involvement of children. PROMs exist that are designed to be relevant to the perceptions of 
children.38 Additional care may be required, in terms of appropriate interviewing, determining intellectual 
capacity, not relying solely on chronological age, and the role of observation and proxy informants.39
Dementia poses related challenges. There are dementia-specific PROMs, which appear to work 
satisfactorily for patients with mild to moderate dementia.40 However, for those with more severe levels of 
dementia, assessments by a proxy carer are the more plausible option. Nevertheless, proxy ratings should 
not be treated simplistically or uncritically because their rates may, in turn, be influenced by burden of care 
and carer burnout, and appropriate adjustments are, therefore, required.41
In some areas of health care it is impossible to obtain a pretreatment or baseline assessment for obvious 
reasons; patients who experience sudden health events such as a stroke or hip fracture will not have any 
reason to have completed such an assessment. A number of approaches may be adopted for which the 
patient’s perspective is needed. One approach is simply to give up on pre-event assessment and assess 
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progress and possible impact of interventions after the sudden event and as soon as it is feasible to 
engage the patient.42 Alternative strategies can include inviting the patient retrospectively to assess their 
pre-event health or to use appropriately matched population-based data. Neither of these two strategies 
is straightforward.
There is only limited evidence of the impact of social exclusion in relation to PROMs. The problem is, 
however, well highlighted in a study by Jahagirdar et al.,43 who found that excluded groups, such as those 
with learning difficulties or low literacy, were less likely to be involved in the development of PROMs 
for chronic obstructive pulmonary disease. The commonest pragmatic solution to social exclusion more 
generally is to weight evidence for under-represented groups in surveys. A recent review of the sparse 
evidence argues that multiple and flexible approaches are needed properly to ensure that socially excluded 
groups’ views are not overlooked44 (www.pssru.ac.uk/archive/pdf/4390.pdf). The importance of social 
inequalities and social exclusion in health services research is further discussed in Essay 5 in this volume.
Health professional engagement
If the role of PROMs is to be expanded, it is likely to require greater engagement of clinicians so that 
collection of PROMs becomes more a part of routine care. Reference has already been made to evidence 
from trials introducing PROMs into individual patient care and showing mixed evidence of impact on 
management decisions, patient experience of care and ultimate health outcomes. This variable impact may, 
in turn, be attributable to health professionals’ attitudes, beliefs and experiences regarding PROMs; these 
have been the subject of some research. A recent study of surgeons’ views of PROMs found considerable 
diversity with a range from enthusiast to sceptic.45 In this and other studies, a number of concerns have 
been expressed. Cognitive problems include the view that PROMs data are difficult to interpret and 
relate to management decisions.46,47 Other concerns focus on logistics, time constraints and difficulties 
of incorporating PROMs into clinical routines.46–48 These studies generally stress clinicians’ expressed 
need for greater training to incorporate PROMs into practice.49 At worst, some studies suggest concerns 
that PROMs actually may cause harm if evidence from them is misunderstood or misused by third-party 
audiences such as managers, commissioners or politicians.50,51
Patient-reported outcome measures and routine health-care revisited
A recent survey obtained the views of relevant experts from the USA, England and the Netherlands about 
prospects for future use and impact of PROMs.52 There was a clear consensus that for PROMs to have 
their fullest impact in assessing the performance of health services, there needed to be greater integration 
of information systems for routine patient care and for system performance measurement. Currently 
in all three countries, information systems for the two different functions are effectively independent. 
The experts identified a number of barriers that would need to be overcome to integrate these two 
worlds of activity, including lack of trust from participants and insufficient belief in the value of PROMs in 
patient care.
A number of reports are beginning to appear broadly supportive of the conclusions of Van der Wees 
et al.52 and also express optimism that the integration of information from PROMS for patient care and 
system performance can be achieved. In the USA, Wu et al.53 describe a number of health record systems 
already available and in use to support the two functions. They identify three developments favourable to 
this integration: the positive trend towards patient-centeredness and electronic applications for PROMs, 
the growth of electronic health records and trend towards comparative effectiveness research that is 
patient oriented. More recently, Jensen et al.48 reported a number of encouraging case studies in the USA 
in which PROMs served both patient care and system evaluation. They effectively identify the same three 
generally supportive developments as Wu et al.53
Warrington et al.54 provide a positive account of a NHS setting in which PROMs have been successfully 
implemented to provide long-term follow-up of cancer survivors. They acknowledge that in a systematic 
review of their field of cancer care, Nama et al.55 could find no high-quality evaluations to demonstrate 
clearly the benefits of such systems. This lack of evidence remains a major challenge.
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Conclusion
Patient-reported outcome measures have an important role in evaluating services in terms of outcomes 
that matter to patients. They will continue to play a role as primary or secondary end points in bespoke 
research trials and evaluative studies in which the patient is recruited to participate as research subject. 
In addition, there is likely to be a larger role of patients’ routinely contributing information about their 
health and outcomes of their care as health-care systems adapt to take advantage of developments in 
informatics and PROMs. In anticipation of such developments, it has been argued that further evolution 
in PROMs is still needed so that they focus as much on practical, feasible and clinically actionable content 
as on the psychometrically validated content emphasised to date.56 Further development and testing 
is needed of feasible software, platforms and electronic health records to support PROMs as a routine 
feature of both clinical care and evaluative research. Major issues of trust, confidentiality and sustainability 
remain to be addressed. As already emphasised, training to strengthen understanding will be essential. 
Evaluative studies will be needed to test the overall viability of electronic health-based health records 
that include PROMs. Most outstanding of all will be the need to establish benefits to patients. There is 
much speculation of PROMs supporting and informing patients’ choice of health-care options, health and 
consulting behaviour and self-management, but there are very few studies to demonstrate such benefits.
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3Department of Health Sciences, University of York, York, UK
4Department of Management, London School of Economics and Political Science, London, UK
Declared competing interests of authors: none
Published May 2016
DOI: 10.3310/hsdr04160-69
This essay should be referenced as follows:
Raine R, Or Z, Prady S, Bevan G. Evaluating health-care equity. In Raine R, Fitzpatrick R, Barratt H, 
Bevan G, Black N, Boaden R, et al. Challenges, solutions and future directions in the evaluation of 
service innovations in health care and public health. Health Serv Deliv Res 2016;4(16). pp. 69–84.
EVALuATINg HEALTH-CARE EquITY
70
NIHR Journals Library www.journalslibrary.nihr.ac.uk
List of abbreviations
CI confidence interval
FNP Family Nurse Partnership
GP general practitioner
HR hazard ratio
IMD Index of Multiple Deprivation
PMB post-menopausal bleeding
QCA Qualitative Comparative Analysis
RAWP Resource Allocation Working Party
SEC socioeconomic circumstances
Abstract
The evaluation of health-care equity necessitates measuring both horizontal and vertical equity 
components to establish whether or not patients receive the health care across levels of need. Examining 
interactions between social factors of concern and need, or stratifying analyses according to different 
levels of need, can be used to identify horizontal and vertical equity. Increased data linkage across sectors 
and settings is vital for identification of sources of inequity and, crucially, to ascertain whether or not any 
identified variation has clinical relevance. Macro-, meso- and micro-level determinants of equity should 
always, ideally, be considered. However, examination of the ‘gap’ or the ‘gradient’ will depend on the 
intervention studied. Emerging techniques should be harnessed, for example machine learning to more 
completely exploit data sources on need, case mix and outcomes; and interactive multimedia techniques to 
examine social variations in clinical decision-making.
Scientific summary
Universal health-care systems aim to provide care for all, solely according to clinical need. Despite this, 
the ‘inverse care law’ has been demonstrated to operate in these systems. In this essay we discuss key 
methodological challenges in the measurement of health-care equity and propose ways forward.
The ascertainment of equity in health care requires the evaluation of both horizontal and vertical 
components: horizontal equity refers to the equal treatment of those with equal needs and vertical equity 
recognises that people with greater clinical needs should have more intervention. Methods to examine 
varying levels of need include stratifying analyses according to different levels of need or examining 
interactions between the social factor of concern and a measure of need.
Data on the population in need of care and case-mix data may be poorly recorded or available only as 
free text. Emerging innovations in machine learning enable extraction of valuable information from both 
existing and hitherto unused data sources. Data linkage of data from different settings is also required to 
identify source(s) of inequity and whether or not it matters in terms of outcomes.
Careful consideration should be given on whether it is most appropriate to examine the gap or the 
gradient in sociodemographic differences in the uptake of health-care/public health interventions. 
Statistical techniques are now available to calculate the sample size needed for gradient analyses.
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In addition to examining equity at the intervention level, innovative methods are now being developed to 
examine the impact of national policies. Evidence from North America is that dismantling universal systems 
will not only create greater inequities in access but also mean increases in total costs of health care. 
Researching inequalities at the individual level and in clinical encounter are also beginning to be addressed. 
Recent approaches include the use of web-based interactive multimedia vignettes with actor ‘patients’ 
to simulate key features of health-care consultations. Qualitative, longitudinal study designs which allow 
the exploration of decision-making at different points of a patient’s health-care journey could also yield 
valuable insights.
The development of innovative techniques and application of emerging methods for collecting and 
analysing data will enable equity to be measured with greater accuracy, precision, relevance and 
comprehensiveness. This will, in turn, better inform interventions for their remediation.
Introduction
Universal health-care systems, whether publicly funded or insurance based, aim to provide health care 
for all, according to clinical need, and undistorted by social or economic factors, geographical location or 
ability to pay. Yet observers have long recognised the presence of the so-called ‘inverse care law’ operating 
in these systems.1 This term was first coined in 1971 by Dr Julian Tudor Hart, a general practitioner (GP) 
who worked in socially deprived mining communities in the Welsh valleys. His observation that ‘the 
availability of good medical care tends to vary inversely with the need for it in the population served’ 
was largely based on his personal experiences rather than on empirical research. However, a wealth of 
confirmatory data has since been published internationally. In England, this led the Chief Medical Officer to 
observe in 2005 that, in the publicly funded NHS:
. . . healthcare [. . .] is to some extent inequitable at present: the preference of clinicians, the 
socioeconomic status and empowerment of patients, and decisions regarding specific local resource 
allocation may influence clinical practice as much as the actual health needs of patients, the behaviour 
of any pathological process or the scientific evidence base.
p. 22 (reproduced under the terms of the Open Government Licence for Public 
Sector Information)2
For those health-care systems which aim to provide universal coverage based solely on clinical need, 
health-care inequity matters because it undermines the capacity of the system to remain true to its core 
values or its constitution. The robust measurement of equity is, therefore, crucial.
In this essay we discuss key methodological challenges in the measurement of health-care equity and 
propose some ways forward. We also briefly review evidence on policies to achieve equity using the 
method of the natural experiment.
Equality, equity and its horizontal and vertical components
Equity is about fairness and justice and implies that everyone should have an equal opportunity to attain 
their full potential for health or for the use of health care.3 It should be distinguished from the related 
concept of equality. Equality is about the equal distribution of shares (of health or health care) so that 
each individual receives the same amount. The notion of equity transcends equality. Some inequalities may 
be unavoidable and therefore are not generally considered unjust. Others, for example associated with 
one’s area of residency, ethnic group, sex, age, socioeconomic circumstances (SEC) or disability, might be 
avoided and so are considered inequitable. They may be unfair or unjust as well as unequal and, because 
they are not solely determined by need, they may lead to differences in outcomes.
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We recognise that definitions of fairness vary according to libertarian, liberal and collectivist perspectives. 
However, universal health-care systems define fairness in terms of needs. Mooney4 pointed out that 
equitable distribution according to clinical need might refer to the distribution of expenditure, access, 
use or health. With respect to expenditure distribution, in the UK, the NHS uses formulae to promote 
equitable allocation of funding for care. The Resource Allocation Working Party (RAWP) and its successors 
have developed different methods of formula funding for the four countries of the UK (England, Scotland, 
Northern Ireland and Wales) which recommend that money should be distributed on the basis of 
population size, weighted for relative need and accounting for variations in unavoidable costs of providers 
(e.g. higher living costs in London, excess costs for delivering services in remote areas in Scotland).5 The 
components of the RAWP formula have been reviewed and revised for over 30 years and they continue to 
be subject to reanalysis. For example, although the RAWP recommendation to account for relative need 
by weighting for age and sex using national average rates of utilisation is relatively uncontroversial, their 
use of the standardised mortality ratio to account for additional need has raised many questions, which 
are discussed by Bevan.5 In 1999, a new objective for the allocation of resources in the English NHS was 
introduced to contribute to the reduction in avoidable health inequalities.6 As a consequence, a health 
inequalities component was introduced into the allocation formula and increases in allocations have 
since favoured more deprived areas. Local NHS commissioners were free to use these additional funds 
to purchase primary or secondary health care or public health services, to better meet their population’s 
needs and improve the quality of care received. The underlying rationale is that additional health-care 
expenditure translates into improved population health outcomes. A recent analysis of this policy found 
that geographical inequalities in mortality from causes amenable to health care declined in absolute terms 
during the 10-year period in which this allocation policy was applied.7 Moreover, the association between 
additional NHS funds and reduced mortality was stronger in deprived areas than in more affluent areas. 
Analyses such as these, using aggregated, routinely available data, cannot exclude the possibility that 
the associations observed were attributable to unmeasured confounders, such as smoking, or to other, 
concurrent non-NHS policies implemented to tackle social exclusion in disadvantaged areas. Moreover, 
they do not tell us about the types and content of services received and their relative contributions 
to outcomes.
Indicators of access include the availability of resources, waiting times, user charges and others barriers to 
care. Thus, equity of access is a purely supply-side phenomenon, in the sense that equal services are made 
available to patients in equal need. The difficulty with measuring equity according to this definition is that 
individuals may not use services to which they have access. Their reasons for non-use are socially patterned 
and are, at least in part, because of structural and environmental barriers which are proportionately greater 
for the socioeconomically disadvantaged, older people, people with disabilities or those for whom English 
is not their first language. Routine data such as medical records may not, therefore, strictly give a measure 
of access, because they can supply information only about services which have been taken up.
The definition of equity which takes this into account is equal use for equal need. This definition 
recognises the influence of both demand and supply factors on the pursuit of equity. These factors are 
influenced by the preferences, perceptions and prejudices of both patient and health-care provider. Most 
studies on equity and access analyse utilisation rates (often adjusted by sociodemographic and clinical 
indicators of need) as a proxy measure of access.
The final definition is equal health for equal need. This definition addresses the fact that there are 
inequalities in health arising from the level of resources, housing conditions, exposure to environmental 
hazards and different lifestyles and behaviours. It is an ideal rather than an operational definition, as both 
avoidable and unavoidable influences affect our health. Neighbourhood renewal8 and Sure Start9 are 
examples of initiatives in the UK that move towards this ideal.
There is another issue surrounding distribution according to need which should be considered. This is that 
distribution on the basis of need comes in two versions: a horizontal version (people with equal needs 
should be treated the same) and a vertical version [people with greater clinical needs should have more 
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intervention (provided it is effective) than those with lesser needs (unequal use for unequal need)]. From a 
macroeconomic perspective, Mooney and Jan10 defined vertical equity in terms of positive discrimination, 
arguing that achievement of horizontal equity is rarely enough. They propose differential weighting of 
the level of need by socioeconomic group in order to more thoroughly investigate the distribution of 
health and health care and to facilitate the movement of disadvantaged people up to the level of the 
advantaged.10 Mooney and Jan10 do not provide the differential weights that would allow examination of 
the presence of vertical equity. Sutton11 takes the approach forward by specifying a target level of use for 
people at different levels of need and then comparing whether or not actual use equals the target.
An alternative way of operationalising vertical equity is generated by the understanding that the 
demonstration of equal use for equal need does not necessarily indicate unequal use for unequal need.12 
For example, although male and female patients with a mild form of a disease may be treated equally 
(horizontal equity), it cannot be assumed that the likelihood of treatment varies according to the degree 
of abnormality in both men and women. Men with severe disease may be more likely to receive treatment 
than men with mild disease (vertical equity), but the likelihood of treatment for women may not differ 
with disease severity (vertical inequity). The vertical component is often overlooked by researchers and 
policy-makers, and this prevents the comprehensive measurement of equity, the likely consequence of 
which is overestimation of fair use of care. Unless both components of equity are measured, it cannot be 
concluded that patients are receiving the health care that they need. Studies that use multivariable analysis 
alone to adjust for need assume that social differences in use are the same at every level of need, which 
may not be the case. Other analysis strategies should be employed to examine varying levels of need, such 
as stratifying analyses according to different levels of need or examining interactions between the social 
factor of concern and a measure of need.12
Identifying the population in need of care
To examine the equitable distribution of health care and public health interventions, we need to 
understand how interventions are distributed across the social factors of concern. This requires 
identification of both the complete population in need and their sociodemographic characteristics.
This is not always straightforward. Many of the social factors of interest, such as ethnicity, language skill or 
religion, are poorly recorded in national data sets or available only as free text (which is unstandardised). 
These data may not always be missing at random, potentially leading to selection bias. An emerging 
innovation is to apply machine learning techniques to ‘code’ free-text data in medical records. Thoughtful 
application of these methods has the potential to increase our ability to extract valuable information 
from both existing and hitherto unused or underused data sources. Machine learning could revolutionise 
systematic data collection in terms of comprehensiveness, completeness, timeliness and accuracy.
There are many sources of data that can be used to characterise socioeconomically disadvantaged groups. 
Area-based measures of SEC are often freely available and readily linked with postcode data; for example, 
in England the Index of Multiple Deprivation (IMD) scores and ranks areas containing approximately  
650 households across several domains of deprivation.13 Relying on area-based measures to ascertain 
SEC for individuals, however, can result in ecological fallacy, where lack of precision or incorrect inference 
stems from within-area pockets of relative advantage and disadvantage masked by the ‘average’ area 
score. In the absence of individual-level data, such effects can potentially be reduced by adding in data 
from commercially available data sets at smaller geographic units which provide information on consumer 
habits. Such data may distinguish the advantaged from the disadvantaged within an area and provide 
greater resolution on SEC when used in combination with the IMD.14 The method is not bias free, however, 
as relatively high levels of consumerism may be the result of high debt, not affluence. Health and  
health-care researchers are perhaps less familiar with using sources such as local and national taxation 
information and education data, but forging links with data providers to explore such sources has the 
potential to reap benefits for future equity research.
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Some relationships between health and measures of SEC are best characterised by J-shaped curves, 
meaning that the most disadvantaged group may not be where you expect to find them. For example, 
in the USA, health insurance coverage may not be linear with income; the wealthy may opt not to have 
health insurance, and benefit recipients may have state-provided coverage. Policy-related changes leading 
to changes in insurance patterns for different social groups over time complicate longitudinal analyses. The 
relationship between coverage and health for working poor is likely to be highly variable and associated 
at the micro level with heterogeneous contextual factors such as size of employer and family composition. 
In England, benefit recipients (and those with long-term chronic conditions) are exempt from prescription 
charges, so in this context it may be the working poor paying for prescriptions who suffer the highest 
financial burden of ill health. Examining and characterising the group most at risk by considering the 
context of the population setting is a crucial step in measuring inequalities. Quadratic terms can be added 
to regression models to allow for non-linear relationships.15
Accurate ascertainment of the population in need of health care may be hampered by several factors. First, 
incidence and prevalence from health-care data are likely to be inaccurate if there are a high number of 
undiagnosed cases of the condition in the community. Diagnosis (and diagnostic delays) are influenced by 
help-seeking behaviour, which is itself socially patterned. Second, disease presentation can also vary by 
social group. For example, women with ischaemic heart disease may present with symptoms that differ 
from the typical chest pain presentation by men.16 This could lead to underascertainment in women if 
these differences are not reflected in study diagnosis criteria. Third, there may be a lack of consensus about 
the definition of need for intervention, for example in total hip replacement. Where the clinical rationale 
for intervention is not clear-cut, investigation and treatment may be influenced as much by the availability 
of doctors and diagnostic equipment, or by financial factors (such as a fee-for-service system), as by clinical 
need.17 This highlights the problem of inequity owing to the overuse of medical interventions, which puts 
patients at risk of complications unnecessarily and drives up the cost of health care. Finally, health-care 
systems which are not universal are limited by their access to medical record databases which relate only to 
the insured population, excluding those without coverage, and there may be also unknown missing data 
bias for out-of-area medical visits.
Examining whether or not inequalities matter
We have already described why it is necessary to examine whether or not health-care inequalities matter in 
terms of their impact on outcomes. For example, in a study of the effect of secondary prevention in 30-day 
stroke survivors it was found that people aged 80–89 years were only half as likely to receive a lipid-lowering 
drug as those aged 50–59 years.18 This treatment inequality was important because the receipt of secondary 
drug prevention was associated with a halving of the mortality risk. Crucially, there was little evidence that 
the effect of treatment differed by age. Therefore, the undertreatment of older people cannot be justified, 
unless it is explained by informed patient choice. If patient preferences explain some of the differences 
observed, then it is important to unravel their origin. This is a theme that we discuss later, in Social variations 
in the clinical encounter.
The gap versus the gradient
Policy-makers distinguish between the gap (the relative difference between advantaged and disadvantaged 
groups) in service provision, and the gradient (the continuum along which increasingly worse health is 
associated with a unit drop in the social factor of interest). An example of an approach to target the 
most disadvantaged subgroups only is the Nurse Family Partnership in the USA,19 named the Family 
Nurse Partnership (FNP) in the UK20 and VoorZorg in the Netherlands,21 which provides intensive support 
to multiply disadvantaged first-time mothers. Three evaluations of these programmes in the USA report 
positive results for mothers and their babies, including improvements in birth outcomes, children’s 
cognitive development and uptake of preventative health care.19,22,23 A trial of the intervention in the 
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Netherlands reported lower smoking rates in nurse-visited pregnant women and increased breastfeeding 
duration. However, in England, where FNP was added to the usually provided health and social care, 
no additional benefits were achieved in the primary outcomes, which included smoking in pregnancy, 
birthweight, rates of second pregnancies and emergency hospital visits for the child.24 There were 
important differences in both the trial design and the health-care context between the US and English 
studies: the English trial was a large, pragmatic, independently led evaluation, in contrast to the US 
evaluations, which were single centre and led by the intervention developers with a greater emphasis on 
efficacy. Women in England have access to more statutory public health, health care and social services 
than US women. The lack of any additional benefit from the English FNP suggests that macroeconomic 
policies and structural changes are required to complement intensive support services when tackling 
complex, multifactorial and enduring problems.
The costs of inequalities are borne not only by those at the bottom of the socioeconomic hierarchy, but 
by those at every level. Policies that target the most disadvantaged subgroups only, or which aim to 
narrow the gap between the most and least disadvantaged, underestimate the pervasive effect across 
the socioeconomic hierarchy and exclude those in need in the intermediate socioeconomic groups. Even 
for targeted interventions which are found to be effective, the population-level impact maybe smaller for 
these than for universal interventions. Such arguments augur in favour of tackling the gradient to address 
inequalities. Although it is rarely done, the gradient can be measured to examine the effect of universal 
interventions which are expected to reach the whole population, for example in Wardle et al.25 Where 
gradients are measured, the time frame over which effects are evaluated should be carefully chosen. This is 
because universal interventions can increase health inequalities in the short term, as the more advantaged 
are usually the first to take up new services, but this effect can level over time as the advantaged groups 
plateau in terms of their ability to benefit.26
Calculating the sample size needed for gradient analyses can present challenges. One strategy was 
developed for a universal screening programme intervention in which uptake needed to increase more 
in disadvantaged groups than in advantaged groups.25 Here, the solution was to use the weighted 
averages of the association between the deprivation quintile and the previously observed response to 
screening instead of the usual proportions in the formula, with the response rate held a constant across 
quintiles.27 Efficiency can be optimised by post-stratification, where treatment groups are stratified with 
a pre-treatment variable, treatment effects within the strata are estimated, and the weighted average of 
these estimates is used to calculate the overall average treatment effect estimate.28 In studies that aim to 
estimate average effects, reporting by disadvantaged subgroup, even with insufficient within-study power, 
increases the pool of health inequality studies available for potential synthesis. There are also additional 
approaches that can be taken alongside subgroup analyses to estimate within-study differential effects. 
One method is to conduct a latent class analysis across the whole sample where key response patterns 
are identified across different social groups of participants.29 This method has the advantage of not being 
sample size dependent, although very small samples with many multicategory variables may run into 
estimation problems.
Identifying the sources of inequitable provision of care
Most research undertaken in this area examines sociodemographic variations in health-care use for a 
defined intervention (or package of interventions) at one point in the management pathway. Inequalities 
have been demonstrated at each stage of the pathway: in participation in population-based screening 
programmes in the community, in the management of health problems in primary care, in the access to 
and use of diagnostic and therapeutic procedures within secondary care, and in rehabilitation and  
end-of-life care.
For example, the UK breast, cervical and bowel cancer screening programmes are run by the NHS without 
financial cost to participants. Nonetheless, the uptake of all programmes shows a gradient by SEC.30,31 
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The strongest gradient is for bowel cancer screening. This involves offering a guaiac faecal occult blood 
testing kit for use at home. In the first 2.6 million invitations in 2006–9, uptake was 61% in the least 
deprived quintile of residential areas and only 35% in the most deprived quintile.32 Bowel cancer screening 
is currently being extended to include one-off flexible sigmoidoscopy of the lower bowel to identify polyps 
that may develop into bowel cancer. Overall uptake in the first six pilot centres was 33% in the most 
deprived areas, rising to 53% in the most affluent areas.33
Within primary care, Lyratzopoulos et al.34 demonstrated that, in England, younger patients, ethnic 
minorities and women are more likely to have visited their GP a minimum of three times prior to referral to 
hospital for cancer diagnosis, suggesting potential avoidable delay in their management.
Sociodemographic variations in the likelihood of referral by GPs into secondary care has also been found 
to vary depending on the presence of explicit national guidelines on referral.35 This study used The Health 
Improvement Network, a widely used primary care database, to examine sociodemographic variations in 
referral for potentially life-threatening conditions where national guidance on referral has been published 
[post-menopausal bleeding (PMB) and dyspepsia in people > 55 years of age] and for symptoms where 
there is clinical uncertainty regarding the decision to refer (hip pain and dyspepsia in people < 55 years of 
age). For the three conditions examined, older patients were less likely to be referred, after adjusting for 
comorbidity. Women were less likely than men to be referred for hip pain [hazard ratio (HR) 0.90,  
95% confidence interval (CI) 0.84 to 0.96]. More deprived patients with hip pain and dyspepsia (if 
< 55 years old) were less likely to be referred. Adjusted HRs for those in the most deprived quintile 
compared with the least deprived were 0.72 (95% CI 0.62 to 0.82) and 0.76 (95% CI 0.68 to 0.85), 
respectively. There was no socioeconomic gradient in referral for PMB. These findings are important given 
the widespread prevalence of non-specific symptoms for which explicit referral guidance does not exist, 
but which could, nonetheless, be indicative of serious underlying pathology (e.g. lung, colorectal and 
ovarian cancers).
Access to timely secondary care has also been demonstrated to be inequitable: in England, patients from 
deprived areas, older people and women are more likely to be admitted to hospital as emergencies than 
electives for colorectal, breast and lung cancer. This was inequitable (rather than simply unequal) because 
people from deprived areas and older people were also less likely to receive preferred surgical procedures 
such as breast-conserving surgery and lung cancer resection.36 The research was limited by the data 
available from routinely collected Hospital Episode Statistics. The findings suggest that social variations 
in both timely presentation and pathways to care need to be prospectively examined. Prospective data 
collection would allow the impact of potential confounders, such as tumour characteristics including stage, 
as well as case mix and patient preferences, to be examined.
Once in the secondary care system, women from less affluent neighbourhoods in France have lower 
probability of receiving ‘best practice’ treatments (Or Z, Rococo E, Bonastre J, Institute for Research and 
Information in Health Economics, France, 2016), and in England, patients referred from deprived practices 
have reduced levels of diagnostic angiography and higher waiting times.37 There is also significant variation 
for women with breast cancer who live in deprived areas in England: they are more likely to be diagnosed 
at end stage (Stage IV)38 and less likely to receive surgery and radiotherapy,39 and area-based disparity in 
receipt of treatment may be the major driver of variation in lung cancer survival in England.40 Inequalities in 
the effective provision of rehabilitation care are also evident.41
When inequalities such as these are uncovered it is not possible to conclude whether the disparity occurs 
at the level of the intervention under consideration, or as a consequence of inequalities in the provision of 
preceding interventions, or in direct (and appropriate) response to the results of previous investigations. For 
example, a review of sex bias in use of cardiac care found that high-quality prospective studies reported sex 
differences in favour of men in the use of angiography.12 However, there was consistent evidence of no sex 
difference in those patients in whom the results of previous investigations had been taken into account. 
This indicates that the sex inequalities identified were not inequitable, in that they were fair and made on 
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the basis of clinical need (identified by the earlier investigation). Thus, the entire management pathway 
needs to be examined to establish the reasons for the differences found. The challenge is to identify data 
that will permit unbiased ascertainment of need and use across two or more settings (primary, secondary 
and community care). It is here that carefully specified individual record linkage between survey data 
to databanks of routinely collected data, and linking different sources of routinely collected data, is of 
high value.
Furthermore, while attention to the meso (organisational) level is appropriate, a comprehensive 
understanding of the sources of inequity also requires consideration of the impact of national policies 
(i.e. macro-level factors).42 For example, although the European Union provides universal coverage, 
the comprehensiveness of care varies from country to country. This is in part explained by the density 
and position of generalist clinicians, the presence of out-of-pocket payments and the referral system 
(gatekeeping or not), all of which have an impact on the use of preventative, primary and specialist care.43 
In addition, in social insurance-based systems, for example in France, complex rules for reimbursement for 
different services appear to act as a disincentive for service use among some population groups.44
In the UK, Cookson et al.45 evaluated these policies by examining trends in primary care access, quality 
and outcomes by SEC between 2004 and 2012. They did this using routinely available whole population 
data including health data from four national administrative databases. The IMD (IMD 2010)46 was used 
to assign socioeconomic status to neighbourhoods of approximately 1500 people each. Slope indices of 
inequality were measured in four indicators: patients per family doctor, primary care quality, preventable 
hospitalisation and amenable mortality. They found that, during this period, the NHS succeeded in 
substantially reducing socioeconomic inequalities in primary care access and quality but made only modest 
reductions in health-care outcome inequalities.
Such analyses cannot assess the extent to which observed trends in preventable hospitalisation and 
amenable mortality are attributable to, for example, trends in multimorbidity outside the control of the 
NHS or in social variations in illness behaviour. However, they both provide much-needed evidence of 
the influence of national policies and highlight the need to address health-care inequity in every sector 
and setting.
Finally, synthesising equity effects of health-care interventions can be challenging. One approach that may 
be useful when comparing several different interventions is Qualitative Comparative Analysis (QCA),47 
which can be used in tandem with quantitative analyses to work out what works for whom and under 
what conditions,48 very much under a realist perspective.49 Blackman and Dunstan50 illustrate QCA’s utility 
in health inequalities research by applying the method to survey data in order to understand the influence 
of place-based contextual factors related to variation in narrowing mortality gaps. Individual participant 
data meta-analyses (e.g. Virtanen et al.51) or other synthesis techniques such as QCA (e.g. Thomas et al.52)  
could be applied to studies in the health-care setting to explore variation in outcomes with regard to 
contextual effects such as the policy environment, and differential effects by disadvantage. The role of 
evidence synthesis in health services research is further discussed in Essay 1 of this volume.
Social variations in the clinical encounter
A potential contributing cause of demonstrated health inequalities are social variations in individual 
behaviour and interactions between patients and health-care professionals. However, there are significant 
methodological challenges to researching the clinical encounter. Direct observation of doctors and patients 
offers no opportunity to control patients’ clinical and sociodemographic characteristics, and would require 
observation of prohibitively vast numbers of consultations to obtain the necessary numbers in specific risk 
or demographic categories. Use of ‘standardised’ patients (i.e. consultations with doctors by trained actors) 
is considered a gold-standard method because it enables more control over patient characteristics, but 
it is costly. The use of fictional patient profiles (vignettes) can provide a valid, generalisable and efficient 
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approach to studying variations in decision-making by health-care professionals. Most studies, however, 
use text-based vignettes, and omit many features of real consultations such as real-time responses to 
clinicians’ questions or nuanced presentation of patient characteristics. This risks bias by offering clinicians 
a limited selection of response options, which primes them to consider certain actions. Many studies are 
small, with limited generalisability.
In one novel study, a website was constructed using interactive multimedia vignettes with actor ‘patients’ 
to simulate key features of consultations. GPs undertook consultations from each of six clinical profiles 
which varied according to the ‘patients’ sociodemographic characteristics and lung cancer risk. No GP saw 
the same actor twice. Within this constraint, allocation of GPs to vignettes was random. This achieved 
balance by sex, ethnicity and SEC, and thus GPs’ decisions to initiate lung cancer investigation could be 
studied in a factorial design across different combinations of clinical and sociodemographic characteristics 
(Sheringham J, Sequeira R, Myles J, Hamilton W, McDonnell J, Offman J, et al., University College London, 
2016). This research demonstrated that, regardless of clinical risk, GPs were less likely to investigate older 
and black ‘patients’.
Patient vignettes can provide insight into clinical decision-making but do not contribute towards our 
understanding of the patient perspective or of factors influencing the interaction between patients and 
health-care professionals. It is often suggested that patient choice underlies inequalities in uptake of health 
care and public health interventions. Even if decisions to forego some aspects of care reflect ‘informed’ 
choice, we still need to understand the origins of and influences on these choices. Choices are influenced 
by individual-level factors (motivation, perceived consequences of different actions and values placed on 
those consequences), social networks (families, peer groups), local environments (e.g. school ethos)  
and the national context (taxation, regulation, advertising, subsidies). There appear to be systematic 
differences in expectations for good health and in perceptions of risk and benefits of treatment between 
advantaged and less advantaged groups.53 Patients’ ‘choice’ for less intensive treatment may reflect 
inaccurate perceptions about the availability, effectiveness or risk of treatment, or be influenced by 
accurate observations that outcomes are worse in their community.53 Furthermore, communication in 
clinical encounters is socially patterned, with clinicians providing less information and adopting a less 
participatory consulting style when consulting with less articulate, socially disadvantaged patients.54  
This is likely to directly impact on the decisions that patients make.55
Innovative approaches are therefore needed to explore and explain patient ‘choice’. In-depth, 
observational, qualitative, longitudinal study designs are likely to be required which allow the exploration 
of decision-making at different points of a patient’s health-care journey. For example, interviews  
before and after consultations about beliefs and expectations, and how they change, together with  
non-participant observation of clinical encounters, could yield valuable insights.
Designing interventions to improve equity
Given (and in spite of) the current pre-eminence of the concept of individual choice and responsibility, 
these observations suggest three levels of intervention. At the level of the patient–clinician interaction it 
is important to understand patients’ and health professionals’ assumptions about risks and benefits of 
medical interventions and their accuracy. Health-care delivery preferences may be shaped by quality  
of service, so we need to ensure equity in the quality of services and focus on quality improvement where 
certain communities are poorly served. At the societal level, the observation that preferences/perceptions 
of opportunities are often defined by social, economic and cultural factors underscores the importance of 
addressing fundamental structural inequities and sociocultural norms.
One area emerging in response to the problem of complex policy and population settings is to design 
intervention strategies on multiple levels. A host of interventions can often be theorised; for example, 
simultaneous economic, organisational and behavioural interventions may be needed to tackle diabetes. 
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The intervention framework needs consider factors at macro, meso and micro levels and their interactions, 
even though much of the dynamism may be focused at only one of these levels. Hawe56 suggests ways 
to move towards interventions characterised not by a programme but by relationships, routines, power 
structures and sets of values. A number of essays in this volume take forward in a number of different 
ways the issue of complexity and how it can be appropriately addressed in evaluative research (see 
particularly Essays 1, 6 and 7).
Can austerity threaten equity?
Cutler57 argued that consequences of governments aiming for equity by increasing coverage were 
increases in costs, which led to top-down policies to control costs, which, in turn, resulted in a 
deterioration in quality (such as long waiting times), and the interest in market-type reforms to remedy 
that problem. Tuohy58 has argued that governments’ search for a system that achieves equity, controls 
costs with high-quality care and results in policy cycling as governments emphasise policies that tackle the 
most serious failure of these three objectives and implicitly neglect the other two. So, following the global 
financial crisis, fiscal pressures mean that governments now focus on cost control rather than on equity 
and quality. An obvious question is whether or not there is evidence that systems of universal coverage 
that are mainly free at the point of delivery, on grounds of promoting equity of access, are poorly designed 
to control costs. This essay has demonstrated that even with these structural characteristics, there is 
evidence that the inverse care law1 still applies. Changing to partial coverage and high user charges would 
mean that that law would apply with even greater force. But the question is whether or not austerity 
would justify cycling to such policies as a way of controlling costs.
In trying to assess the impacts of government policies for the twin objectives of equity and cost control, 
we typically lack controlled experiments. Although there is the famous landmark study of the RAND Health 
Insurance Experiment,59 which randomly allocated people to different insurance packages (with differing 
co-payments and co-insurance) and also included a Health Maintenance Organisation, this still falls short 
of assessing the macro questions of whether or not a financial system with universal coverage and services 
free at the point of delivery will have more serious problems of cost control than one with partial coverage 
and high user charges. Evans et al.60–62 used the ‘natural experiment’ between the USA and Canada to 
investigate the impact of policies to improve equity of access to health care in terms of control of total 
costs. Prior to 1970, both countries were structurally similar in how health care was financed (with multiple 
insurers, partial coverage and high user charges) and in the delivery of care (with hospitals and physicians 
being independent of government and paid charges and fees for services delivered). After 1970, in 
Canada, only the financial system changed with the introduction of universal coverage free at the point of 
access for hospital care and physicians’ services. Evans60 emphasises that an unintended outcome of policy 
cycling by the Canadian government was that these policies that were directed at equity were later found 
to be highly effective in controlling total costs of health care in Canada as compared with the USA.
Evidence from ‘natural experiments’ is always open to challenge from potential influence from other 
factors and other outcomes that have not been measured. Their value is hence even more strongly 
dependent on developing a sound theoretical explanation, which is just what Evans60 does in explaining 
what is a paradoxical outcome. Given the characteristics of health care, it is folly to regard patients as 
well-informed consumers making cost-conscious choices when confronted with high user charges,  
which are a poor way of trying to control costs when doctors typically make decisions. Indeed,  
Brook et al.63 summarised the results of the RAND study as showing that ‘. . . cost sharing can be a blunt 
tool. It reduced both needed and unneeded health services’ (p. 4)63 and that ‘. . . subsequent RAND work 
on appropriateness of care found that economic incentives by themselves do not improve appropriateness 
of care or lead to clinically sensible reductions in service use’ (p. 4).63 Evans60 goes on to argue that the key 
to cost control is targeting not patients but suppliers, and that is most effectively done by empowering 
government as the single payer with monopsony power in negotiations with physicians and hospitals. 
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Thus, he concludes: ‘The standard theoretical analyses of health insurance, focussing on (an incomplete 
specification of) the incentives faced by patients, counts the peanuts but ignores the elephants’.60
Spend on health care as a percentage of Gross Domestic Product in 2013 was 16.4% for the USA, 10.2% 
for Canada and 8.4% for the UK.64 Thus, although Canada and the USA have similar delivery systems, 
what appears to matter in controlling costs is that Canada and the UK have similar institutional financial 
systems. So, although austerity strains universal systems which are largely free at the point of delivery, 
the evidence from North America is that dismantling that system will not only create greater inequities in 
access but also mean increases in total costs of health care. Such universal systems need to be developed 
to manage insurance to relate to differences in patients’ preferences (as revealed, e.g., through shared 
decision-making) but that is beyond the scope of this essay.
Conclusions
In this essay we have highlighted strategies to address some of the methodological challenges faced when 
evaluating health-care equity. These include the measurement of both horizontal and vertical equity, the 
use of machine learning to enhance the completeness and quality of data collection and considerations 
on the appropriateness of gap or gradient analyses. Linkages between routinely collected data from 
primary, hospital and social care; disease cohort and audit data, deprivation indices, mortality registers; 
and judiciously chosen other sources (e.g. from education and consumer surveys) increase our ability to 
precisely identify sources of inequity along the patient pathway and to disentangle the influences of case 
mix, social and organisational context. Together with innovative methods to capture expectations and 
patient and health professional decision-making in real time, these strategies will inform the design and 
evaluation of national-, organisational- and individual-level interventions to improve health-care equity.
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Abstract
The scale and complexity of major system change in health care (typically involving multiple change 
processes, organisations and stakeholders) presents particular conceptual and methodological challenges 
for evaluation by researchers. This essay summarises some current approaches to evaluating major 
system change from the field of management and organisational research, and discusses conceptual and 
methodological questions for further developing the field. It argues that multilevel conceptual frameworks 
and mixed-methods approaches are required to capture the complexity and the heterogeneity of the 
mechanisms, processes and outcomes of major system change. Future evaluation designs should aim to 
represent key components of major system change – the context, processes and practices, and outcomes – 
by looking for ways that quantitative and qualitative methods can enrich one another. Related challenges 
in ensuring that findings from evaluating major system change are used by decision-makers to inform 
policy and practice are also discussed.
Scientific summary
The scale and complexity of major system change in health care (typically involving multiple change 
processes, organisations and stakeholders) presents particular conceptual and methodological challenges 
for its evaluation by researchers. This essay summarises some current approaches to evaluating major 
system change from the field of management and organisational research, and discusses conceptual and 
methodological questions for further developing the field.
Major system change can be seen as a complex intervention; measuring effectiveness is challenging, as 
contextual factors and processes play a key and often dominant role. In evaluation design, the potential 
impact of an intervention, and unintended effects, should be captured at different levels of change. 
Furthermore, rather than seeking to assess ‘effectiveness’, we advocate exploration of the broader concept 
of the ‘value’ of an intervention.
Developing a theoretical framework based on a synthesis of existing theories of organisational change 
could aid both the design and the evaluation of major system changes. This would help to advance 
the field through the accumulation of knowledge across projects. However, critical thinking should be 
employed to ensure that frequently used concepts, including ‘leadership’ and ‘culture’, are unpicked and 
not just taken for granted.
Multilevel conceptual frameworks and mixed-methods approaches are needed to attempt to capture the 
complexity and the heterogeneity of the mechanisms, processes and outcomes of major system change.
Future evaluation designs should aim to represent key components of major system change – the context, 
processes and practices, and outcomes – by looking for ways that quantitative and qualitative methods 
can enrich one another, for example by combining ‘what works at what cost’ with analysis of ‘how’ and 
why’ change takes place. To impact on decision-making concerning policy and practice, researchers should 
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work closely with decision-makers on evaluation design and tailor their findings to different stakeholders, 
although more focus is needed on overcoming political and structural challenges to collaboration.
Introduction
The complexity and scale of major system change in health care (i.e. typically involving multiple change 
processes, organisations and stakeholders) presents particular conceptual and methodological challenges 
for its evaluation by researchers. Drawing on a realist review of literature in this field,1 we take major 
system change in health care to involve ‘interventions aimed at coordinated, system-wide change affecting 
multiple organisations and care providers, with the goal of significant improvements in the efficiency of 
healthcare delivery, the quality of patient care, and population-level patient outcomes’. The authors of the 
review used the term ‘large-system transformation’ rather than major system change,1 but we assume here 
that the two terms are synonymous. The aim of this essay is to summarise some current approaches to 
evaluating major system change from the field of management and organisational research, and to discuss 
conceptual and methodological questions for further developing the field. Related challenges in ensuring 
that findings from evaluating major system change are used by decision-makers to inform policy and 
practice are also discussed.
Four talks were given during the plenary on major system change at the London meeting in 2015 
described in the Introduction to this volume. Jean-Louis Denis made the case for using process- and 
practice-based research to evaluate complex interventions in context, in order to maintain the balance 
with investment in approaches from the clinical sciences that tend to focus on outcome-driven research. 
Ruth McDonald discussed the use of theory in evaluating major change projects in health systems, 
suggesting that often taken-for-granted concepts (such as ‘leadership’ and ‘culture’) need to be contested 
and re-evaluated through ongoing critical theory development and in dialogue with empirical research. 
Naomi J Fulop and Simon Turner described challenges in evaluating major system change at scale 
using social science theory and methods. They argued that multilevel approaches and mixed methods 
are necessary for representing the complexity of major system change, but practical challenges for 
researchers lie in grappling with the scale, significant time and politics often associated with major change 
programmes. Brian Mittman gave a number of reasons for viewing major system change as a form of 
complex intervention and the challenges this presents for evaluation, notably that neither interventions 
nor settings are fixed and their main effects are often weak relative to contextual factors. All four 
presentations underlined the importance of seeing major system change as complex interventions, that 
are situated, involve multiple processes of change and operate at multiple levels. There was consensus 
that multilevel analytical frameworks and mixed-methods approaches are needed to attempt to capture 
the complexity and the heterogeneity of mechanisms, processes and outcomes of major system change in 
future evaluations.
Stimulated by the talks and the roundtable discussions that followed at the London meeting, we identified 
five key themes relating to the evaluation of major system change that we discuss in this essay: (1) type 
of change and complexity; (2) defining and measuring effectiveness; (3) the role and use of theory in 
evaluation; (4) the contribution of mixed methods to evaluation; and (5) the use of knowledge from 
evaluations of major system change to inform policy and practice. Following discussion of each theme, 
the conclusion summarises the implications, both practical and methodological, for evaluating major 
system change.
It is important to note that this essay presents a partial view on evaluating major system change, 
influenced by the particular emphasis of the talks and discussions at the roundtable event, rather 
than an inclusive, systematic review of the different methodological approaches to evaluating major 
system change.
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Theme 1: type of change and complexity
This theme focuses on the distinctive characteristics of major system change and describes the conceptual 
and methodological challenges that its complexity and scale present for evaluation.
Characteristics of major system change
Major system change has a number of characteristics that distinguish it from change at a smaller scale, for 
example change that involves a single organisation or health-care delivery site. Returning to Best et al.’s1 
definition, three key characteristics of major system change can be identified. First, major system change 
often involves the participation of multiple stakeholders, from both within and outside the health-care 
service. Second, the changes desired are system-wide, meaning that the aim is to produce a collective 
impact on outcomes across different, often heterogeneous, health-care organisations within a system. 
Third, major system change involves co-ordinated change over a larger canvas, with mechanisms needed 
to engage and align stakeholders during the planning and implementation of change, such as leadership, 
resources or a political mandate from government. Additionally, from an evaluation perspective, major 
system change can be understood as a complex intervention. It has multiple (sometimes conflicting) goals; 
it involves change processes at multiple levels; and it takes place within and across heterogeneous settings 
and often over a significant period of time.
The scale and complexity of major system change creates challenges for its evaluation. It has many of the 
characteristics of complex interventions. This contrasts with simple interventions that are more likely to 
have a single fixed component, a stable process, distinct goal, and are applied in relatively homogenous 
settings, although this is also contested. Major system change involves interventions that change over 
time, for example they may be adapted on the basis of formative feedback from evaluation; the settings 
in which they are introduced are not fixed and can be modified; the main effects of the intervention 
are often weak and contextual factors often dominate; and all three aspects (interventions, settings and 
effects) can vary over time and space. As we discuss below, evaluation approaches need to be equipped to 
track this complex set of interactions over time.
Scale and complexity: conceptual implications for evaluations
The distinctive characteristics of major system change when compared with change at a smaller scale, 
including its relative complexity, imply a range of conceptual and methodological implications for its 
evaluation by researchers. The first conceptual implication stems from the understanding of major system 
change as a multilevel process,2 that is, one involving change processes at the macro level (political, 
economic and societal context), meso level (organisational) and micro level (sociopsychological behaviour 
of individuals and groups). When compared with smaller-scale change, major system change is likely to 
involve significant interaction (and potential tensions) between these different levels. For instance, at the 
macro level, the external political environment may directly influence change processes, rather than being 
a mere ‘backdrop’ to change. For example, a key factor in the implementation of the Scottish Patient 
Safety Programme was the early involvement of politicians and policy-makers who helped to assemble a 
national infrastructure to support delivery of the programme.3 In relation to the reconfiguration of stroke 
services in major metropolitan areas of England, the ‘top-down’ implementation of change in London, 
underpinned by political authority and financial and performance management levers, enabled services to 
be fully centralised, while a less radical transformation of services took place in Greater Manchester where 
a more ‘bottom-up’ (network-based) approach was used.4
The second conceptual implication is that, given the need for behaviour to be co-ordinated across a 
health-care system to achieve major system change, collective organisational structures with political 
authority, along with the agency of individuals, are likely to be important in the implementation of change. 
One potential barrier to major system change is the presence of multiple stakeholders’ interests associated 
with the different types of organisations involved. Health-care systems are ‘pluralistic settings’ in which 
perceived costs and benefits of change may differ by stakeholder group.5 Patients, their families and the 
public are also key stakeholders in the development of major system change programmes.1 Some evidence 
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suggests that more ‘bottom-up’ approaches to change may not be appropriate at larger scales of change 
where multiple stakeholders, with potentially divergent interests, may impede implementation.6 One 
implication of this is that complex interventions, and consequently complex change processes, should be 
thought of as a mix of bottom-up activity with top-down guidance.
A third conceptual implication is that, given the scale of change involved in major system change, collective 
social processes that transcend organisational boundaries and energise change may play an important role 
in achieving major system change, such as social movements7 and collaborative communities of medical 
professionals.8 For example, transformation of Denver’s health system was aided by political support, 
including the ‘symbolic’ role of prominent citizens.9 The nature of these social processes, and the methods 
needed to identify and evaluate them, will differ from those associated with the study of face-to-face 
interactions that are often assumed to influence improvement, for example within clinical micro systems.10
Scale and complexity: methodological implications for evaluations
The study of change at a large scale also raises methodological challenges. First, there is the problem 
of representing change processes across a wide range of settings (e.g. heterogeneous provider and 
purchasing organisations) and over significant periods of time. Ethnographic case studies, that involve 
‘thick description’11 of everyday practices through sustained observation within different sociocultural 
contexts, appear well suited to generating a detailed understanding of how change processes unfold 
within a small number of settings over time, but may be more limited in representing the breadth of 
change processes taking place over a large scale. One way forward is to combine ethnography with 
methods at other levels, for example wider stakeholder interviews or documentary analysis to capture the 
macro system context.12 Context and qualitative methods in health services research are further considered 
in Essay 7 in this volume.
Second, major system change programmes may have multiple, often conflicting, goals and may involve 
multiple components, some of which may be ill-defined by programme leaders, not visible to those 
carrying out the evaluation, transient in nature or not applied equally across different sites. One way 
forward is for practitioners and researchers to work closely together in order to build up an understanding 
of both the intervention’s goals and components and its appropriate evaluation. In England, collaboration 
is being enabled through organisational partnerships such as the National Institute for Health Research 
Collaborations for Leadership in Applied Health Research and Care (CLAHRCs). However, close 
collaboration via CLAHRCs has thrown up ‘political’ challenges, including tensions at times between 
‘service-centred’ and ‘research-centred’ models of knowledge production.13
Theme 2: defining and measuring effectiveness
This theme focuses on the ways in which the effectiveness of major system change might be defined 
and measured in evaluations. According to the Oxford English dictionary, effectiveness is the degree to 
which something is successful in producing a desired result. There was much debate about the feasibility 
of attributing success to ‘something’ (e.g. an intervention), the measurement of success and identifying 
outcomes. It was suggested that the characteristics often associated with major system change – its 
complexity, heterogeneity and instability – renders attempts to evaluate its effectiveness challenging.
Influence of context on an intervention’s effectiveness
One of the key challenges in evaluating a complex intervention is the observation that outcomes are often 
only partially related to the intervention itself; contextual factors/processes play a key and often dominant 
role. Consequently, it is often impossible to estimate the inherent effectiveness of an intervention deployed 
as part of a major system change owing to the difficulty of separating the intervention from the context 
in which it is applied. Even among those who consider that it is possible to decouple the intervention and 
context, current thinking suggests that it is vital to take into account how contextual factors influence 
implementation.14 Even a relatively simple intervention, based on a single fixed component, might have a 
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range of effects depending on the analytical level that is being studied and the co-occurring factors and 
influences on outcomes. For example, a doctor prescribing an oral antibiotic medicine to a patient might 
be regarded as a ‘simple’ intervention, and yet its effectiveness may vary among different people owing 
to biological (e.g. absorption rate and amount), psychological (motivation), interpersonal (doctor and 
patient relationship) and wider sociocultural factors.15 Responses to an intervention or innovation that aims 
to produce major system change can differ owing to the influence of contextual variables at the system 
(macro), organisational (meso) and clinical (micro) levels.16 Taking into account potential change at multiple 
levels, more recognition and appropriate methods are required to capture the impact of an intervention, as 
well as its unintended consequences, which may be larger and occur at more levels than was anticipated 
by programme designers.
Identification of outcomes
The identification of appropriate outcomes or results from major system change was regarded as a key 
challenge. While often appealing to policy-makers and other stakeholders, it was suggested that single 
measures of effectiveness (e.g. whether or not an intervention improved a clinical outcome) was unduly 
narrow and neglected other potential benefits, and unintended consequences, of a given intervention. 
One suggestion was that a wider concept of ‘value’ needed to be developed, that goes beyond measuring 
effectiveness in binary terms (i.e. whether it ‘works’ or ‘does not work’), to capture a broader array of 
potential benefits and limitations of an intervention. This might include the impact on patient experience, 
effects on people within organisations and increased understanding of how to manage change. In 
judging which outcomes to include, it is important to consider the audiences for whom the evaluation 
is being produced. For instance, a taxpayer of a publicly funded health service such as the NHS may also 
be interested in ‘hard’ measures of effectiveness, including cost. In addition to effectiveness and cost, 
health service managers and researchers are also likely to be interested in what else can be learnt from an 
intervention programme, for example barriers and enablers to the approach to implementation adopted, 
and then use this information to adapt the current approach or inform the planning of future programmes.
There was consensus in our discussions that multiple outcomes, that meet the needs of different 
audiences, should be included in evaluation design and that further work was needed to articulate and 
agree how wider ‘value’ beyond effectiveness should be measured. Measuring both effectiveness and 
value appropriately in different contexts should be informed by greater dialogue between service leaders, 
researchers and policy-makers. At the service level, researchers can contribute to this dialogue by engaging 
with how programme designers define ‘effectiveness’ and whether or not they have a programme theory 
which might lead them to expect certain impacts.17 Information on outcomes can also be valuable in 
acting as a trigger to induce changes in the process and practices deployed by actors and organisations. 
At the wider policy level, researchers can help to broaden the definition of outcomes or impact beyond 
effectiveness. For example, an analysis of health-care reform in the UK, Canada and the Netherlands 
highlights changes in expectations among various publics, in the instruments used to regulate or transform 
the systems and in the relations of power among concerned publics and key stakeholders.18
Measuring outcomes and improving practice
It was suggested that measures of the overall effectiveness of a major change programme should be 
qualified (e.g. that such outcomes measure results on average) and complemented with finer-grained 
analyses of experiences of change in a variety of places, among specific stakeholder groups and over 
different periods of time. Where results deviate from the average, this variation can be used as a source 
of insight through qualitative research into which contexts and components of an intervention are most 
effective and why barriers to implementation may emerge in some contexts and not others. However, 
recognising the interplay between intervention and context raises methodological challenges with 
measuring the influence of the latter on perceived success, as well as the ways in which the intervention 
influences the context. For instance, uptake of the Canadian ‘Heart Health Kit’ (a patient-education 
resource for preventing cardiovascular disease) among physicians in Alberta was influenced by attributes 
of the innovation itself as well as contextual and situational factors (e.g. local collegial interaction among 
potential users).19
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The embedding of an intervention in a particular context limits the generalisability of the findings to 
diverse settings. However, if the mechanisms of action associated with an intervention are well understood, 
this evidence may be transferable to other settings as lessons concerning the mechanisms of action that 
underpin a given intervention’s effectiveness.20 Here, there is a role for theories in providing external 
validity of evaluative research of complex interventions. For instance, understanding the interactions 
between context and interventions implies developing robust theories to examine the relationship between 
these two.21 Insights into the effectiveness of an intervention in contexts with particular characteristics 
could inform future planning: that is whether efforts should be focused on adapting the intervention itself 
or the underlying context in which it is situated in order to enable improvement.
From the perspective of health-care professionals, relevant questions to improve practice might include 
understanding how a programme can be adapted and customised in order to increase effectiveness, 
and how to modify or manage the organisation or setting in order to increase effectiveness. In relation 
to these questions, it was suggested that the purpose of research is to contribute to the evaluation of a 
programme’s effectiveness by explaining ‘how, why, when and where does it work’ and, as researchers, 
address the question of ‘how can I make it work better?’. With regard to how the programme operates 
and why it produces its effects in different contexts, it is important that evaluations take account of 
potential changes over time in the answers to these ‘how’ and ‘why’ questions. Change can be interpreted 
as either episodic (i.e. radical or exceptional) or continuous (i.e. as an ongoing process of becoming).22,23 
To reflect this, evaluation should seek to analyse how and why an intervention’s effects are produced both 
initially and continuously over time.
Theme 3: the role and use of theory in the evaluation of major 
system change
This theme outlines the role and value of using theories to inform the evaluation of major system changes. 
The explicit application of formal theory is needed for both the design and evaluation of major system 
changes to understand the conditions of context that affect success, to enhance the transferability of 
learning from changes introduced in one context to another context and therefore to aid accumulation 
of knowledge across projects.17 However, the importance of theory in designing, implementing and 
evaluating interventions arguably remains under-recognised. The ability to informally theorise is often used 
in day-to-day activities, yet many are alienated by the idea of formally applying theory.17
Selecting and applying theories
Different people make sense of phenomena in different ways. A health services researcher will not 
necessarily view and interpret the mechanisms involved in change and the interaction with the surrounding 
context in the same way as an anthropologist, geographer, organisational scientist or health policy-maker. 
Within our occupational silos, we become accustomed to adopting certain familiar theories. We must be 
aware that adopting a certain theory results in seeing the world through a particular lens: as the adage 
goes ‘when all you have is a hammer, everything looks like a nail’. Our understanding of major system 
change is shaped by the theories that we use to describe change processes, as individual theories may 
highlight different parts of the process or encourage similar processes to be interpreted in different ways. 
Thus, the theoretical standpoint adopted influences the design, conduct and analysis of an evaluation. It 
is therefore important for evaluators to recognise the importance of selecting appropriate theory and the 
influence that theory selection will bear on the interpretation of findings. For these reasons, rather than 
identifying an individual theory to frame a major system change, implementers and evaluators should 
contemplate adopting multiple relevant theories and ensure that the composition of the team is made 
up of an appropriate mix of theorists. Having different theoreticians involved increases the number and 
breadth of questions asked and may help to paint a more diverse and vivid picture of the context in which 
a major change is delivered.
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Deriving insight from theories at different scales
Theories can be broadly categorised as one of three types according to the scale at which they are applied: 
grand theory, mid-range theory (big theory) and programme theory (small theory). Grand theories are 
‘formulated at high levels of abstraction’ and ‘make generalisations that apply across many different 
domains’.17 For example, having studied health-care system reforms in the USA, Canada and the UK in 
the 1990s, Tuohy24 argues that different patterns of change resulted from the particular logic of each of 
the systems and that reform was influenced by the distribution of power between different institutions 
(governments, markets and medical profession) and mechanisms of social control. Mid-range theories 
‘are intermediate between minor working hypotheses and the all-inclusive speculations comprising a 
master conceptual scheme’.17 Examples of mid-range theories include ‘diffusion of innovations’16 and 
‘normalisation process theory’.25 Programme theories specify the way in which an intervention is thought 
to work. They specify the structures (inputs), processes (actions) and outcomes (results) that are anticipated 
with the links between these providing the theory of change. The influence of behaviours and contextual 
factors on these components should also be incorporated.17
Insight can be derived through dialogue between theories at different scales. For instance, a systematic 
review of factors affecting innovation adoption in health services categorised these factors according to 
the theoretical level at which they operate: the sociopolitical climate, system readiness and incentives 
(grand level); social networks, champions and boundary spanners (mid level); and internal communication, 
feedback and resources (programme level).16 Combining theories at different scales may be particularly 
important in understanding the multilevel influences on major system change and how factors at different 
levels influence each other (e.g. by mediating or moderating the implementation of a change). As a 
consequence, multiple levels of analysis are required to assess the links between theory and primary 
research findings.
Developing theory
Researchers can be criticised for using theory at a level that is too high and too general, taking concepts 
‘off the shelf’ without exploring how applicable these concepts are to the real world. For example, 
conclusions are often drawn about the importance of ‘leadership’ and ‘culture’ without unpacking what 
it is about these factors that makes them so influential. It was proposed that we need to continue to 
build theories about what concepts like ‘leadership’ really mean with regard to major system change. The 
evaluation of specific programmes, therefore, affords the opportunity to contribute to the refinement or 
generation of theory at a wider scale.
Using theory in the context of politically charged evaluations
Evaluation of large health system changes places evaluators in a highly political context.26 Policies are 
usually the product of political decisions and the recommendations of evaluators are intended to inform 
policy. Both policy-makers and researchers have an agenda whether or not they are consciously aware 
of this, highlighting the importance of formally applying theory and making this explicit and accessible 
to stakeholders. An evaluation may assess whether or not the theory adopted by policy-makers was 
appropriate. For example, an evaluation of the Commissioning for Quality and Innovation Framework, 
launched by the Department of Health in England in 2009, sought to refine the theory behind the 
framework by exploring how it was envisaged to work and comparing this with actual practice.27  
Policy-makers had based the framework on existing literature and had theorised that financially 
incentivising clinical teams to set and achieve desired quality targets would be a successful way to 
encourage behaviour change and thereby drive up quality. In reality, the evaluation team found that the 
task of selecting quality targets was often undertaken by managers rather than clinical staff, and that staff 
were concerned that setting quality targets high would put the hospital at financial risk; thus, the focus 
often shifted from ‘high’ quality targets to ‘achievable’ quality targets.27
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Theme 4: the contribution of different methods to evaluation
Major system changes in health care can be evaluated using a wide range of methods. Within this 
theme we describe some of these methods, distinguishing between quantitative, qualitative and 
mixed-methods approaches.
Quantitative approaches to evaluating major system change
Quantitative approaches are used to measure the effectiveness of interventions. Methods adopted include 
randomised controlled trials (RCTs), natural experiments, interrupted time series (ITS) designs, controlled 
before-and-after studies and uncontrolled before-and-after studies. The merits of alternative approaches 
are extensively rehearsed in Essays 2 and 3 in this volume.
The appeal of a well-designed and well-conducted RCT is that observed differences in outcomes between 
intervention and control groups can be attributed to the change introduced in the intervention group. 
Examples of RCTs carried out to evaluate major system change in health care include ‘The Health Insurance 
Experiment’, a RCT of the effect of payments for health care on health-care usage and quality of care 
received conducted in California between 1974 and 1981;28 ‘The Oregon Health Insurance Experiment’, an 
ongoing RCT launched in 2008 that is designed to evaluate the impact of the Medicaid insurance system 
in the USA on health service use, patient outcomes and economic outcomes;29–31 the ‘Whole System 
Demonstrators’, three large pilots of telehealth launched by the Department of Health in England in 2006 
that have been evaluated using a range of methods including a RCT;32 and the ‘Head Start’ programme, 
a RCT of a complex intervention designed to improve the ‘school readiness’ of children from low-income 
backgrounds in the USA.33
However, there are methodological and implementation challenges in conducting RCTs. Ettelt and Mays34 
discuss these challenges in relation to health policy-making in England. A particular concern regarding 
results from RCTs is that estimates of effectiveness may not be directly generalisable to the target 
population of interest if, for example, subgroups of patients/carers are excluded from the trial.35 The use 
of observational data is, therefore, advocated to ‘assess and strengthen the generalisability of RCT-based 
estimates of comparative effectiveness’.35 Furthermore, RCTs are expensive and time-consuming to 
conduct in comparison with other methods and, in some situations, it is not possible, feasible or ethical to 
randomise people or organisations to intervention or control conditions.
In 2012 the Medical Research Council published guidance on the use of natural experiments to empirically 
study population health interventions in situations where randomisation and indeed manipulation of  
exposure to an intervention is not possible. Natural experiments are therefore defined as ‘events, 
interventions or policies which are not under the control of researchers, but which are amenable to 
research which uses the variation in exposure that they generate to analyse their impact’.36
Interrupted time series designs can be adopted in cases where randomisation is not possible but 
introduction and rollout of the intervention can be regulated. For example, Yellend et al.37 provide a 
protocol for an ITS evaluation of a system reform addressing refugee maternal and child health inequalities 
in Melbourne, Australia. It is preferable for ITS designs to employ concurrent control sites.38
Although absence of randomisation is justified in certain circumstances, the use of control groups is 
essential to estimate whether or not the intervention has a statistically significant impact on outcomes 
compared with an alternative. For example, Benning et al.39 conducted a RCT of a patient safety 
programme in the UK known as the ‘Safer Patients Initiative’. The trial revealed robust improvements in 
control sites that were almost as great as the improvements observed in the intervention sites. Had control 
groups not been in place, it is possible that the improvements in patient safety seen in the intervention 
group would have been attributed to the intervention and spurious conclusions about effectiveness might 
have been drawn.
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Pronovost and Jha38 summarise the pitfalls associated with uncontrolled before-and-after studies. Their 
summary draws on the example of the widely celebrated ‘Partnerships for Patients Program’ in the USA, 
which was evaluated using a simple before-and-after design without the use of concurrent controls. They 
contend that the study design adopted, the absence of valid metrics, the lack of peer review and deficient 
transparency in reporting make it almost impossible to determine whether or not the programme led to 
better patient care. Furthermore, before-and-after studies assume that there is a clear definition of what 
constitutes both ‘before’ and ‘after’, although complex interventions are likely to continue to evolve over 
time and, thus, regular follow-up measurements are recommended.40
The appropriateness of different quantitative methods must be considered on a case-by-case basis. 
Researchers should strive to use the most robust feasible design, adopting control groups and regular 
measurement, and therefore avoiding uncontrolled before-and-after studies. Those who are evaluating 
major system changes should be mindful that adopting quantitative methods in isolation may be 
insufficient. For example, in their discussions of the methodological considerations needed to evaluate 
the introduction of electronic health records in the English NHS, Takian et al.40 propose the need for an 
‘interpretive approach’ which considers the impact of the national and local context. In addition,  
Moore et al.41 comment that ‘effect sizes do not provide policy-makers with information on how an 
intervention might be replicated in their specific context, or whether or not trial outcomes will be 
reproduced’, thus highlighting the need to consider qualitative and mixed methods.
Qualitative approaches to evaluating major system change
Experimental and quasi-experimental research designs are appropriate to respond to certain type of 
research questions and objectives, such as effectiveness, but are not appropriate to respond to research 
questions that address the ‘how’ and ‘why’ questions that modulate the effectiveness of complex 
interventions in ‘natural’ settings. Qualitative approaches can help to address these questions by 
highlighting the contextual factors, and mechanisms of action, that contribute to the effectiveness of an 
intervention programme, including reasons for results varying across different settings. Process evaluations 
are useful in accessing the ‘black box’ of an intervention, that is, understanding the mechanisms through 
which it produces its effects, and can be used alone or in tandem with other methods (e.g. RCT studies).15 
At the more qualitative end of the evaluation spectrum, case studies are a useful approach for analysing 
processes of major system change. As described by Yin,42 case studies involve ‘in-depth inquiry into a 
specific and complex phenomenon (the ‘case’), set within its real-world context’. The conduct of case 
studies involves analysis of the case (‘how things are’ or an intervention), the context (social, political, 
financial and so forth), and the interaction between the case and the context and the ways in which they 
influence one another. These methodological issues are further rehearsed in Essay 7.
Rather than describing one method, case studies can be undertaken using a range of methods  
(including descriptive and theory-driven approaches) and can form a critical component of mixed-methods 
studies that also aim to explain outcomes.43 The choice of method depends for the most part on the 
research questions driving the evaluation. For example, a standalone process evaluation, based on 
descriptive and theory-driven case studies, was used to conduct a retrospective cross-sectional study of 
nine health-care mergers in London, as the interest was in how and why the organisational context in 
which mergers took place, including differences in organisational culture among providers, influenced 
processes of change.44 Suggested reporting standards for organisational case studies related to health care 
have recently been published.45
Another theory-driven method is realist evaluation which asks ‘what works for whom and under 
what circumstances?’ in an attempt to uncover context–intervention–outcome relationships in change 
programmes.46 Realist evaluation recognises that context is complex and always changing. For example, 
Greenhalgh et al.47 carried out a realist evaluation of the ‘modernisation’ of stroke, sexual health and 
kidney services in London. Marchal et al.48 provide a useful overview of studies using realist evaluation in 
health systems research and propose a need for more methodological guidance on use of the method  
(e.g. on defining ‘mechanisms’ and ‘context’).
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Comparative case study research
Although clinical researchers may more easily replicate their observations by studying the effectiveness 
of a drug on groups of patients, the evaluation of major system change often involves single case 
studies, making replication of results and assessments of potential generalisability difficult. It is, however, 
possible to generate cumulative knowledge about the factors that influence major system change 
through comparative case studies. This involves adopting a structured and theoretically driven approach 
to summarise, compare and contrast in-depth information derived from two or more studies of major 
system change.
Comparative research on different major system change programmes can be carried out using studies 
that were not originally designed with this purpose in mind. For example, Langley et al.49 retrospectively 
compared cases of large scale health-care transformation in Alberta and Quebec, Canada, in order 
to explore identity struggles associated with the merger of organisations. Data from a wide range of 
actors involved in and/or experiencing the change are essential to enable comparisons within and across 
cases and to generate significant theoretical insights. However, if analysis is planned and undertaken 
retrospectively, in-depth data of this quality may not be readily available and outputs may not be timely 
enough to inform practice. On the other hand, prospective data collection is resource intense, requiring 
considerable time and forward planning between researchers and service leaders to collect as well as risk if 
proposed changes are not implemented.
Structured comparisons should be made within and across cases and should examine the personnel, 
process, context and content features of the interventions. For example, Cloutier et al.50 undertook a 
comparative case study to generate theories about how organisations in Quebec had implemented 
health-care reform. The study involved a detailed analysis of practice within and between different cases 
to examine how health-care managers ‘recreate’ reform through conceptual work and testing ideas. The 
findings suggest that way that people work both dilutes and gives shape to reform at the same time and 
offers ‘improved understanding of the importance of managerial agency in enacting reform, and the 
dynamics that lead to slippage in complex reform contexts’.50
Hypotheses should be used to structure the comparisons between cases. For example, Øvretveit and 
Klazinga51 conducted a mixed-method systematic comparison of factors affecting implementation success 
of six large-scale quality improvement programmes in the Netherlands. The researchers assessed whether 
or not there was evidence from their evaluation to support or refute 17 hypotheses about what might 
predict successful implementation of improvement programmes. The hypotheses were created by an 
expert team comprising researchers who had worked on the six improvement programmes following a 
review of the literature. Systematically describing and comparing the different change programmes and 
their fit (or lack of) with the proposed hypotheses led to the creation of a list of factors thought to be 
key to the successful implementation of large-scale change. A comparative case study approach has also 
been used to test hypotheses regarding factors critical to the success of large-scale quality improvement 
initiatives in Sweden.52
Challenges of comparative case study research
Øvretveit and Klazinga51 discuss four main challenges of comparative case study research into  
large-scale change, all of which are key considerations for decision-makers when deliberating whether 
or not apparently successful interventions are replicable elsewhere. Challenges of description arise when 
limited information is given to describe a change programme, the surrounding context and developments 
over time. Challenges of attribution arise when the study designs employed (e.g. process research using 
case studies) make it difficult to say with certainty to what extent a change programme has produced 
certain outcomes rather than some other factor(s). Challenges of generalisation relate to the extent to 
which findings from a major system change programme may be generalisable elsewhere. Again, the 
use of comparative case studies across different programmes can aid assessment of generalisation in 
different settings. Theories, and research hypotheses that aim to test these, are key to harnessing the 
cumulative power of doing multiple comparative case studies for the evaluation of complex interventions. 
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Finally, challenges of use contemplate the utility of research findings for the user. Evaluation designs 
should strive to be ‘useful’; in some situations this may mean that conducting research which gives 
less-certain answers about whether or not a complex intervention ‘works’ and more information about the 
associated processes and context is a better option than conducting a study to answer a single question 
about effectiveness.
Use of mixed-methods approaches
There is a case for outcomes research, which tends to be more quantitative, and process-based 
research, which relies more on qualitative methods, to be used in a balanced way, with insights drawn 
from both approaches and neither dominating. As defined by Langley et al.,53 process studies ‘address 
questions about how and why things emerge, develop, grow, or terminate over time’, which differs 
from quantitative studies that tackle ‘variance questions dealing with covariation among dependent and 
independent variables’. Evaluations involving mixed methods are one way of bringing together quantitative 
and qualitative analyses of major system change. For example, mixed methods have been used to evaluate 
reconfiguration of acute stroke services across two large metropolitan areas in England (London and 
Greater Manchester), combining quantitative analysis of the impact of change on patient outcomes and 
cost using a controlled before-and-after study with a process evaluation of ‘how’ and ‘why’ different 
approaches to the planning and implementation of change were adopted in each area.54 Additionally, 
mixed-methods approaches have been used to evaluate the Advancing Quality pay-for-performance 
programme in North-West England55 and a large-scale transformational change programme in the 
North East.56
Theme 5: using knowledge from evaluation to inform policy 
and practice
This theme focuses on the challenges that arise in ensuring that findings from major system change 
evaluations are used by decision-makers to inform policy and practice. The creation of knowledge about 
how major system change programmes can best be delivered and evaluated and the informed assessment 
of the potential transferability of successful major system change programmes to other settings are central 
to the impact of management and organisational research in health care.
Accumulation of knowledge: theoretical and methodological considerations
The third theme in this essay demonstrated the importance of employing theory. Theory allows inferences 
about social and organisational process to be extrapolated beyond a surface description of individual cases, 
thus playing a vital role in the assessment of potential transferability of findings from a given context to 
another context and aiding the accumulation of knowledge across studies.
The sections on qualitative and mixed methods within the fourth theme of this essay detail the 
contribution of process- and practice-based research to evaluate major system change in health care. 
Case studies are often employed to describe how and why change emerges (and potentially disappears) 
over time. A particular challenge of case study designs of this type is moving beyond the production of 
idiosyncratic descriptive accounts of change towards a deeper understanding of the underlying generative 
mechanisms that interact to create change. It is essential to explore how to gain generalisable insights 
that have value in terms of transferability beyond the original context in which major system change 
was deployed in order that others might improve their own systems with increased ease and efficiency. 
Comparative case study research can be a useful method in this regard, as described in the fourth theme 
of this essay.
Creating actionable findings
When discussing how to build actionable knowledge in the field of major system change in health care, 
participants suggested that a potential way forward would be to create a theoretical framework based 
on a synthesis of existing theories of organisational change. Such a framework would resemble the 
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Theoretical Domains Framework (TDF) which was developed by Michie et al.57–60 to make behaviour change 
theories accessible for implementation researchers. The TDF contains constructs from 33 different theories 
that explain behaviour change in individuals. It enables researchers to use theory to target the behaviour 
change of patients or health-care professionals by providing operational guidance on the development 
of complex interventions that are designed to reduce the gap between clinical practice and the 
evidence base.61 The benefits of creating a framework containing constructs from organisational change 
theories would be twofold: the framework would provide a theoretically informed ‘road map’ for those 
implementing major system changes and would essentially create a feedback loop, allowing researchers to 
use findings from one study to inform another.
Communicating findings
The likelihood that findings from major system change evaluations are used by decision-makers to inform 
policy and practice is linked to the ability of evaluators to communicate their findings. For maximum 
impact, researchers must tailor the dissemination of their findings to different stakeholders. Furthermore, 
the dissemination piece must describe and debate issues relating to the implementation of the major 
system change, rather than solely focusing on headline-grabbing statistics relating to outcomes, in order 
that decision-makers and other stakeholders can assess the potential for transferability to other settings. 
However, researchers can, arguably, be poor at communicating, marketing and ‘selling’ their knowledge, 
and could perhaps learn lessons from the large health-care consultancies in this regard. The way in 
which academic careers are structured, with a particular focus on peer-reviewed journal articles, can be a 
disincentive to invest time in dissemination via other channels of communication, including those channels 
that are likely to be accessed by decision-makers. Further investment in science communication could 
help to correct this imbalance and therefore drive an increase in evidence-based approaches to major 
system change.
The role of researchers: collaborators or evaluators?
Decision-makers do not solely rely on research evidence when making decisions about the major changes 
required to improve health care and how these changes should be implemented. Policy documents, 
data collected by organisations, journalistic accounts and anecdotal accounts are important sources of 
information that are likely to influence decisions regarding major system change. Rigorous evaluation that 
applies research methods is time-consuming and costly relative to data gathering using these alternative 
forms of evidence. One school of thought suggests that it is, therefore, necessary for researchers to work 
more dynamically and in closer partnership with other stakeholders in order to inform and strengthen the 
implementation and evaluation of ongoing change. However, there can be political challenges associated 
with working in this way, as outlined in this essay. Furthermore, another school of thought advocates that 
researchers should maintain a critical distance in order to evaluate objectively.
The predominant view expressed at the roundtable event was that researchers should play one of two 
roles: they should either ‘sit at the table’ with decision-makers and help them to plan the interventions 
and their implementation (but not conduct the evaluation of this) or independently conduct an evaluation. 
Thus, it can be proposed that there is a need for separate implementation and evaluation teams in order to 
maintain transparency of the evaluation methodology. Nevertheless, where introduction of a major system 
change and evaluation activities take place contemporaneously, researchers should strive to produce 
evaluation findings in a timely manner in order to guide the ongoing implementation of the change  
to enhance relevance and impact of the evaluation. Researchers have produced guidance to help  
decision-makers to decide whether or not and how to introduce change.62 Considerations of 
implementation are further addressed in Essay 8.
Expectations of researchers versus expectations of decision makers
Researchers are usually commissioned to conduct evaluations of major system changes in health care by 
decision-makers who are the driving force behind the change. Challenges may arise for researchers when 
they are asked to evaluate a change that is not readily ‘evaluable’ or when there is not clear consensus 
between what decision-makers want and what researchers are able to offer. For example, decision-makers 
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may hope that researchers are able to evaluate the effectiveness of a complex major system change at a 
whole-system level, yet it is not always possible to deliver this. There then begins a negotiation between 
decision-makers and researchers to determine and agree what is possible and meaningful for both parties.
It is also important to establish a shared understanding of the way in which evaluation findings will be 
used from the outset. For example, different stakeholders may have different understandings of the 
term ‘pilot study’.63 In the eyes of the decision-maker, a pilot study may strongly signify the intended 
direction of travel. The evaluation is intended to shape but not dramatically alter this direction of travel: 
it is the oar that steers the boat. On the other hand, a researcher may understand the words ‘pilot study’ 
to mean a test to determine whether or not the intervention should be continued. They may expect an 
intervention to be terminated if the findings of the pilot study suggest that the change is not effective 
or is having unintended consequences. In reality, this may not be the case. For example, an urgent care 
telephone triage service known as ‘NHS 111’ was introduced as a pilot in four geographically defined 
areas in England in 2010. The aim of the telephone service was to ‘improve access to urgent care, increase 
efficiency by directing people to the “right place first time” including self-care advice, increase satisfaction 
with urgent care and the NHS generally, and in the longer term reduce unnecessary calls to the 999 
emergency ambulance service and so begin to rectify concerns about the inappropriate use of emergency 
services’64 [quote reproduced as this is an Open Access article distributed in accordance with the Creative 
Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, 
adapt, build upon this work non-commercially, and license their derivative works on different terms, 
provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.
org/licenses/by-nc/3.0/]. An evaluation of the pilot demonstrated that the introduction of the NHS 111 
telephone service actually increased ambulance use in pilot sites in comparison with control sites.64 Despite 
the negative findings uncovered in the pilot evaluation, the NHS 111 telephone service was subsequently 
rolled out nationwide.
Ettelt et al.65 provide further reflections on the tensions that can arise as a result of the different 
perspectives held by researchers and decision-makers.
Conclusion
There was broad consensus from the meeting that major system change is a complex and unstable 
process, which operates at multiple levels, and is context dependent and thus varies by place and over 
time. The complexity, heterogeneity and instability of major system change also presents challenges for 
defining and measuring its effectiveness, although a range of approaches are being used from quantitative 
measures of outcomes through to broader measures of the ‘value’ of change used in qualitative and 
process-based studies. The use of different methods and perspectives to study major system change, and 
their combination in the design of evaluations (e.g. mixed-methods approaches), is important in order to 
represent different aspects of the complexity of major system change and to evaluate its effectiveness, 
which should be broadly defined in terms of potential impacts.
Theory allows inferences about social and organisational process to be extrapolated beyond a surface 
description of individual cases, thus playing a vital role in the assessment of potential transferability of 
findings from a given context to another context and aiding the accumulation of knowledge across 
studies. The creation of a theoretical framework based on a synthesis of existing theories of organisational 
change could aid both the design and the evaluation of major system changes and help to advance the 
field through accumulation of knowledge across projects. However, there is a tension between, on the one 
hand, the need to accumulate a stable body of knowledge (e.g. on implementation) that could be used 
to inform policy and practice and, on the other, the maintenance of critical thinking in relation to existing 
theory to ensure that concepts that have achieved widespread acceptance are not just taken for granted, 
but remain provisional and open to challenge.
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There are implications for furthering the development of both process-based and outcome-based studies 
of major system change, as well as identifying and pursuing novel ways of bringing the two approaches 
together. In particular, future evaluation designs should aim to represent and capture key components 
of the dynamics of major system change – the context, process and practices, and outcomes – as 
understanding of these elements is currently held back by the tendency to specialise in either qualitative 
or quantitative methods of research, rather than look for common ground where they can enrich 
one another.
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Abstract
The need to understand the contextual influences that subvert, neutralise, intensify or otherwise influence 
interventions is well recognised, yet the role that context plays in the design and evaluation of health 
and social care interventions remains understudied. Concerted effort from the research community – 
researchers, funders and publishers – is needed to address this problem. Mixed-methods studies are  
likely to be critical. Researchers should expend greater effort earlier in the development and evaluation 
process to optimise interventions, identify causal mechanisms and characterise contextual influences.  
The development of quantitative measures to explore structural features of context should be a future 
focus, as should better reporting of interventions and the development of guidance to support explicit 
descriptions of context. Encouraging the conduct of mixed-method process evaluations alongside trials 
and other evaluations will require new norms and expectations of research and associated funding 
commitments, attention to collaborative relationships and changes in publishing practices.
Scientific summary
The need to understand the contextual influences that subvert, neutralise, intensify or otherwise influence 
interventions is increasingly well recognised, yet the role that context plays in the design and evaluation 
of health and social care interventions has remained understudied. Concerted effort is needed to address 
the conceptual, methodological and practical challenges associated with conducting contextually 
sensitive research.
Several key issues present barriers to progress. First, poor-quality reporting of interventions (and 
programmes more broadly) hampers understanding of what an intervention comprises, the mechanisms 
through which it works and the likely influences on implementation, including those of context. Second, 
the need to understand and give accounts of context is continually challenged by the problem of 
conceptualising what ‘context’ means in practice. Third, inadequate time is given over in the early stages 
of research to theorising about context.
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Effort expended early in the development and evaluation process is needed to optimise the theoretical 
basis of interventions and to characterise the systems into which they will be introduced. Quantitative 
measures to explore structural features of context are essential; more effort in helping to specify these 
measures and support data collection will be an important focus for the future. Qualitative methods are 
particularly suited to securing understanding of the theoretical basis of interventions, exploring how, 
where, when and by whom an is intervention delivered and received, identifying effects and how they 
are achieved, and characterising how interventions are adapted in response to contextual influences and 
how contexts themselves are modified by interventions. For the future, researchers, funders and publishers 
should be encouraged to think in terms of mixed-methods studies where qualitative and quantitative 
methods are seen as complementary methods. Better reporting of interventions and the development of 
guidance to support explicit descriptions of context are also needed.
Realisation of these ideas will require funder commitments to adequately resource both developmental 
work and process evaluations that run alongside trials and evaluation designs, more realistic expectations 
about the time frame for developing an intervention, and journals that are willing to publish the results 
of this kind of work. The institutional features of the research landscape – including funding structures, 
publishing models, and the norms, values and practices of the researcher community and the users of 
evidence – also need critical scrutiny to ensure that they support contextually sensitive research.
Introduction
Medical Research Council (MRC) guidance on developing and evaluating complex interventions 
recommends that researchers should ‘first develop the intervention to the point where it can reasonably be 
expected to have a worthwhile effect’.1 But health and social care systems continue to be challenged by 
the problem that initially promising interventions often prove difficult to replicate and scale: what works in 
one setting may not be as effective, and may sometimes even be harmful, when implemented elsewhere.1 
Efforts to understand the contextual influences that may subvert, neutralise, intensify or otherwise 
influence interventions are, therefore, critical. Yet current practices of research and evaluation are pervaded 
by a tendency to defer thinking about ‘contextual contingencies’ until too late.2
Participants at the London meeting in 2015, which is described in the Introduction to this volume, 
suggested that the sparse attention given to context in the design and evaluation of health and social 
care interventions3 is explained not by the perception that context is unimportant, but by the formidable 
conceptual and practical challenges associated with defining, measuring and articulating the role of 
contextual factors and influences. Even a consensual definition of context remains elusive. The need for 
serious attention to questions of context is now, however, increasingly well recognised across a range 
of disciplines,4,5 to the extent that participants emphasised the need for guidance on how to structure 
thinking about context and to select appropriate methods for its study.
In this essay, we propose that moving the field forward will require more sophisticated characterisation of 
interventions and their contexts of implementation. We emphasise the benefits of quantitative measures, 
but highlight the value of qualitative methods and of combining qualitative and quantitative methods 
when addressing questions of context.
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Understanding and reporting interventions
One major challenge in studying context and contextual influences is the persistent problem of  
poor-quality reporting of interventions and programmes. Good accounts of what a programme/
intervention is, how it works and how it is influenced by and exerts influence on the surrounding context  
are rare.6 Although the Consolidated Standards of Reporting Trials (CONSORT) requires that ‘the 
interventions for each group with sufficient details to allow replication, including how and when they 
were actually administered’ (item 5)7 be reported, only a minority of non-pharmacological interventions 
are adequately described.8,9 Without a complete and explicit description of an intervention,11 clinicians, 
patients, researchers and other decision-makers are left unclear about what an intervention comprises 
and the likely influences on implementation, including those of context.11 This essay therefore expands on 
considerations regarding trial design and evaluation discussed in Essay 2 in this volume.
Publication guidelines now increasingly support the view that a complete description means that that the 
theoretical basis of interventions must be reported alongside the components of interventions,11 not least 
because this allows an assessment of how far the intervention is theoretically well founded. It may also 
help in explaining the findings of studies and in optimising the design and implementation of interventions 
in the light of those findings. For instance, the American College of Surgeons National Surgical Quality 
Improvement Program (NSQIP), a large-scale audit and feedback exercise that provides feedback to 
hospitals on their risk-adjusted outcomes (e.g. mortality, specific complications and length of stay), was 
found in a quasi-experimental study to have no additional effect on the outcomes of participating  
hospitals relative to matched controls after taking into account pre-existing secular trends.12 A possible 
explanation for this disappointing result is that the audit and feedback mechanism used in NSQIP is not 
fully consistent with the findings of the significant body of research and theory on features of feedback 
effectiveness, including those relating to frequency of feedback, selection of solutions and setting of goals 
and action plans.13–15
Use of theory can also help in explaining why interventions may fare differently in different contexts, as 
shown by studies of the quality improvement collaborative (QIC) model. The model requires organisations 
to come together over a defined period of time to engage in collaborative learning and exchange of 
insights to achieve improvement goals.16,17 Although QIC models have proliferated widely,18 understanding 
of whether or not they work – and, if so, how, when and where they work best – has remained 
underdeveloped.17 Here, again, theories are important. An evaluation of a QIC model to improve stroke 
care in the north-west of England16 using a randomised design to assess performance on nine aspects 
of stroke care found that hospitals participating in the QIC model showed only modest improvements 
on selected aspects of care compared with non-participants. A qualitative study to explore the views 
and experiences of those involved in designing and implementing the QIC model found that it conferred 
some benefits but also introduced significant tensions – many of them possible to predict using theory 
on collective action.19 For example, participation required substantial effort on the part of participating 
organisations, introducing the risk of ‘free-riding’ where some organisations gave less than they received. 
Importantly, this qualitative study also identified the influences on organisations’ commitment to the 
collaborative ethos by characterising features of both the inner context of individual hospitals (e.g. baseline 
performance) and an outer context of competition over the provision of stroke services.
When descriptions of interventions and accounts of how they work are inadequate, attempts to replicate 
successful programmes risk disappointment that may be blamed on context, when the true culprit is that 
only the superficial outer appearance of the intervention has been reproduced and not the mechanisms  
(or set of mechanisms) that produced the outcomes in the first instance: a phenomenon known as  
‘cargo cult science’.10 This was exemplified when the success of a complex intervention that reduced 
central venous catheter bloodstream infections across a large number of intensive care units (ICUs) in the 
state of Michigan20 was simplistically credited to the implementation of a basic checklist.21 A post hoc 
analysis to discern the mechanisms through which the programme worked revealed a complex web of 
interacting social processes, including the technical and cultural shifts that ultimately increased patient 
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safety.10 A qualitative study of the attempt to replicate the programme in England suggested that the 
mechanisms that underpinned the programme’s success in Michigan were generally not activated in the 
English version, even though its components were similar.22
These findings, like those of other studies, add weight to the recent suggestion that the fidelity of an 
intervention may reside in the mechanisms of action rather than in specific programme components, 
such that individual components of an intervention may be varied across contexts without comprising the 
effects of the programme.23,24 This requires an understanding of the role and meaning of each intervention 
component, in terms of how it will interrupt the causal mechanisms which perpetuate and sustain a 
problem in the context being investigated, rather than simply a description of its form.24 It also requires 
a deep understanding of the system into which the intervention will be placed to consider ‘fit’ between 
intervention and context, how the intervention will interact with context to bring about, aid or sustain the 
hoped for change, and the likely consequences of attempting to change the context through introducing 
a new intervention. The realist evaluation approach25 is one, among several, that strongly emphasise 
the interaction between context and intervention, contending that programmes have differential effects 
because the mechanisms by which an intervention influences outcomes may not be activated in all 
contexts, or may differ from one context to the other.
Understanding the role of contextual influences
The term ‘context’ has its etymological roots in the Latin contextus, meaning ‘joining together’. 
Understanding what happens when a particular intervention is joined together with an individual, team, 
organisation or health system remains a critical challenge both for science and for practice and policy. 
But the need to understand and give accounts of context is continually challenged by the problem of 
conceptualising what ‘context’ means in practice.3,6 A taxonomy that could be used across multiple 
studies to identify and describe critical components of interventions and their contexts might be helpful,3 
as might a synthesis of evidence from a range of disciplines to identify those aspects of context that are 
most consistently related to intervention success and sustainability.26 Some inroads have been made to 
this end in implementation science by Damschroder et al.,27 who synthesised constructs from existing 
implementation theories to create a framework comprising five key domains (intervention characteristics, 
outer setting, inner setting, characteristics of the individuals involved and process of implementation) 
that can be used to guide choices about relevant aspects of the intervention, context and process of 
implementation to assess in any given evaluation.
To date, many intervention studies lack even basic information about the research and clinical contexts 
in which they are undertaken,8 even though item 4b of the CONSORT statement (setting and location)7 
states that researchers should report on ‘other aspects of the setting (including the social, economic, and 
cultural environment and the climate) [that] may also affect a study’s external validity’.7 A specific extension 
to reporting guidelines to include more detail on context has been proposed.3,6 Data produced by such 
reporting may enable the identification of candidate factors suitable for quantitative measurement and the 
modelling of contextual variables28 that may be important in revealing variations and inequalities.
This kind of work may also be especially useful in exploring how structural features of contexts may 
moderate the mechanism through which an intervention produces its effects. For example, a cluster 
randomised trial of breakfast clubs delivered on a universal basis29 found that the provision of breakfast at 
school had no overall impact on rates of breakfast skipping. However, further analysis found that schools 
in more deprived areas showed an increase in the number of healthy foods eaten at breakfast and found 
that rates of breakfast skipping were reduced at these schools, suggesting that context moderated the 
impact of the intervention. Similarly, a peer-led smoking prevention programme aiming to prevent smoking 
uptake among young people had a greater effect in areas characterised by dense social networks that 
supported the more efficient diffusion of smoking prevention messages.30
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The relationship between context and intervention is not, of course, unidirectional. Increasingly, context is 
seen as having effects so powerful that it may ‘shape or co-construct complex interventions and therefore 
cannot be considered separately from those interventions’.3 Accordingly, Hawe et al.23 conceive of 
interventions as events in systems that either ‘leave a lasting footprint or wash out depending on how well 
the dynamic properties of the system are harnessed’. To this end, qualitative research during the earlier 
stages of intervention development can be used to give insight into the context into which an intervention 
will be delivered, enabling researchers to better articulate what aspects of the existing context the 
intervention attempts to change, and why. Where this process of intentional adaption takes place, work 
by Jansen et al.31 suggests that researchers may attempt to adapt the context to fit the intervention, rather 
than fashion the intervention to suit the setting.
Interventions may also ‘evolve’ over time, shaped by a range of contextual influences and pragmatic 
considerations.3,32 Interventions involve attempts to change the functioning of ‘complex adaptive 
systems’,23 and the survival of these systems is dependent on ceaseless adaptation in response to changing 
internal and external environments. Hence adaptations to interventions are often necessary because 
aspects of the system or its wider context may change after the study has begun, including changes in the 
economic or political context or local changes.3,33 Mutations in an intervention may be highly functional, 
resulting in an intervention that is better suited to the setting in which it is delivered, although adaptations 
may also have unintended consequences.3
Fundamentally, the dynamic interplay between intervention and context inherent to many complex 
interventions means that it is often difficult, and indeed not always helpful, to separate intervention from 
context.23 Viewing interventions as attempts to change aspects of their contexts means that they cannot 
be understood in isolation from those contexts. Yet adaptations have traditionally been viewed simply as 
methodological shortcomings, particularly in relation to trials.3 As a result, researchers may describe  
(often poorly) the intervention that they intended to deliver rather than that which was actually 
implemented, thus hampering efforts to replicate or build on research findings. Wells et al.3 urge a 
cultural shift in which the open and honest reporting of issues such as local adaptations and differences 
in implementation is perceived as an indicator of study strength and research integrity, rather than a study 
weakness or lack of researcher ability: what is important is not that these adaptations occurred, but that 
they are ‘known, understood, and reported’. The key to this shift in thinking, Hawe et al.34 argue, is the 
idea that the integrity of complex interventions is defined functionally, rather than compositionally.
As Figure 7.1 depicts, capturing the complexity and emergent nature of the interaction between context 
and intervention35 is likely to require well-conducted process evaluation at all stages of intervention design, 
implementation and evaluation.
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The role of qualitative and mixed-methods research
The MRC guidance1 emphasises the role of qualitative methods during the development and modelling 
stage that precedes evaluation, thus helping to convince funders of the value of qualitative research.36 
Discussants at the 2015 London meeting felt that the exemplary case studies and synthesis of existing 
work, like that undertaken by O’Cathain et al.36 and Lewin et al.,37 play an essential role in demonstrating 
the value that qualitative methods bring. This was seen as especially important for participants, who 
reported a sense that funders historically have been reluctant to fund development and feasibility work, 
perhaps especially when policy-makers are eager to get on with implementing a new intervention or policy.
Further mitigating the fruitful use of qualitative research is the emphasis on high-impact publications 
in assessing the value of institutions, research disciplines and individual researchers. O’Cathain et al.36 
found that researchers perceived randomised controlled trials (RCTs) as more likely to facilitate this type of 
output, with qualitative papers more likely to be published in lower-impact journals. This often resulted in 
quantitative and qualitative papers being published separately and, in some cases, where qualitative papers 
were seen as lower-status outputs, not at all.36 O’Cathain et al.36 suggest a need to address publishing 
norms that serve as a barrier to the publication of applied mixed-methods research, and for publishers 
to recognise that in an output-driven environment a lack of high-quality forums for this type of research 
may have a detrimental influence on the work that is undertaken in the first place. O’Cathain et al.36 also 
recommend that care is taken to explicitly articulate the role played by the qualitative research and the 
value brought to the trial (or evaluative study) as well as lessons learned for studies in the future.
An example of this kind of useful work is the study conducted by Redfern et al.,38 who used a range of 
qualitative methods to develop Stop Stroke, an intervention to improve clinician and patient management 
of risk factors to prevent stroke recurrence. In establishing the theoretical rationale for the intervention, 
the research team conducted a systematic review and exploratory interviews to understand patients’ 
experiences of secondary prevention as well as non-participant observation of staff during clinical 
consultations to understand how prevention advice was given in local contexts; they also mapped 
patterns of risk factor management practices as well as identifying barriers and facilitators to risk factor 
management. The resulting programme used these data to design a complex multiple component 
intervention targeting patients, carers and health-care professionals with tailored advice at three time 
points post stroke.
This work shows how qualitative methods can be used during the development and modelling phase to 
design an intervention that takes into consideration the preferences of patients and practitioners, but 
also takes account of existing local provision. However, this kind of work-up of interventions and contexts 
remains relatively rare: a number of studies have highlighted the need for more effort to be expended at 
earlier stages of intervention development and evaluation to maximise the value that qualitative methods 
in particular can bring.31,36 These modelling considerations are also discussed in the context of making best 
use of available evidence in Essay 1.
Table 7.1 reports the diverse ways in which qualitative research is used alongside trials to explore various 
aspects of intervention and study design. The largest subcategory focused on exploring the feasibility and 
acceptability of the intervention in practice (23%), but relatively little of this work (28%) was undertaken 
at the pre-trial stage. Only 13% of all papers published between 2008 and 2010 reported pre-trial 
intervention development work and only one published paper explored the mechanism of action prior to 
the full trial, suggesting that this important stage of work could be given more emphasis.
Beyond the development phase, qualitative research that runs alongside programme implementation 
offers a useful way of generating an account of the programme as it happened, rather than as it was 
planned.10,28 O’Cathain et al.36 advocate for qualitative research to take a more challenging role, rather 
than one that is simply descriptive. The programme theory should be specified from the earliest point 
in the design and development phase1 but with the expectation that the mechanism that is specified 
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in advance may not necessarily hold true or may need to be adjusted.10,40 Thus, for example, a study 
undertaken by Dixon-Woods et al.22 to characterise the Matching Michigan programme in practice 
involved approximately 855 hours of observational fieldwork in 17 ICUs, including observation of training 
events, team meetings and external reference group meetings, over 100 interviews with ICU staff and 
documentary analysis. This enabled them to establish that the programme as implemented was not the 
same as the one on which it was modelled, and that outcomes varied as a function of outer and inner 
contextual influences as well as differences in data collection that undermined the comparability of 
supposedly standardised measures of infection rates across units.41
Davidoff et al.40 highlight that aspects of the broader contextual landscape such as cultural, emotional and 
political challenges, as well as aspects of local context, are all likely to become much more salient as the 
work proceeds. With this in mind, theoretical accounts of how a programme works should be developed 
through a continual cycle of theory testing and refinement.1 To facilitate the enquiring and often iterative 
nature of qualitative research, O’Cathain et al.36 recommend that ethics boards be more sympathetic to the 
evolving role of qualitative research throughout a study, allowing researchers to pursue emergent findings 
without requiring substantial amendments to ethical approvals.
A mapping study carried out by O’Cathain et al.36 that explored the use of qualitative methods alongside 
RCTs gives some sense of how researchers may employ mixed-methods designs to study complex 
interventions. The potential value of the qualitative research to the endeavour of generating evidence of 
TABLE 7.1 Framework of the focus of qualitative research used with trials
Category Subcategory
Intervention content and delivery Intervention development
Intervention components
Models, mechanisms and underlying theory development
Perceived value and benefits of intervention
Acceptability of intervention in principle
Feasibility and acceptability of intervention in practice
Fidelity, reach and dose of intervention
Implementation of the intervention in the real world
Trial design, conduct and processes Recruitment and retention
Diversity of participants
Trial participation
Acceptability of the trial in principle
Acceptability of the trial in practice
Ethical conduct of trial
Adaptation of trial conduct to local context
Impact of trial on staff, researchers or participants
Outcomes Breadth of outcomes
Variation in outcomes
Measures of process and outcome Accuracy of measures
Completion of outcome measures
Development of outcome measures
Target condition Experience of the disease, behaviour or beliefs
Reproduced from O’Cathain et al.39 under the terms of the Creative Commons Attribution Non-Commercial Licence, 
which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is 
non-commercial and is otherwise in compliance with the licence (http://creativecommons.org/licenses/by-nc/2.0/).39
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effectiveness of health interventions was found to be considerable, and included improving the external 
validity of trials, facilitating interpretation of the trial findings, improving sensitivity to the human beings 
who participate in trials, and saving money by steering researchers towards interventions more likely to 
be effective in future trials.39 Some researchers perceived qualitative research as peripheral or an ‘add-on’ 
to the trial, but others saw the qualitative research as essential and of equal value to the trial. Those 
researchers who were interested in influencing practice in the real world, and who were aware of the 
complexity of the intervention they were testing, were particularly likely to see qualitative research as 
essential; accordingly, they were more likely to attribute more resources to the qualitative research and 
work within integrated teams. Importantly, they were also more likely to value the integration of the 
qualitative and quantitative findings, thus enhancing the impact of the qualitative findings on the current 
or future trial.
These challenges need to be addressed given mounting evidence of the benefits of qualitative research in 
ensuring success in the design and implementation of interventions and in ensuring adequate accounting 
for context. Case study methodology, particularly when comparative, may be especially powerful in 
producing in-depth, multifaceted understandings of a complex issue in its real-life context.28 For example, 
a prospective longitudinal ethnographic study undertaken by Hoddinott et al.42 alongside a cluster 
randomised trial of a group intervention to facilitate breastfeeding in Scotland combined qualitative data 
with descriptive quantitative data on intervention ‘dose’ to construct case studies, enabling comparison 
of policy implementation and impact across seven different localities. The techniques used in Hoddinott 
et al.’s study42 allowed the development of a model of health service attributes necessary to successfully 
deliver the policy. For instance, in localities where breastfeeding rates had declined, negative aspects 
of place (rising deprivation, availability of other group interventions, lack of suitable venues), personnel 
resources and organisational change predominated, preventing teams from creating or exploiting 
opportunities for the multidisciplinary partnership working that was crucial for successful implementation. 
The study design also enabled a full analysis of implementation processes prior to knowing the trial 
outcomes, thus minimising retrospective selection bias and the kinds of rationalisations that can occur 
when questions about failure (of the technical intervention or the implementation strategy) are asked 
in retrospect.42 As this study shows, the attribution of causality in case studies can be supported by 
iterative pattern-matching processes that develop explanations, deduce implications of those explanations 
and seek additional information to check these explanations out. See further considerations regarding 
implementation in Essay 8 of this volume.
Their evaluation of the Multi-Payer Medical Home Demonstration, RTI International, The Urban Institute 
and the National Academy of State Health Policy33 also employ multimethod case studies with the express 
purpose of building a detailed picture of the state context and programme structure that can be used to 
interpret variation in implementation and outcomes. Advanced primary care practices, or ‘medical homes’, 
utilise a team approach to care, and aim to improve the quality and co-ordination of health-care services 
through emphasis on prevention, health information technology, care co-ordination and shared  
decision-making among patients and their providers. The demonstration will evaluate whether or not 
advanced primary care practice will reduce unjustified utilisation and expenditures, improve the safety, 
effectiveness, timeliness and efficiency of health care, increase patient decision-making and increase the 
availability and delivery of care in underserved areas in participating practices, compared against matched 
controls. Emerging findings already suggest that context has a bearing on the extent to which practices are 
able to implement improvement practices. For example, smaller practices and practices in rural areas with 
provider shortages (e.g. specialists, dentists, mental health providers) and a lack of patient transportation 
both encountered barriers that practices could not always overcome. Preliminary outcome data suggest 
some variation across states in health-care utilisation and expenditure, and subsequent investigation will 
examine whether or not differences at the state, practice and programme levels can account for this. 
This work highlights how qualitative evidence produced as part of a mixed-methods evaluative study 
has the potential to be of huge interest to policy-makers, especially where it can be used as a formative 
mechanism of feedback to augment aspects of the context or intervention that are likely to improve 
implementation in ‘real time’.1,30,43
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This raises an important point, however, about the role of evaluators in feeding back information during 
the course of a study. Formative feedback loops may be most easily accommodated during the feasibility 
and pilot stages of evaluation, but researchers may assume a more passive role in studies that aim to 
establish effectiveness under real-world conditions to avoid interfering with implementation and changing 
how the intervention is delivered. Ambiguity about the information that can be expected to be fed back, 
when, to whom and in what level of detail can create tensions between the different stakeholder groups 
involved in a collaborative evaluative endeavour.43,44 It is, therefore, important to establish systems for 
communicating process information to key stakeholders at the outset of the study, to avoid perceptions of 
undue interference or that vital information was withheld.43 To this end Brewster et al.44 have developed a 
concordat or framework that is designed to be completed collaboratively between evaluation partners with 
the aim of setting expectations and resolving conflict as it arises during evaluation activity. The process of 
completing a joint mandate for working appears to be a constructive way of building local ownership and 
shared vision and emphasising the interdependency of all parties.44
Despite the evident value that qualitative evidence brings to the development and evaluation of complex 
interventions, some participants at the 2015 meeting in London felt that a bias towards favouring 
quantitative research was pervasive. A number of structural issues were identified by O’Cathain et al.36  
as driving the privileging of quantitative over qualitative methods, many of which resonated with 
the views of researchers participating in the meeting in London. They spoke of a historical climate of 
underfunding qualitative research, which O’Cathain et al.36 identified as a function in part of researchers 
either underestimating the cost of the research, or deliberately ‘squeezing’ the qualitative budget in an 
attempt to keep the costs of a bid down. At the same time, participants also described the tension created 
by the unrealistic expectations placed on qualitative research to answer all questions not addressed by 
quantitative methods,45 especially where qualitative research is undertaken retrospectively to explain 
intervention failure.
Conclusions
Context has remained understudied in comparison with interventions. An urgent task is that of deepening 
the conceptual underpinnings of the interactions between contexts and interventions and developing 
methods that allow for their exploration and evaluation. In understanding interventions as attempts 
to change their contexts, theorising about context could, for instance, become the starting point for 
approaches to intervention and evaluation design that are rooted in understanding of how the problem of 
interest is created and maintained in a particular community organisation or system.34 This kind of thinking 
may help to challenge the currently dominant assumption that the ‘best’ or the ‘ideal’ comes from the 
laboratory and gets progressively compromised in real-world applications, and instead force attention onto 
the need to avoid simplistic and etiolated accounts of what drives change.10
It is now clear that a description of the components of an intervention is not enough to ensure replication 
and scaling: what matters is likely to be the activation of mechanisms, even if precise activities undertaken 
to activate those mechanisms differs across contexts. Thinking in this way requires far more attention 
to the upfront specification and piloting of programme theories and to the characterisation of contexts. 
It also requires the subsequent updating of these in the light of process evaluations that are explicitly 
attentive to context.
Poorly reported interventions compound the problems of weak accounting for context. Recent efforts to 
promote improved reporting includes a checklist to prompt authors to describe interventions (including 
comparator interventions) in sufficient detail to allow their replication.11 Comprising 12 items, the Template 
for Intervention Description to Enable Replication (TIDieR) encourages authors to describe features 
including which interventions (or control conditions) are delivered to different groups (e.g. materials, 
procedures, provider, mode of delivery, setting, dose), as well to explain legitimate variants of the 
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intervention as well as unplanned adaptations that occur during the course of delivery. However, further 
work to support explicit descriptions of context is needed.
Such work should identify the benefits of mixed-method approaches to the study of context. Quantitative 
measures to explore structural features of context are essential, and more effort in helping to specify these 
measures and support data collection will be an important focus for the future. Qualitative methods are 
particularly suited to securing the theoretical basis of interventions, exploring the process by which an 
intervention or programme is delivered, identifying effects and how they are achieved, and characterising 
how interventions are adapted in response to contextual influences and contexts themselves are modified 
by interventions. However, when using mixed methods, researchers need to be sensitive to the fact that 
qualitative and quantitative research methods have grown out of different paradigms. The strengths of 
each method should not simply be used to bolster the weakness of the other, but instead should be used 
as complementary methods to study different phenomena related to the same question.46,47
Deepening understanding of the contextual factors that influence the delivery and function of 
complex interventions will require new norms for the conduct of evaluations of complex interventions. 
Gathering the rich and varied multimethod data needed to conduct a high-quality evaluation involves 
close collaboration with intervention developers and implementers. The different goals, perspectives, 
expectations, priorities and interests, professional languages and norms of practice of these groups may 
lead to tensions that need to be acknowledged and managed from the outset.
For the future, researchers and funders should be encouraged to think in terms of mixed-methods 
studies where qualitative and quantitative methods are seen as complementary methods, and to expend 
greater effort earlier in the development and evaluation process to optimise interventions, identify 
causal mechanisms and characterise contextual influences. Realisation of these ideas will require funder 
commitments to adequately resource development work and process evaluations that run alongside trials 
and other types of outcomes-focused evaluations, more realistic expectations about the time frame for 
developing an intervention, and journals that are willing to publish the results of exploratory work.
Despite current challenges, there was a sense of an improving climate in which qualitative work was 
valued. O’Cathain et al.36 highlighted the explicit value placed on qualitative methods and mixed-methods 
studies in the MRC evaluation framework,1 and the inclusion of qualitative and mixed-methods researchers 
on research commissioning panels as key drivers of this positive shift. Participants in the London meeting 
proposed that current calls for examples of impact (by research councils, Research Excellence Framework, 
the National Institute for Health Research) should be used to further highlight the contribution of 
qualitative research and the value of mixed-methods studies.
Finally, it is clear that institutional features of the research landscape – including funding structures, 
publishing models, and the norms, values and practices of the researcher community and the users of 
evidence – need critical scrutiny in order that they support contextually sensitive research that is capable of 
determining if and how complex interventions have their desired effects on health and social care services 
and systems, and, ultimately, on the people who use them.
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ASPIRE Action to Support Practices Implementing Research Evidence
CLAHRC Collaboration for Leadership in Applied Health Research and Care
Abstract
As the field of implementation science comprises a range of different ontological and disciplinary 
orientations, there is not always consensus on the boundaries of the research agenda or the challenges 
faced. Explicit discussion about the terminology used in the field would be useful to clarify differences 
in perspective and conceptual foundations. There is a need to generate an in-depth understanding 
of intervention design and development by considering the role of theory, the influence of context 
and meaningful involvement of relevant end-users. Theory-driven, pragmatic evaluation designs are 
proposed as a solution to produce evidence of intervention effects, and the potential of ‘implementation 
laboratories’ is also discussed. A balance has to be sought, however, between rigidly controlled studies 
and adaptive evaluations that allow emergent changes to the intervention or the implementation process 
through timely feedback. Practical recommendations would support the development of the field in 
evaluating the implementation of evidence-based practice.
Scientific summary
Implementation science comprises a range of methodologies, frameworks and theories utilising a variety 
of assumptions and terminology. The challenges inherent within different approaches were debated in 
the session on ‘Interventions to disseminate and implement evidence-based practice’ and have been 
summarised here.
Participants at the London meeting in 2015, described in the Introduction to this volume, debated the 
need for an overarching definition to establish the scope of implementation science as a field of enquiry. 
One definition suggested implementation science as encompassing the ‘study of theories, process, models 
and methods of implementing evidence-based practice’. There was also discussion on a more strategic 
function of the term as a ‘boundary object’ to communicate different meanings across disciplines and 
practice communities. Differences between complicated and complex interventions were particularly 
highlighted, acknowledging the role of complexity, non-linearity and unpredictability.
Discussions at the meeting also focused on the importance of clearly defining the problem being 
addressed, in order to design rigorous evaluations that ask the right questions while maximising 
implementation pragmatism. The relevance of a ‘pragmatic’ approach was deemed necessary in terms of 
both intervention design and implementation.
The role of theory-based intervention design and development was extensively considered. There was 
consensus on the significant challenges around how theory becomes applied, when and to what end. 
It was argued that using conceptually transferable mechanisms to explain interventions and how these 
might work differently in different contexts and across time could improve transferability, adaptation and 
scale-up.
Participants at the meeting further debated the need for providing timely feedback and ‘good enough’ 
evidence on the effect of interventions in practice. Although, on the one hand, the adoption of more 
iterative, adaptive and incremental designs may enable the incorporation of formative evaluation and 
feedback, this could also limit the power of studies designed on the basis of statistically measured effects.
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The importance of paying attention to context was mentioned throughout the session, along with 
consideration of the ontological and epistemological assumptions that underlie different notions of how 
context influences intervention design and implementation. Other topics included the need to tailor user 
engagement to the problem at hand to ensure relevance, and understanding the role of researchers at the 
intersection of academia and clinical practice.
Consistent messages were identified at the London meeting about the need for a theory-driven 
understanding of intervention design, implementation and evaluation. Practical recommendations about 
how and when to use the range of evaluation options available would further support the development of 
the field and support health service improvement.
Background
Debates on challenges for the implementation and dissemination of evidence-based practice have been 
inherently fragmented within different fields and particular areas of expertise. The increasing emphasis 
on implementation, through both the Medical Research Council framework for complex interventions1 
and the more recent guidance on process evaluation,2 has been accompanied by a rapid and broad 
development of a range of approaches, frameworks and theories utilising a variety of assumptions and 
terminology. Although there are some helpful reviews of the area,3,4 there are few widely accepted 
approaches to implementing evidence-based practice and evaluating implementation. This lack of 
clarity has proven a barrier to considering the bigger picture of intervention design, implementation, 
development and evaluation in a comprehensive manner. It has also hindered the development of 
recommendations that recognise the diverse interests of health-care and implementation communities, 
while being directly relevant to researchers and policy-makers.
This essay presents a summary of the presentations and discussions from the session on implementing and 
disseminating evidence-based practice that took place at the meeting in London in 2015 described in the 
Introduction to this volume (referred to below as the London meeting). Key themes include delineating 
the scope of implementation science as a field of enquiry and conceptualising what constitutes complex 
interventions in this context; designing rigorous evaluations that ask the right questions while maximising 
pragmatism of implementation in the real world of practice; using theory-based intervention design and 
development methodologies; providing timely and appropriate feedback; adequately studying context 
and engaging in user involvement; and understanding the challenges of scaling up implementation 
interventions and their evaluation. Participants also reflected on the role of researchers in implementation.
Terminology and definitions
What is implementation science?
A key area of contention at the London meeting concerned the need (or otherwise) for an overarching 
definition of implementation science to clarify the subject matter of the field. One of the participants 
argued that a strict or constraining definition might not serve a useful purpose. Instead, it was suggested 
that a certain level of flexibility in the way ‘implementation science’ is understood could contribute to the 
term acting as a ‘boundary object’5 between different communities of research and practice. This flexibility 
would allow an organising vision to be developed which could potentially pull people together in the 
direction of a shared understanding.
Attempts were made to combine different views, with the proposal that implementation science be 
defined as the ‘study of theories, process, models and methods of implementing evidence-based practice’. 
Apart from considering the effectiveness of interventions in terms of clinical outcomes, the aim of 
implementation science would be to research approaches and methods for closing the gap between what 
‘we think we know’ from evidence, and what is routinely practised. It was acknowledged that the subject 
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matter of implementation science is multifaceted, ranging from the introduction, integration, adaptation 
and sustainability of innovations, to user engagement, sense-making and division of labour. Intended 
and unintended consequences of adoption and adaptation would need to be considered in a recursive 
relationship with intervention design (telecare was mentioned as an illustrative example).
The discussion on terminology at the London meeting extended to consider differences between terms 
such as implementation and improvement science. It was argued, however, that an extensive discussion 
on terminology might be esoterically serving the interests of scientists/academics, rather than solving 
key underlying issues and being of direct relevance to those trying to evaluate how best to close the 
gap between evidence and practice and to those implementing improvement projects ‘on the ground’. 
Countering that, it might be important to clarify terminology in order to generate a better understanding 
of epistemological and ontological underpinnings. It was also deemed necessary to develop a common 
language to engage clinicians. The word ‘science’ was considered useful in establishing credibility and 
signifying the authority required for the field to be recognised in the medical world. However, it can also 
be argued that the term implementation ‘research’ might better signify the substance and mission of this 
area, as it does not imply that a new discipline is created. The group concluded that it would be useful 
if people at least explained the terms they are using, especially if coming from different disciplines and 
ontological positions.
One of the presentations at the meeting further elaborated on the subject matter of implementation 
science, by reflecting on different conceptualisations of the ‘gap’ between evidence and practice. Drawing 
on Best and Holmes,6 three approaches were discussed: linear (i.e. knowledge transfer), relationship 
(i.e. partnerships and coproduction) and system models (i.e. implementation being one component of 
how an organisation develops/changes). By conceptualising the gap in different ways, the evaluations of 
interventions are built on different underlying epistemologies and assumptions, and differing relationships 
with stakeholders. This underpinning frame of reference should be taken in account when evaluating 
interventions to implement and disseminate evidence-based practice.
What do we mean by complex interventions?
The term ‘complex interventions’ was another area of contention at the meeting, primarily around 
conceptual clarity and consistency of use. There was a range of views about the term, with some favouring 
more ‘interrogation’ of its meaning, while others provided a more definite picture of what complex 
interventions comprise. Reference was made to a presentation on randomised controlled trials earlier in 
the day that defined interventions (1) as complicated to place emphasis on the internal variability of the 
task (e.g. building a car); and (2) as complex to encapsulate their relationship and variable interactions with 
context (e.g. raising a child is complex because of the uncertainty and unpredictability of social behaviour). 
These issues are picked up in a number of other essays emerging from the meeting and appearing in this 
volume (see Essays 2, 3, 6 and 7).
The role of complexity, non-linearity and unpredictability was particularly highlighted and many 
acknowledged the need for a more in-depth understanding of change mechanisms, or underlying theories 
of change, when interventions have fuzzy boundaries and their purpose is not clearly defined. This has 
implications for the methodologies used to study implementation. One of the participants at the meeting 
also noted how complexity emerges when spreading change that does not directly fit with existing 
culture. Different levels of complexity were illustrated by discussing the example of shared care between 
patients and health professionals as an intervention where multiple feedback loops and power boundaries 
might lead to variable outcomes. By contrast, clinical interventions, such as changing the boundaries for 
reporting abnormality in liver function tests, were deemed to be less complex as their rationale would be 
less challenging for local health-care cultures.
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Intervention design and development
Many of the topics discussed referred to the need for a clear definition of the problem being addressed, 
the role of theory and the relevance of a ‘pragmatic’ approach in terms of both intervention design 
and implementation.
Asking the right question and defining the ‘problem’
One of the presentations suggested that intervention design has been one of the weakest elements in 
implementation science over the last 30 years. Intervention design often happens without consulting 
previous literature and theory, in what has been characterised as ‘an expensive version of trial-and-error’.7,8
Before deciding on the optimal design, participants agreed that it was important to fully define the 
implementation challenge with enough specificity, along with understanding the determinants and 
barriers to implementing interventions and policies in practice. Specifying the right question should be an 
interdisciplinary process carried out in conjunction with those implementing the intervention. The right 
design and appropriate methods would follow from the specification of the question. Discussions also 
acknowledged a need for finding a middle-ground between resource-intensive interventions that are 
difficult to implement in practice and ‘light’ interventions that have little potential for making a difference. 
This highlights how implementation research and implementation practice are not always viewed as 
separate, but can be inherently interconnected.
Prospective use of theory was deemed important to identify targets for interventions. However, despite 
a significant pool of theoretical knowledge available to inform intervention design, how theory becomes 
applied, when and to what end remains a challenge. The groups at the meeting discussed the importance 
of establishing what the problem is first (what we need to know) and then looking at which theories might 
be useful, rather than pre-determining what theory to use. One of the speakers argued for an explicit 
process of developing interventions, based on an understanding of the determinants of the ‘problem’ and 
the perceived mechanism of action of the proposed intervention, as well as logistics and practicalities. 
Although, pragmatically, implementation researchers are not always involved in prospectively embedding 
theory in intervention design – for example, where the intervention has been developed by a third party 
such as a health-care organisation – evaluations can still adopt a theoretically informed approach to explain 
mechanisms of action.
‘Timely and good enough’ feedback
Another challenge highlighted was that of providing timely feedback about the effect of interventions and 
their influence on practice. In cases where intervention studies take years to complete, findings may have 
diminished relevance to the changing context of the health service. An increased focus on the adoption of 
more iterative, adaptive and incremental designs may enable the incorporation of formative evaluation and 
feedback, although the extent of modification of the intervention as a result of this type of feedback gives 
rise to additional issues about how to make sense of the modifications and their effects. Two examples of 
projects currently incorporating elements of formative development were given:
 z Translating Research in Elder Care (TREC) uses routine data from a minimum data set to provide 
feedback to care homes piloting interventions and studying the effects on performance  
(www.kusp.ualberta.ca/Research/ActiveProjects/TREC.aspx).
 z A chronic disease management project from the first round of the Greater Manchester Collaboration 
for Leadership in Applied Health Research and Care (CLAHRC), using Quality and Outcomes 
Framework information overlaid with a quality improvement intervention, Plan-Do-Study-Act 
methodology and facilitation, with data fed back on a monthly basis and benchmarked against other 
sites (http://clahrc-gm.nihr.ac.uk/our-work-2008–2013/chronic-kidney-disease/).
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Along with timeliness, the balance between formative and summative evaluation naturally raised questions 
about what is ‘good enough’ evidence for service and practice change, what constitutes ‘enough’ 
information and at what point would early findings be fed back constructively. It was argued that the 
potential of generating more implementable evidence at initial trial stage warrants further thought.9 
Discussions seemed to indicate a need for balancing ‘rigorous’ controlled studies with opportunities to 
design trials in a way that facilitates the emergence of findings throughout the process. Although  
stepped-wedge designs were mentioned as a possible methodology, the issues relating to changes in the 
intervention throughout the process would impact on the statistical power of this type of study, unless it 
was carefully designed with each step being a separate comparison.
The role of contextual influences was also deemed particularly important, given the need to deliver timely 
evidence to understand how to embed interventions in the real world. Data accessibility and quality were 
also considered as issues that might prove challenging in implementation research projects, along with  
the ability to extract data and using the appropriate analysis tools.
The need to build a cumulative science: the example of audit 
and feedback
Presentations at the London meeting discussed ways of maximising pragmatism in trials of implementation 
strategies, referring to audit and feedback (A&F) interventions as an area with a robust evidence base 
about likely effectiveness of commonly used strategies. The latest Cochrane systematic review of A&F 
interventions identified 140 randomised trials that, on average, improve care processes (median absolute 
improvement of +4%), but with a substantial variation in the observed effects (interquartile range of 
+0.5% to +16%) under specific circumstances or when delivered in certain ways.10 Metaregression 
identified some features associated with larger effects from A&F: gaining more information about 
the context and the nature of the targeted behaviour(s), adding co-interventions or considering the 
intervention content and delivery strategies.11 Further analysis identified that no new information on 
common effect modifiers is emerging from new trials,12 yet we still need to expand our understanding of 
how to optimally use A&F.
A pragmatic implementation trial: the ASPIRE example
Policy and practice need to be informed by rigorous evaluations of implementation strategies. As argued 
by one of the presentations, pragmatic randomised trials generally provide the most valid estimates 
of ‘real-world’ intervention effects. To judge the level of pragmatism in trials, the revised PRagmatic 
Explanatory Continuum Indicator Summary tool (PRECIS-2) proposes nine domains: eligibility criteria, 
recruitment, setting, organisation, flexibility (delivery), flexibility (adherence), follow-up, primary outcome 
and primary analysis.13 As an example meeting these criteria, ASPIRE (Action to Support Practices 
Implementing Research Evidence) is a National Institute for Health Research-funded programme 
aiming to develop and evaluate an adaptable implementation package targeting ‘high-impact’ 
clinical practice recommendations in primary care (http://medhealth.leeds.ac.uk/info/650/aspire/132/
what_is_the_aspire_programme).
Through a process of selecting guideline recommendations, analysing variations in adherence and 
identifying those with most scope for improvement, the ASPIRE programme involves primary care 
professionals and patients in developing implementation packages for each of four priorities. The effects 
of these implementation packages are currently being evaluated in two balanced incomplete block cluster 
randomised trials. In one trial, 80 practices are randomised to packages to either improve diabetes control 
or reduce risky prescribing. In the other, 64 practices are randomised to packages to either improve blood 
pressure control or increase the use of anticoagulation in atrial fibrillation.
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However, maximising pragmatism is necessary but insufficient by itself to build a cumulative science 
of implementation. Theory-guided approaches to both intervention development and evaluation offer 
advantages in terms of generalisability from using a common conceptual framework, the potential to 
understand mechanisms of action and the ability to predict consequences in other settings. The role of 
theory in the study of implementation is further elaborated in Using theory in implementation science.
Embedding evaluations within health-care systems: the example 
of ‘implementation laboratories’
‘Implementation laboratories’ were proposed as a way of utilising existing large-scale service 
implementation programmes to embed sequential randomised trials that would be testing different ways 
of delivering implementation interventions in head-to-head comparisons at scale. By being embedded 
in the health system, implementation laboratories may be useful in clarifying the roles of different 
stakeholders, creating buy-in and allowing service providers to sustainably develop priorities based 
on clinical need. This would create a synergistic relationship between clinicians and researchers: the 
intervention would be developed jointly by the two groups, as would be the interpretation of the results, 
while clinicians would deliver the intervention and collect data as part of their routine processes. By relying 
on existing structures, the actual cost of the research would be marginal.
Other benefits for a health system may include it becoming a learning organisation, demonstrable 
improvements in its quality improvement activities and linkages to academic experts. Implementation 
science may also benefit from the ability to test important (but potentially subtle) variations in the 
intervention that may be important effect modifiers. The development of multiple implementation 
laboratories addressing the same intervention would additionally provide the opportunity to establish 
a metalaboratory (i.e. a cross-laboratory steering group involving health system participants and 
internationally leading implementation researchers) to maximise learning (including planned replications 
and prospective meta-analysis). Examples of existing implementation laboratories include the Affinite 
programme with the NHS Blood and Transplant programme in the UK14 and the Ontario Health 
Implementation Laboratory in Canada.
The role of theory could inform which variations of the intervention should be tested, for example whether 
or not embedding action/coping plans leads to more effective A&F interventions (based on control theory), 
or whether or not A&F delivered by credible sources is more effective (drawing on social influence theory). 
However, variations such as mode of delivery, perceived credibility of source or presenter, frequency 
of feedback, comparator or level of aggregation would result in a significant number of head-to-head 
combinations of trials. Follow-up discussions questioned the feasibility of creating intervention laboratories 
for complicated or complex interventions and noted how theory could be used to identify the necessary 
elements for intervention design, rather than just guiding which combinations of trials are needed in the 
first place.15
Using theory in implementation science
As is strongly argued in other essays in this volume (particularly Essays 6 and 7), theory plays a pivotal 
role in evaluative methods. Theory-guided approaches to implementation research (rather than purely 
for intervention design) were considered important for generalisability. It was suggested that using 
conceptually transferable mechanisms to explain interventions and how these might work differently, 
in different contexts and across time, can improve transferability, adaptation and scale-up. Theory was 
deemed to offer a common language to explore and identify influences on practice, enhancing the 
transparency of intervention development and description.
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Which theories?
Phenomena studied by implementation science were deemed multifaceted and dynamic in a way that 
excludes universal explanations. Combining specific theories to understand different aspects of a problem 
was suggested as a potentially more productive approach (‘horses for courses’).
There is a range of different types of knowledge and theoretical perspectives (e.g. middle range, inductive 
vs. deductive, theory vs. frameworks) with a number of them being used in implementation research and 
a good summary provided by Nilsen.4 Examples mentioned included the Theoretical Domains Framework 
used prospectively in the Translation Research in a Dental Setting (TRiaDS) programme16 and in ASPIRE 
(http://medhealth.leeds.ac.uk/info/650/aspire/132/what_is_the_aspire_programme). Some suggested 
that increased learning could be gained from theories like diffusion of innovations, Normalisation Process 
Theory,17 the Promoting Action on Research Implementation in Health Services (PARIHS) framework,18 the 
Knowledge to Action framework19 and the Consolidated Framework for Implementation Research.20
Others distinguished between levels of analysis, proposing health and social psychology theories at a 
more micro level and health services research theories at an organisational level. The usefulness of realist 
methods and context–mechanism–outcome configurations was also debated. Participants conceded that 
research should be both problem-driven as well as theory-driven and identified a need to unpack the 
tensions between the two. They also recognised that theory use can be driven by fads which vary over 
time. Discussions concluded that the need to use more theory should be accompanied by using it in better 
ways, not just following the theory path for the sake of it.
The need for developing tools for tracking theoretical fidelity and the integrity of implementation 
interventions was highlighted. If we accept that interventions change through their enactment with 
context, then we need to find ways to ‘track implementation interventions’. There are a number of existing 
frameworks which can be used, including the conceptual framework for implementation fidelity21–24 with 
ongoing work to expand this described, which includes a learning loop that captures the adaptation 
processes evolving over time.
Engagement with context and research users
Several features of the context of implementation were discussed at the meeting, along with the role of 
and potential for engagement with research users.
Studying context
Increasing focus on theory-guided interventions in implementation science led to consideration of 
the role and influence of context in more depth. One of the presentations outlined different ways of 
paying attention to context, including natural experiments, such as the CLAHRCs and other relevant 
cases in the literature.25 It was also explained how realist methods can elucidate ‘what works for whom, 
how and in what context’, as part of implementing interventions which in themselves change as a 
result of being embedded in particular contexts (capturing generative causation). Examples of realist 
evaluations have been discussed in the literature,26 along with debates on how to do realist evaluation 
within an implementation context, how to identify specific mechanisms and how to demonstrate their 
interaction with context. The concept of realist trials was also introduced, accompanied by a note on the 
epistemological and ontological contradictions underlying this approach. This points to relevant debates 
in the literature that discuss whether randomised controlled trials based on positivist ontological and 
epistemological assumptions can be synergistically reconciled with a realist approach to context and 
complexity that draws attention to non-linearity, emergence, adaptation, path-dependence and human 
agency.27–29
One view of context was articulated as consisting of specific elements that need to be taken in account 
in each setting, such as environment characteristics that differ between, for example, an emergency 
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department and an inpatient ward. By identifying the six most common elements of the context or 
those that are more likely to have an impact, the ability to scale-up and transfer between contexts can 
be improved.
User engagement
The importance of user engagement was consistently mentioned, but at the same time it was 
acknowledged as one of the most challenging aspects of intervention design and implementation. 
While there was consensus on the importance of user involvement to create appropriately designed 
interventions, this did not always mean that these interventions would be more ‘implementable’. 
Participants recognised that there is no set recipe for engagement, but this needs to be tailored depending 
on the problem at hand to ensure relevance. For example, in some cases the end-user might be the 
patient; in others it might be the hospital Chief Executive Officer who needs to be engaged. Many 
conceded that the problem should be owned by the clinical community, with the researchers responsible 
for helping clinicians think through the situation, use appropriate theoretical lenses and contribute with 
external knowledge. However, the discussion appeared to be based on an unarticulated assumption 
that ‘researchers’ are not already clinicians themselves. Difficulties identified included involving the right 
people (e.g. which constituencies do people represent), especially those who are going to encounter the 
most barriers during implementation at different stages of the process (design, conduct and evaluation). 
Participants also recognised the importance of acknowledging the politics of user engagement, in terms of 
vested interests on the side of practitioners and academics that need to be negotiated and resolved.
Scaling up
The challenge of scaling up interventions was also mentioned, especially regarding how scale-up could be 
incorporated in evaluation methods and approaches to implementation science in order to improve the 
chances of successful spread. The role of theory building was again particularly highlighted in supporting 
implementation across different settings, thus enabling transferability of the intervention. Another aspect 
of this discussion was the tension between flexibility and standardisation of interventions: how to scale up 
and at the same time allow adaptation to local structures and increased ownership.
Experiences were described where a lack of understanding about prerequisites to implementation and 
scale-up had led to interventions having to be deconstructed retrospectively to understand the mechanisms 
of action. This was especially found to be a limitation when funders of projects decide to spread 
innovations without a clear understanding of whether or not these are ‘implementable’ before scale-up.
The role of researchers
Having identified challenges around providing timely and good enough evidence, discussions at the 
London meeting ensued on the role and responsibilities of researchers as implementation scientists. 
Participants debated whether or not implementation scientists could act as mediators or brokers 
responsible for translating research in different settings to ensure relevance between existing studies and 
the clinical world. It was also suggested that pressure from policy-makers to deliver change in ways that 
may seem unrealistic could be countered by sharing expertise on what has already been found to be 
ineffective or should be avoided.
Participants recognised, however, that career incentives in many areas of academia do not always overlap 
with health service priorities and dissemination in academic journals was deemed to have little impact 
on policy-making. Some also mentioned how they had encountered difficulties aligning implementation 
research studies with career paths driven by performance measures of traditional clinical academic 
disciplines. Overall, there was consensus about the fact that researchers working in the area have to 
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reconcile career incentives and structures that may often seem conflicting (high-impact, high-quality 
research and direct benefit to patients in practice).
Implications
This summary indicates the need for appropriate communication of the aims and objectives of 
implementation science to a wider audience. As the field is constituted through the contribution of 
different ontological and disciplinary perspectives, consensus on the boundaries of the research agenda 
for implementation scientists might be useful, with some agreement on terminology and conceptual 
foundations, such as the meaning of complex interventions.
Consistent messages were identified throughout the session at the London meeting about the need for 
a clear understanding of intervention design and development on the basis of engaging end users and 
adequately considering contextual influences. Theory-driven, pragmatic evaluation designs were suggested 
as suitable to producing evidence of intervention effects, along with a consideration of the potential of 
implementation laboratories. A balance was sought between evaluations that allow emergence through 
timely feedback and more rigidly controlled studies where the ‘intervention’ itself does not change 
(adaptive vs. fixed designs). Persisting limitations with current application of theory remain a challenge 
towards developing transferable concepts or building what was described as ‘cumulative science’.
Practical recommendations that can be meaningfully adopted across research and implementation 
communities would support the future development of the field in implementing evidence-based practice 
to improve patient care and outcomes in health-care settings. Implementation scientists operating at the 
intersection of academic enquiry and practical application may need to be better equipped and supported 
to respond to what may often be viewed as conflicting priorities.
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Generalisable insights
This collection of essays offers insights from world-leading researchers on important methodological issues 
in health care and public health evaluation. The authors have stimulated debate as to how these issues 
might be addressed and proposed thoughtful approaches to tackle often competing priorities such as 
rigour and the need for prompt results. In doing so, the case for plurality in methodological approaches 
and for sustained investment in new and diverse methods is well made. Other commonly occurring themes 
can be drawn out from these essays.
For example, authors provide wise counsel about the need to engage early and often with policy-makers, 
practitioners, funders and interdisciplinary researchers about potential research. Discussions should be 
transparent and wide ranging to ensure that common understandings are achieved about perceived 
objectives, the identification of relevant and feasible outcomes and the maintenance of appropriate 
boundaries between interested parties. Such discussions will often shift the focus from the traditional 
binary question of effectiveness towards a broader understanding of mechanisms, processes and 
outcomes. They might, for example, lead to a greater focus on understanding how to manage major 
service change, or the interplay between system change, context and time. They can lead to rich and 
valuable discussions about outcomes of relevance to stakeholders with differing perspectives, priorities 
and timelines.
The role of theory and of models to predict and explain mechanisms of change was analysed. Any 
tendency to regard specific theories as inviolable was challenged. However, the value of critically applying 
and developing theories and models, for the evaluation both of intervention quality and of implementation, 
is endorsed.
There is also consensus for the use of mixed and multiple methods. The importance of integrating 
observational research with experimental methods is now recognised. Methods to combine quantitative 
and qualitative research designs in evidence synthesis are rapidly improving. However, authors went further 
and provided exemplars of uniting established methods with innovative techniques to enhance the quality 
and utility of research, such as placebo tests alongside randomised trials to tackle external validity.
These essays include a clear call to co-ordinate analyses of macro-, meso- and micro-level determinants of 
system change. Research conclusions are incomplete if we do not take account of the interplay between 
political, structural, economic and organisational factors, with the sociopsychological determinants of 
behaviour in groups and individuals. Referred to as ‘context’, macro- and meso-level factors are too often 
dismissed as unique features, too intangible to define and therefore immovable barriers to the successful 
transplantation of service innovation to other settings. This is unhelpful; instead, the key is to identify 
generalisable elements of beneficial processes and outcomes by exploring the mutual influence of the 
intervention with the various, distinctly defined contextual components.
Such extensive analyses require access to health and care data from multiple sources and sectors. This 
raises issues concerning the urgent need to improve the quality and comprehensiveness of routine data, 
particularly from non-acute settings and with regard to clinical information such as comorbidity and 
severity. Although data security is paramount, the lack of progress in giving researchers prompt and 
appropriate access to these data is placing a genuine strain on the ability to conduct research. The problem 
is well known and solutions have been exhaustively worked through. Decisive leadership from key  
policy-makers is now essential to expedite the course of action required.
Finally, we are urged to be ambitious and to innovate by drawing from other disciplines. Applied health 
research is beginning to benefit from collaborations with computer scientists, spatial analysts and 
mathematicians. Examples cited include the application of machine learning to code narrative data, 
computer adaptive testing to reduce response bias and interactive multimedia techniques to examine 
clinical decision-making. However, it is clear that our colleagues in other fields are making rapid progress 
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in areas of immense value to our research and that our response so far has been spasmodic. We must 
investigate and embrace opportunities to make methodological leaps which could transform our ability to 
deliver comprehensive, rigorous and timely evaluations of service change.
What we missed and a way forward
We know that we have missed important topics. We have not, for example, explored the application of 
artificial intelligence to modelling and analysis, and have barely mentioned relational methods (such as 
social and organisational network analysis) or qualitative methods such as participatory research and action 
ethnography. More needs to be said about how best to develop the vital contributions from patients, the 
public and policy-makers.
No doubt readers will identify other opportunities overlooked which will broaden the debate. However, 
we never intended to present an exhaustive account of the field. Instead, we hope that these essays 
reinvigorate dynamic engagement in a fast-moving area by providing authoritative guidance on the 
best ways forward. They have put paid to any notion that it is necessary to forego excellence in order to 
deliver prompt results. The opportunity costs of ‘quick and dirty’ research can be profound. This collection 
has, therefore, maintained a keen eye on the need to achieve accurate, comprehensive, relevant, timely 
and generalisable results. We hope that this collection will stimulate further responses and to maintain 
momentum in developing the field for the benefit of patients and the public.
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